RAS4ReisaSperlingReisa Anne Sperling, M.D.42.33710500000000-71.1023170000000020632Sperling, ReisaAnne617/732-8060Professor of Neurologycatalyst:eCommonsLogineCommons Loginprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofvivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 10455203Authorship 10501952Authorship 1046950729425267Rabin JS, Perea RD, Buckley RF, Neal TE, Buckner RL, Johnson KA, Sperling RA, Hedden TCerebral cortex (New York, N.Y. : 1991)Global White Matter Diffusion Characteristics Predict Longitudinal Cognitive Change Independently of Amyloid Status in Clinically Normal Older Adults. Cereb Cortex. 2019 03 01; 29(3):1251-1262.Cereb Cortex2019-03-01T00:00:002019Global White Matter Diffusion Characteristics Predict Longitudinal Cognitive Change Independently of Amyloid Status in Clinically Normal Older Adults.29429971Liu E, Wang D, Sperling R, Salloway S, Fox NC, Blennow K, Scheltens P, Schmidt ME, Streffer J, Novak G, Einstein S, Booth K, Ketter N, Brashear HRNeurologyBiomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab. Neurology. 2018 03 06; 90(10):e877-e886.Neurology2018-02-02T00:00:002018Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab.29435558Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, Johnson KAJAMA neurologyAssociation Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. JAMA Neurol. 2018 05 01; 75(5):548-556.JAMA Neurol2018-05-01T00:00:002018Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.11559958Sperling RA, Bates JF, Cocchiarella AJ, Schacter DL, Rosen BR, Albert MSHuman brain mappingEncoding novel face-name associations: a functional MRI study. Hum Brain Mapp. 2001 Nov; 14(3):129-39.Hum Brain Mapp2001-11-01T00:00:002001Encoding novel face-name associations: a functional MRI study.Authorship 10512112Authorship 1052327Authorship 10530643Authorship 105223930Authorship 105177041873134Berrier J, Sperling R, Preisinger J, Evans V, Mason J, Walther VAIDS education and prevention : official publication of the International Society for AIDS EducationHIV/AIDS education in a prenatal clinic: an assessment. AIDS Educ Prev. 1991; 3(2):100-17.AIDS Educ Prev1991-01-01T00:00:001991HIV/AIDS education in a prenatal clinic: an assessment.28611871Haliburton JR, Kim SC, Clark IC, Sperling RA, Weitz DA, Abate ARBiomicrofluidicsEfficient extraction of oil from droplet microfluidic emulsions. Biomicrofluidics. 2017 May; 11(3):034111.Biomicrofluidics2017-05-19T00:00:002017Efficient extraction of oil from droplet microfluidic emulsions.1873135Mason J, Preisinger J, Sperling R, Walther V, Berrier J, Evans VAIDS education and prevention : official publication of the International Society for AIDS EducationIncorporating HIV education and counseling into routine prenatal care: a program model. AIDS Educ Prev. 1991; 3(2):118-23.AIDS Educ Prev1991-01-01T00:00:001991Incorporating HIV education and counseling into routine prenatal care: a program model.29389750Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JPAnesthesiology18F-florbetapir Positron Emission Tomography-determined Cerebral ß-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. 2018 04; 128(4):728-744.Anesthesiology2018-04-01T00:00:00201818F-florbetapir Positron Emission Tomography-determined Cerebral ß-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.29522171Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, Laske C, Koeppe RA, Galasko DR, Xiong C, Masters CL, Schofield PR, Kinnunen KM, Salloway S, Martins RN, McDade E, Cairns NJ, Buckles VD, Morris JC, Bateman R, Sperling RABrain : a journal of neurologyPreferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain. 2018 05 01; 141(5):1486-1500.Brain2018-05-01T00:00:002018Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.Authorship 1055706429592889Ge T, Sabuncu MR, Smoller JW, Sperling RA, Mormino ECNeurologyDissociable influences of APOE e4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. 2018 05 01; 90(18):e1605-e1612.Neurology2018-03-28T00:00:002018Dissociable influences of APOE e4 and polygenic risk of AD dementia on amyloid and cognition.Authorship 10562971029614677Lee CM, Jacobs HIL, Marquié M, Becker JA, Andrea NV, Jin DS, Schultz AP, Frosch MP, Gómez-Isla T, Sperling RA, Johnson KAJournal of Alzheimer's disease : JAD18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. J Alzheimers Dis. 2018; 62(4):1691-1702.J Alzheimers Dis2018-01-01T00:00:00201818F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.17135807Salmon DP, Cummings JL, Jin S, Sano M, Sperling RA, Zamrini E, Petersen RC, Edland SD, Thal LJ, Ferris SHAlzheimer disease and associated disordersADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S139-46.Alzheimer Dis Assoc Disord2006-10-01T00:00:002006ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials.17893294Diamond EL, Miller S, Dickerson BC, Atri A, DePeau K, Fenstermacher E, Pihlajamäki M, Celone K, Salisbury S, Gregas M, Rentz D, Sperling RANeurologyRelationship of fMRI activation to clinical trial memory measures in Alzheimer disease. Neurology. 2007 Sep 25; 69(13):1331-41.Neurology2007-09-25T00:00:002007Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.12897209Monsonego A, Zota V, Karni A, Krieger JI, Bar-Or A, Bitan G, Budson AE, Sperling R, Selkoe DJ, Weiner HLThe Journal of clinical investigationIncreased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest. 2003 Aug; 112(3):415-22.J Clin Invest2003-08-01T00:00:002003Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.Authorship 10579032029653606Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling RAlzheimer's & dementia : the journal of the Alzheimer's AssociationNIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018 04; 14(4):535-562.Alzheimers Dement2018-04-01T00:00:002018NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.16087905Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RANeurologyIncreased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005 Aug 09; 65(3):404-11.Neurology2005-08-09T00:00:002005Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD.19571734Pihlajamäki M, O' Keefe K, Bertram L, Tanzi RE, Dickerson BC, Blacker D, Albert MS, Sperling RAAlzheimer disease and associated disordersEvidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis Assoc Disord. 2010 Jan-Mar; 24(1):28-36.Alzheimer Dis Assoc Disord2010-01-01T00:00:002010Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease.19640477Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KANeuronAmyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009 Jul 30; 63(2):178-88.Neuron2009-07-30T00:00:002009Amyloid deposition is associated with impaired default network function in older persons without dementia.20069392Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KANeuromolecular medicineFunctional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med. 2010 Mar; 12(1):27-43.Neuromolecular Med2010-03-01T00:00:002010Functional alterations in memory networks in early Alzheimer's disease.21575871Marshall GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RAAlzheimer's & dementia : the journal of the Alzheimer's AssociationExecutive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):300-8.Alzheimers Dement2011-05-01T00:00:002011Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease.22343285Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Weiner M, Aisen P, Petersen R, Jack CR, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson HProceedings of the National Academy of Sciences of the United States of AmericaAssociation of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90.Proc Natl Acad Sci U S A2012-02-16T00:00:002012Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Authorship 10664192229742105Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, F?rster S, Schofield PR, Sperling RA, Johnson KA, Chhatwal JP, Salloway S, Correia S, Jack CR, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AMPloS oneWhite matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. PLoS One. 2018; 13(5):e0195838.PLoS One2018-05-09T00:00:002018White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.Authorship 106745211Authorship 106775717Authorship 10680971629799986Rabin JS, Schultz AP, Hedden T, Viswanathan A, Marshall GA, Kilpatrick E, Klein H, Buckley RF, Yang HS, Properzi M, Rao V, Kirn DR, Papp KV, Rentz DM, Johnson KA, Sperling RA, Chhatwal JPJAMA neurologyInteractive Associations of Vascular Risk and ß-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study. JAMA Neurol. 2018 09 01; 75(9):1124-1131.JAMA Neurol2018-09-01T00:00:002018Interactive Associations of Vascular Risk and ß-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.29780861Orlovsky I, Huijbers W, Hanseeuw BJ, Mormino EC, Hedden T, Buckley RF, LaPoint M, Rabin JS, Rentz DM, Johnson KA, Sperling RA, Papp KVAlzheimer's & dementia (Amsterdam, Netherlands)The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. Alzheimers Dement (Amst). 2018; 10:121-129.Alzheimers Dement (Amst)2017-11-23T00:00:002017The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults.29792874Hanseeuw BJ, Betensky RA, Mormino EC, Schultz AP, Sepulcre J, Becker JA, Jacobs HIL, Buckley RF, LaPoint MR, Vannini P, Donovan NJ, Chhatwal JP, Marshall GA, Papp KV, Amariglio RE, Rentz DM, Sperling RA, Johnson KAAlzheimer's & dementia : the journal of the Alzheimer's AssociationPET staging of amyloidosis using striatum. Alzheimers Dement. 2018 10; 14(10):1281-1292.Alzheimers Dement2018-05-21T00:00:002018PET staging of amyloidosis using striatum.21161449Pihlajamäki M, O'Keefe K, O'Brien J, Blacker D, Sperling RABrain imaging and behaviorFailure of repetition suppression and memory encoding in aging and Alzheimer's disease. Brain Imaging Behav. 2011 Mar; 5(1):36-44.Brain Imaging Behav2011-03-01T00:00:002011Failure of repetition suppression and memory encoding in aging and Alzheimer's disease.21211070Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong CAlzheimer's research & therapyAutosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther. 2011 Jan 06; 3(1):1.Alzheimers Res Ther2011-01-06T00:00:002011Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.Authorship 10701112529803541Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, Maruff P, Donohue MC, Rentz DM, Kirn D, Hedden T, Chhatwal J, Schultz AP, Johnson KA, Villemagne VL, Sperling RAAlzheimer's & dementia : the journal of the Alzheimer's AssociationSex, amyloid, and APOE e4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimers Dement. 2018 09; 14(9):1193-1203.Alzheimers Dement2018-05-24T00:00:002018Sex, amyloid, and APOE e4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.21778725Marshall GA, Olson LE, Frey MT, Maye J, Becker JA, Rentz DM, Sperling RA, Johnson KADementia and geriatric cognitive disordersInstrumental activities of daily living impairment is associated with increased amyloid burden. Dement Geriatr Cogn Disord. 2011; 31(6):443-50.Dement Geriatr Cogn Disord2011-07-20T00:00:002011Instrumental activities of daily living impairment is associated with increased amyloid burden.21919893Amariglio RE, Townsend MK, Grodstein F, Sperling RA, Rentz DMJournal of the American Geriatrics SocietySpecific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc. 2011 Sep; 59(9):1612-7.J Am Geriatr Soc2011-09-15T00:00:002011Specific subjective memory complaints in older persons may indicate poor cognitive function.23137948Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, Fagan AM, Shah AR, Alvarez S, Arbelaez A, Giraldo M, Acosta-Baena N, Sperling RA, Dickerson B, Stern CE, Tirado V, Munoz C, Reiman RA, Huentelman MJ, Alexander GE, Langbaum JB, Kosik KS, Tariot PN, Lopera FThe Lancet. NeurologyBrain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol. 2012 Dec; 11(12):1048-56.Lancet Neurol2012-11-06T00:00:002012Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.Authorship 1071276829866588Munro CE, Donovan NJ, Amariglio RE, Papp KV, Marshall GA, Rentz DM, Pascual-Leone A, Sperling RA, Locascio JJ, Vannini PThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric PsychiatryThe Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia. Am J Geriatr Psychiatry. 2018 08; 26(8):896-904.Am J Geriatr Psychiatry2018-05-03T00:00:002018The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia.17389305Chappell AS, Gonzales C, Williams J, Witte MM, Mohs RC, Sperling RNeurologyAMPA potentiator treatment of cognitive deficits in Alzheimer disease. Neurology. 2007 Mar 27; 68(13):1008-12.Neurology2007-03-27T00:00:002007AMPA potentiator treatment of cognitive deficits in Alzheimer disease.Authorship 1073630229914022Salloway SP, Sperling R, Fox NC, Sabbagh MN, Honig LS, Porsteinsson AP, Rofael H, Ketter N, Wang D, Liu E, Carr S, Black RS, Brashear HRJournal of Alzheimer's disease : JADLong-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study. J Alzheimers Dis. 2018; 64(3):689-707.J Alzheimers Dis2018-01-01T00:00:002018Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.22940426Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, Maye JE, Gidicsin C, Pepin LC, Sperling RA, Johnson KA, Rentz DMNeuropsychologiaSubjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia. 2012 Oct; 50(12):2880-2886.Neuropsychologia2012-08-23T00:00:002012Subjective cognitive complaints and amyloid burden in cognitively normal older individuals.Authorship 1077778729972209Aisen PS, Siemers E, Michelson D, Salloway S, Sampaio C, Carrillo MC, Sperling R, Doody R, Scheltens P, Bateman R, Weiner M, Vellas BThe journal of prevention of Alzheimer's diseaseWhat Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force. J Prev Alzheimers Dis. 2018; 5(3):171-174.J Prev Alzheimers Dis2018-01-01T00:00:002018What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force.14716733Lange N, Lake S, Sperling R, Brown J, Routledge C, Albert M, Heckers SStatistics in medicineTwo macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research. Stat Med. 2004 Jan 30; 23(2):327-50.Stat Med2004-01-30T00:00:002004Two macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research.17234822Alsop DC, Fearing MA, Johnson K, Sperling R, Fong TG, Inouye SKThe journals of gerontology. Series A, Biological sciences and medical sciencesThe role of neuroimaging in elucidating delirium pathophysiology. J Gerontol A Biol Sci Med Sci. 2006 Dec; 61(12):1287-93.J Gerontol A Biol Sci Med Sci2006-12-01T00:00:002006The role of neuroimaging in elucidating delirium pathophysiology.17846109Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BCJournal of neurology, neurosurgery, and psychiatryHippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry. 2008 Jun; 79(6):630-5.J Neurol Neurosurg Psychiatry2007-09-10T00:00:002007Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline.Authorship 1080729329986165Zott B, Busche MA, Sperling RA, Konnerth AAnnual review of neuroscienceWhat Happens with the Circuit in Alzheimer's Disease in Mice and Humans? Annu Rev Neurosci. 2018 07 08; 41:277-297.Annu Rev Neurosci2018-07-08T00:00:002018What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?21784348Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJAlzheimer's & dementia : the journal of the Alzheimer's AssociationAmyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 2011 Jul; 7(4):367-85.Alzheimers Dement2011-07-01T00:00:002011Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.Authorship 10839971330040714Guzmán-Vélez E, Jaimes S, Aguirre-Acevedo DC, Norton DJ, Papp KV, Amariglio R, Rentz D, Baena A, Henao E, Tirado V, Muñoz C, Giraldo M, Sperling RA, Lopera F, Quiroz YTJournal of Alzheimer's disease : JADA Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease. J Alzheimers Dis. 2018; 65(1):107-115.J Alzheimers Dis2018-01-01T00:00:002018A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.Authorship 1087331630093249Yang HS, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA, De Jager PLThe Lancet. NeurologyEvaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE e4 haplotype status: a community-based cohort study. Lancet Neurol. 2018 09; 17(9):773-781.Lancet Neurol2018-08-06T00:00:002018Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE e4 haplotype status: a community-based cohort study.Authorship 1088392730116029Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, Sperling RA, Donovan NJMolecular psychiatryAssociation of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry. 2020 10; 25(10):2599-2607.Mol Psychiatry2018-08-16T00:00:002018Association of anxiety with subcortical amyloidosis in cognitively normal older adults.20479234Wolk DA, Dickerson BCProceedings of the National Academy of Sciences of the United States of AmericaApolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010 Jun 01; 107(22):10256-61.Proc Natl Acad Sci U S A2010-05-17T00:00:002010Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.21228298Van Dijk KR, Sperling RANeurologyDefaulting on the default network: increased risk for dementia. Neurology. 2011 Feb 08; 76(6):498-500.Neurology2011-01-12T00:00:002011Defaulting on the default network: increased risk for dementia.21555634Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RAArchives of neurologyTest-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials. Arch Neurol. 2011 May; 68(5):599-606.Arch Neurol2011-05-01T00:00:002011Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.22784036Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JCThe New England journal of medicineClinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012 Aug 30; 367(9):795-804.N Engl J Med2012-07-11T00:00:002012Clinical and biomarker changes in dominantly inherited Alzheimer's disease.Authorship 1091055830192928Chhatwal JP, Schultz AP, Hedden T, Boot BP, Wigman S, Rentz D, Johnson KA, Sperling RACerebral cortex (New York, N.Y. : 1991)Anticholinergic Amnesia is Mediated by Alterations in Human Network Connectivity Architecture. Cereb Cortex. 2019 07 22; 29(8):3445-3456.Cereb Cortex2019-07-22T00:00:002019Anticholinergic Amnesia is Mediated by Alterations in Human Network Connectivity Architecture.21334099Vannini P, Hedden T, Becker JA, Sullivan C, Putcha D, Rentz D, Johnson KA, Sperling RANeurobiology of agingAge and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiol Aging. 2012 Jul; 33(7):1237-52.Neurobiol Aging2011-02-18T00:00:002011Age and amyloid-related alterations in default network habituation to stimulus repetition.18632739Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RLCerebral cortex (New York, N.Y. : 1991)The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009 Mar; 19(3):497-510.Cereb Cortex2008-07-16T00:00:002008The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.19290745Chua EF, Schacter DL, Sperling RAPsychology and agingNeural basis for recognition confidence in younger and older adults. Psychol Aging. 2009 Mar; 24(1):139-53.Psychol Aging2009-03-01T00:00:002009Neural basis for recognition confidence in younger and older adults.Authorship 10935166Authorship 10942822Authorship 10945363Authorship 10926224Authorship 109287722Authorship 10931084Authorship 10945332Authorship 10941073Authorship 1094542730217935McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, Berman SB, Klunk W, Noble J, Ringman J, Ghetti B, Farlow M, Sperling RA, Chhatwal J, Salloway S, Graff-Radford NR, Schofield PR, Masters C, Rossor MN, Fox NC, Levin J, Jucker M, Bateman RJNeurologyLongitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. 2018 10 02; 91(14):e1295-e1306.Neurology2018-09-14T00:00:002018Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.18476108Jennings TS, Dottino P, Sperling R, Beddoe AMInfectious diseases in obstetrics and gynecologyScreening for human immunodeficiency virus in inner city females with abnormal cervical cytology. Infect Dis Obstet Gynecol. 1996; 4(5):281-6.Infect Dis Obstet Gynecol1996-01-01T00:00:001996Screening for human immunodeficiency virus in inner city females with abnormal cervical cytology.8904402Hsuih TC, Park YN, Zaretsky C, Wu F, Tyagi S, Kramer FR, Sperling R, Zhang DYJournal of clinical microbiologyNovel, ligation-dependent PCR assay for detection of hepatitis C in serum. J Clin Microbiol. 1996 Mar; 34(3):501-7.J Clin Microbiol1996-03-01T00:00:001996Novel, ligation-dependent PCR assay for detection of hepatitis C in serum.30224467Rieckmann A, Johnson KA, Sperling RA, Buckner RL, Hedden TProceedings of the National Academy of Sciences of the United States of AmericaDedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging. Proc Natl Acad Sci U S A. 2018 10 02; 115(40):10160-10165.Proc Natl Acad Sci U S A2018-09-17T00:00:002018Dedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging.7616980Rollinson D, Brodman ML, Friedman F, Sperling RThe Mount Sinai journal of medicine, New YorkTransvaginal small-bowel evisceration: a case report. Mt Sinai J Med. 1995 May; 62(3):235-8.Mt Sinai J Med1995-05-01T00:00:001995Transvaginal small-bowel evisceration: a case report.18401452Pellegrino T, Sperling RA, Alivisatos AP, Parak WJJournal of biomedicine & biotechnologyGel electrophoresis of gold-DNA nanoconjugates. J Biomed Biotechnol. 2007; 2007:26796.J Biomed Biotechnol2007-01-01T00:00:002007Gel electrophoresis of gold-DNA nanoconjugates.8232380Dottino PR, Sperling R, Kee RThe Mount Sinai journal of medicine, New YorkScreening for human immunodeficiency virus and sexually transmitted diseases in an inner-city colposcopy clinic. Mt Sinai J Med. 1993 Sep; 60(4):327-9.Mt Sinai J Med1993-09-01T00:00:001993Screening for human immunodeficiency virus and sexually transmitted diseases in an inner-city colposcopy clinic.8459977Brodman M, Port M, Friedman F, Sperling R, Dottino P, Thomas AGObstetrics and gynecologyOperating room personnel morbidity from carbon dioxide laser use during preceptored surgery. Obstet Gynecol. 1993 Apr; 81(4):607-9.Obstet Gynecol1993-04-01T00:00:001993Operating room personnel morbidity from carbon dioxide laser use during preceptored surgery.1324311Brodman M, Dottino P, Friedman F, Heller D, Bleiweiss I, Sperling RThe Journal of reproductive medicineHuman papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil. J Reprod Med. 1992 May; 37(5):453-6.J Reprod Med1992-05-01T00:00:001992Human papillomavirus-associated lesions of the vagina and cervix. Treatment with a laser and topical 5-fluorouracil.Authorship 10973387Authorship 10955902230258973Amariglio RE, Buckley RF, Mormino EC, Marshall GA, Johnson KA, Rentz DM, Sperling RAAlzheimer's & dementia (New York, N. Y.)Amyloid-associated increases in longitudinal report of subjective cognitive complaints. Alzheimers Dement (N Y). 2018; 4:444-449.Alzheimers Dement (N Y)2018-09-06T00:00:002018Amyloid-associated increases in longitudinal report of subjective cognitive complaints.30266303Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, Vöglein J, Salloway S, Xiong C, Benzinger T, Buckles V, Masters CL, Sperling R, Bateman RJ, Morris JC, Laske CAlzheimer's & dementia : the journal of the Alzheimer's AssociationRelationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimers Dement. 2018 11; 14(11):1427-1437.Alzheimers Dement2018-09-25T00:00:002018Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease.15236399Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, Dale AM, Stern CE, Blacker D, Albert MS, Sperling RAAnnals of neurologyMedial temporal lobe function and structure in mild cognitive impairment. Ann Neurol. 2004 Jul; 56(1):27-35.Ann Neurol2004-07-01T00:00:002004Medial temporal lobe function and structure in mild cognitive impairment.18823230Chua EF, Schacter DL, Sperling RAJournal of cognitive neuroscienceNeural correlates of metamemory: a comparison of feeling-of-knowing and retrospective confidence judgments. J Cogn Neurosci. 2009 Sep; 21(9):1751-65.J Cogn Neurosci2009-09-01T00:00:002009Neural correlates of metamemory: a comparison of feeling-of-knowing and retrospective confidence judgments.22131428Putcha D, Brickhouse M, O'Keefe K, Sullivan C, Rentz D, Marshall G, Dickerson B, Sperling RThe Journal of neuroscience : the official journal of the Society for NeuroscienceHippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci. 2011 Nov 30; 31(48):17680-8.J Neurosci2011-11-30T00:00:002011Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.22982484Huijbers W, Vannini P, Sperling RA, C M P, Cabeza R, Daselaar SMNeuropsychologiaExplaining the encoding/retrieval flip: memory-related deactivations and activations in the posteromedial cortex. Neuropsychologia. 2012 Dec; 50(14):3764-74.Neuropsychologia2012-09-13T00:00:002012Explaining the encoding/retrieval flip: memory-related deactivations and activations in the posteromedial cortex.30374196Sepulcre J, Grothe MJ, d'Oleire Uquillas F, Ortiz-Terán L, Diez I, Yang HS, Jacobs HIL, Hanseeuw BJ, Li Q, El-Fakhri G, Sperling RA, Johnson KANature medicineNeurogenetic contributions to amyloid beta and tau spreading in the human cortex. Nat Med. 2018 12; 24(12):1910-1918.Nat Med2018-10-29T00:00:002018Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.Authorship 110995011Authorship 11106586Authorship 11109821730413934Broce IJ, Tan CH, Fan CC, Jansen I, Savage JE, Witoelar A, Wen N, Hess CP, Dillon WP, Glastonbury CM, Glymour M, Yokoyama JS, Elahi FM, Rabinovici GD, Miller BL, Mormino EC, Sperling RA, Bennett DA, McEvoy LK, Brewer JB, Feldman HH, Hyman BT, Pericak-Vance M, Haines JL, Farrer LA, Mayeux R, Schellenberg GD, Yaffe K, Sugrue LP, Dale AM, Posthuma D, Andreassen OA, Karch CM, Desikan RSActa neuropathologicaDissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathol. 2019 02; 137(2):209-226.Acta Neuropathol2018-11-09T00:00:002018Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.30412493Brashear HR, Ketter N, Bogert J, Di J, Salloway SP, Sperling RJournal of Alzheimer's disease : JADClinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies. J Alzheimers Dis. 2018; 66(4):1409-1424.J Alzheimers Dis2018-01-01T00:00:002018Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies.7723979Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WHNeurologyPlasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology. 1995 Apr; 45(4):824-7.Neurology1995-04-01T00:00:001995Plasmapheresis in fulminant acute disseminated encephalomyelitis.Authorship 111554212Authorship 1113967830419228Chen Z, Mengel D, Keshavan A, Rissman RA, Billinton A, Perkinton M, Percival-Alwyn J, Schultz A, Properzi M, Johnson K, Selkoe DJ, Sperling RA, Patel P, Zetterberg H, Galasko D, Schott JM, Walsh DMAlzheimer's & dementia : the journal of the Alzheimer's AssociationLearnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease. Alzheimers Dement. 2019 03; 15(3):487-496.Alzheimers Dement2018-11-09T00:00:002018Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.30458305Properzi MJ, Buckley RF, Chhatwal JP, Donohue MC, Lois C, Mormino EC, Johnson KA, Sperling RA, Schultz APNeuroImageNonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers. Neuroimage. 2019 02 01; 186:446-454.Neuroimage2018-11-17T00:00:002018Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers.Authorship 13356212Authorship 1115879930482786Huijbers W, Schultz AP, Papp KV, LaPoint MR, Hanseeuw B, Chhatwal JP, Hedden T, Johnson KA, Sperling RAThe Journal of neuroscience : the official journal of the Society for NeuroscienceTau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity. J Neurosci. 2019 01 16; 39(3):548-556.J Neurosci2018-11-27T00:00:002018Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.Authorship 124103620505438Black RS, Sperling RA, Safirstein B, Motter RN, Pallay A, Nichols A, Grundman MAlzheimer disease and associated disordersA single ascending dose study of bapineuzumab in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2010 Apr-Jun; 24(2):198-203.Alzheimer Dis Assoc Disord2010-04-01T00:00:002010A single ascending dose study of bapineuzumab in patients with Alzheimer disease.20886094Desikan RS, Sabuncu MR, Schmansky NJ, Reuter M, Cabral HJ, Hess CP, Weiner MW, Biffi A, Anderson CD, Rosand J, Salat DH, Kemper TL, Dale AM, Sperling RA, Fischl BPloS oneSelective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One. 2010 Sep 23; 5(9):e12853.PLoS One2010-09-23T00:00:002010Selective disruption of the cerebral neocortex in Alzheimer's disease.30563962d'Oleire Uquillas F, Jacobs HIL, Biddle KD, Properzi M, Hanseeuw B, Schultz AP, Rentz DM, Johnson KA, Sperling RA, Donovan NJTranslational psychiatryRegional tau pathology and loneliness in cognitively normal older adults. Transl Psychiatry. 2018 12 18; 8(1):282.Transl Psychiatry2018-12-18T00:00:002018Regional tau pathology and loneliness in cognitively normal older adults.30549303Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, Hanseeuw BJ, Buckley R, Chhatwal J, Hedden T, Marshall GA, Quiroz YT, Donovan NJ, Jackson J, Gatchel JR, Rabin JS, Jacobs H, Yang HS, Properzi M, Kirn DR, Rentz DM, Johnson KAAnnals of neurologyThe impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019 02; 85(2):181-193.Ann Neurol2019-01-21T00:00:002019The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.22169231Sabuncu MR, Buckner RL, Smoller JW, Lee PH, Fischl B, Sperling RACerebral cortex (New York, N.Y. : 1991)The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cereb Cortex. 2012 Nov; 22(11):2653-61.Cereb Cortex2011-12-13T00:00:002011The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects.Authorship 11201371Authorship 11198669Authorship 11204107Authorship 11201581730565287Rabin JS, Yang HS, Schultz AP, Hanseeuw BJ, Hedden T, Viswanathan A, Gatchel JR, Marshall GA, Kilpatrick E, Klein H, Rao V, Buckley RF, Yau WW, Kirn DR, Rentz DM, Johnson KA, Sperling RA, Chhatwal JPAnnals of neurologyVascular Risk and ß-Amyloid Are Synergistically Associated with Cortical Tau. Ann Neurol. 2019 02; 85(2):272-279.Ann Neurol2019-01-07T00:00:002019Vascular Risk and ß-Amyloid Are Synergistically Associated with Cortical Tau.30538309Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, Sperling RA, Donovan NJMolecular psychiatryCorrection: Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry. 2020 Oct; 25(10):2644.Mol Psychiatry2020-10-01T00:00:002020Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults.2025-05-31AISEN, PAUL S. ;JOHNSON, KEITH A.;SPERLING, REISA A.2018-09-30Combination anti-amyloid therapy for preclinical Alzheimer's diseaseR01AG0618482025-11-30AISEN, PAUL S.;ALEXANDER, ROBERT C;JOHNSON, KEITH A.;LANGBAUM, JESSICA BROOKE;REIMAN, ERIC MICHAEL ;SPERLING, REISA A.2018-09-01API A4 Alzheimer's Prevention TrialR01AG058468Co-Principal InvestigatorCo-Principal Investigator30616208Vöglein J, Noachtar S, McDade E, Quaid KA, Salloway S, Ghetti B, Noble J, Berman S, Chhatwal J, Mori H, Fox N, Allegri R, Masters CL, Buckles V, Ringman JM, Rossor M, Schofield PR, Sperling R, Jucker M, Laske C, Paumier K, Morris JC, Bateman RJ, Levin J, Danek ANeurobiology of agingSeizures as an early symptom of autosomal dominant Alzheimer's disease. Neurobiol Aging. 2019 04; 76:18-23.Neurobiol Aging2018-12-05T00:00:002018Seizures as an early symptom of autosomal dominant Alzheimer's disease.Authorship 112564710Authorship 112699018Authorship 11250791730642435Jagust W, Jack CR, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Sperling RAlzheimer's & dementia : the journal of the Alzheimer's Association"Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia". Alzheimers Dement. 2019 01; 15(1):153-157.Alzheimers Dement2019-01-01T00:00:002019"Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".30630529Marshall GA, Aghjayan SL, Dekhtyar M, Locascio JJ, Jethwani K, Amariglio RE, Czaja SJ, Loewenstein DA, Johnson KA, Sperling RA, Rentz DMAlzheimer's research & therapyMeasuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments. Alzheimers Res Ther. 2019 01 10; 11(1):4.Alzheimers Res Ther2019-01-10T00:00:002019Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments.21689670Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, Carmasin J, Maye JE, Johnson KA, Sperling RANeuropsychologiaFace-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia. 2011 Jul; 49(9):2776-83.Neuropsychologia2011-06-12T00:00:002011Face-name associative memory performance is related to amyloid burden in normal elderly.22244033Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker DThe Journal of clinical psychiatryClinical impact of updated diagnostic and research criteria for Alzheimer's disease. J Clin Psychiatry. 2011 Dec; 72(12):e37.J Clin Psychiatry2011-12-01T00:00:002011Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.22456451McLaren DG, Sreenivasan A, Diamond EL, Mitchell MB, Van Dijk KR, Deluca AN, O'Brien JL, Rentz DM, Sperling RA, Atri ANeuro-degenerative diseasesTracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease. Neurodegener Dis. 2012; 9(4):176-86.Neurodegener Dis2012-03-27T00:00:002012Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease.22922821Wadsworth LP, Lorius N, Donovan NJ, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GADementia and geriatric cognitive disordersNeuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord. 2012; 34(2):96-111.Dement Geriatr Cogn Disord2012-08-28T00:00:002012Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.23384193Huijbers W, Schultz AP, Vannini P, McLaren DG, Wigman SE, Ward AM, Hedden T, Sperling RAJournal of cognitive neuroscienceThe encoding/retrieval flip: interactions between memory performance and memory stage and relationship to intrinsic cortical networks. J Cogn Neurosci. 2013 Jul; 25(7):1163-79.J Cogn Neurosci2013-02-05T00:00:002013The encoding/retrieval flip: interactions between memory performance and memory stage and relationship to intrinsic cortical networks.Authorship 112890319Authorship 112978312Authorship 1128597530689776Tan CH, Bonham LW, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL, Yaffe K, Schellenberg GD, Kauppi K, Holland D, McEvoy LK, Kukull WA, Tosun D, Weiner MW, Sperling RA, Bennett DA, Hyman BT, Andreassen OA, Dale AM, Desikan RSBrain : a journal of neurologyPolygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration. Brain. 2019 02 01; 142(2):460-470.Brain2019-02-01T00:00:002019Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.30689584Marshall GA, Gatchel JR, Donovan NJ, Muniz MC, Schultz AP, Becker JA, Chhatwal JP, Hanseeuw BJ, Papp KV, Amariglio RE, Rentz DM, Sperling RA, Johnson KAJournal of Alzheimer's disease : JADRegional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia. J Alzheimers Dis. 2019; 67(2):757-768.J Alzheimers Dis2019-01-01T00:00:002019Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.30704519Halawa OA, Gatchel JR, Amariglio RE, Rentz DM, Sperling RA, Johnson KA, Marshall GAAlzheimer's research & therapyInferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease. Alzheimers Res Ther. 2019 01 31; 11(1):14.Alzheimers Res Ther2019-01-31T00:00:002019Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.30715078Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, Jacobs HIL, Papp KV, Amariglio RE, Properzi MJ, Schultz AP, Kirn D, Scott MR, Hedden T, Farrell M, Price J, Chhatwal J, Rentz DM, Villemagne VL, Johnson KA, Sperling RAJAMA neurologySex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults. JAMA Neurol. 2019 05 01; 76(5):542-551.JAMA Neurol2019-05-01T00:00:002019Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.Authorship 113010521Authorship 1130646330717814Hanseeuw BJ, Lopera F, Sperling RA, Norton DJ, Guzman-Velez E, Baena A, Pardilla-Delgado E, Schultz AP, Gatchel J, Jin D, Chen K, Reiman EM, Johnson KA, Quiroz YTAlzheimer's research & therapyStriatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease. Alzheimers Res Ther. 2019 02 04; 11(1):17.Alzheimers Res Ther2019-02-04T00:00:002019Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease.30756118Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzmán-Vélez E, Jacobs HIL, Hanseeuw B, Pardilla-Delgado E, Artola A, Baena A, Bocanegra Y, Kosik KS, Chen K, Tariot PN, Johnson K, Sperling RA, Reiman EM, Lopera F, Quiroz YTThe journal of prevention of Alzheimer's diseaseBiological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred. J Prev Alzheimers Dis. 2019; 6(2):112-120.J Prev Alzheimers Dis2019-01-01T00:00:002019Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.Authorship 11319331630947113Buckley RF, Mormino EC, Chhatwal J, Schultz AP, Rabin JS, Rentz DM, Acar D, Properzi MJ, Dumurgier J, Jacobs H, Gomez-Isla T, Johnson KA, Sperling RA, Hanseeuw BJNeurobiology of agingAssociations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid. Neurobiol Aging. 2019 06; 78:178-185.Neurobiol Aging2019-03-07T00:00:002019Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid.D000682Chemicals & Drugs2807940.67236AmyloidD000544Disorders127179750.222139Alzheimer Disease30883345Yang HS, Chhatwal JP, Xu J, White CC, Hanseeuw B, Rabin JS, Papp KV, Buckley RF, Schultz AP, Properzi MJ, Gatchel JR, Amariglio RE, Donovan NJ, Mormino EC, Hedden T, Marshall GA, Rentz DM, Johnson KA, De Jager PL, Sperling RAJournal of Alzheimer's disease : JADAn UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults. J Alzheimers Dis. 2019; 68(3):1161-1170.J Alzheimers Dis2019-01-01T00:00:002019An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.D008568Physiology84821610.479898MemoryAuthorship 114089613Authorship 114121220Authorship 1147702330970197Henley D, Raghavan N, Sperling R, Aisen P, Raman R, Romano GThe New England journal of medicinePreliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease. N Engl J Med. 2019 04 11; 380(15):1483-1485.N Engl J Med2019-04-11T00:00:002019Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease.D016229Chemicals & Drugs59335790.387395Amyloid beta-PeptidesD016875Chemicals & Drugs43218610.48412tau ProteinsAuthorship 11501533231039256Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White CL, Yu L, Schneider JABrain : a journal of neurologyLimbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 06 01; 142(6):1503-1527.Brain2019-06-01T00:00:002019Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.Authorship 11518311131062826Gauthier S, Alam J, Fillit H, Iwatsubo T, Liu-Seifert H, Sabbagh M, Salloway S, Sampaio C, Sims JR, Sperling B, Sperling R, Welsh-Bohmer KA, Touchon J, Vellas B, Aisen PThe journal of prevention of Alzheimer's diseaseCombination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force. J Prev Alzheimers Dis. 2019; 6(3):164-168.J Prev Alzheimers Dis2019-01-01T00:00:002019Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force.NeurologyRadiologyBrigham and Women's HospitalMassachusetts General HospitalAS460AaronSchultzAaron Schultz, Ph.D.94095Schultz, AaronAssistant Professor of NeurologyDJS1DennisSelkoeDennis J. Selkoe, M.D.42.33837200000000-71.1032690000000081795Selkoe, DennisVincent and Stella Coates Professor of Neurologic Diseases in the Department of NeurologySMM19ScottMcGinnisScott M. McGinnis, M.D.42.33710500000000-71.1023170000000086771McGinnis, ScottAssistant Professor of Neurology2024-12-31AISEN, PAUL S.;SPERLING, REISA A.2019-05-15Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension StudyR01AG063689Principal InvestigatorDMR7DoreneRentzDorene May Rentz, Psy.D.42.33710500000000-71.1023170000000048152Rentz, DoreneProfessor of NeurologyKRD3KirkDaffnerKirk R. Daffner, M.D.42.33710500000000-71.1023170000000027758Daffner, KirkJ. David and Virginia Wimberly Professor of Neurology31157827Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, Huijbers W, Hedden T, Marshall GA, Chhatwal JP, Rentz DM, Sperling RA, Johnson KJAMA neurologyAssociation of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. JAMA Neurol. 2019 Aug 01; 76(8):915-924.JAMA Neurol2019-08-01T00:00:002019Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study.11518selected publications14.8180.00150124677research areas21.93150.00935681181coauthor of655.26874.064560similar toAuthorship 115859589Authorship 11597902131166241Daiello LA, Racine AM, Yun Gou R, Marcantonio ER, Xie Z, Kunze LJ, Vlassakov KV, Inouye SK, Jones RN, Alsop D, Travison T, Arnold S, Cooper Z, Dickerson B, Fong T, Metzger E, Pascual-Leone A, Schmitt EM, Shafi M, Cavallari M, Dai W, Dillon ST, McElhaney J, Guttmann C, Hshieh T, Kuchel G, Libermann T, Ngo L, Press D, Saczynski J, Vasunilashorn S, O'Connor M, Kimchi E, Strauss J, Wong B, Belkin M, Ayres D, Callery M, Pomposelli F, Wright J, Schermerhorn M, Abrantes T, Albuquerque A, Bertrand S, Brown A, Callahan A, D'Aquila M, Dowal S, Fox M, Gallagher J, Anna Gersten R, Hodara A, Helfand B, Inloes J, Kettell J, Kuczmarska A, Nee J, Nemeth E, Ochsner L, Palihnich K, Parisi K, Puelle M, Rastegar S, Vella M, Xu G, Bryan M, Guess J, Enghorn D, Gross A, Gou Y, Habtemariam D, Isaza I, Kosar C, Rockett C, Tommet D, Gruen T, Ross M, Tasker K, Gee J, Kolanowski A, Pisani M, de Rooij S, Rogers S, Studenski S, Stern Y, Whittemore A, Gottlieb G, Orav J, Sperling RAnesthesiologyPostoperative Delirium and Postoperative Cognitive Dysfunction: Overlap and Divergence. Anesthesiology. 2019 09; 131(3):477-491.Anesthesiology2019-09-01T00:00:002019Postoperative Delirium and Postoperative Cognitive Dysfunction: Overlap and Divergence.BTH2BradleyHymanBradley Theodore Hyman, M.D., Ph.D.42.37904200000000-71.051481000000004393Hyman, BradleyJohn B. Penney, Jr. Professor of NeurologyRE18RebeccaAmariglioRebecca Amariglio, Ph.D.29686Amariglio, RebeccaAssociate Professor of NeurologyRET2RudolphTanziRudolph Emile Tanzi, Ph.D.42.37904200000000-71.0514810000000066118Tanzi, RudolphJoseph P. and Rose F. Kennedy Professor of Child Neurology and Mental RetardationAuthorship 1161893531207468Rabin JS, Perea RD, Buckley RF, Johnson KA, Sperling RA, Hedden TNeurobiology of agingSynergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults. Neurobiol Aging. 2019 09; 81:38-46.Neurobiol Aging2019-05-16T00:00:002019Synergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults.MEM8MaryellenMeadowsMaryellen Meadows, Ph.D.42.33710500000000-71.102317000000006280Meadows, MaryellenAssistant Professor of NeurologyGAM10GadMarshallGad Marshall, M.D.42.33710500000000-71.1023170000000065666Marshall, GadAssociate Professor of Neurology31248770Biddle KD, d'Oleire Uquillas F, Jacobs HIL, Zide B, Kirn DR, Rentz DM, Johnson KA, Sperling RA, Donovan NJThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric PsychiatrySocial Engagement and Amyloid-ß-Related Cognitive Decline in Cognitively Normal Older Adults. Am J Geriatr Psychiatry. 2019 11; 27(11):1247-1256.Am J Geriatr Psychiatry2019-05-10T00:00:002019Social Engagement and Amyloid-ß-Related Cognitive Decline in Cognitively Normal Older Adults.KAJ1KeithJohnsonKeith Alan Johnson, M.D.42.36241700000000-71.0689370000000016670Johnson, KeithProfessor of RadiologyAuthorship 11671928Authorship 11704521931312836Rabin JS, Klein H, Kirn DR, Schultz AP, Yang HS, Hampton O, Jiang S, Buckley RF, Viswanathan A, Hedden T, Pruzin J, Yau WW, Guzmán-Vélez E, Quiroz YT, Properzi M, Marshall GA, Rentz DM, Johnson KA, Sperling RA, Chhatwal JPJAMA neurologyAssociations of Physical Activity and ß-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults. JAMA Neurol. 2019 Oct 01; 76(10):1203-1210.JAMA Neurol2019-10-01T00:00:002019Associations of Physical Activity and ß-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults.Authorship 117763728Authorship 11762491631361916Schultz AP, Kloet RW, Sohrabi HR, van der Weerd L, van Rooden S, Wermer MJH, Moursel LG, Yaqub M, van Berckel BNM, Chatterjee P, Gardener SL, Taddei K, Fagan AM, Benzinger TL, Morris JC, Sperling R, Johnson K, Bateman RJ, Gurol ME, van Buchem MA, Martins R, Chhatwal JP, Greenberg SMAnnals of neurologyAmyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers. Ann Neurol. 2019 10; 86(4):616-625.Ann Neurol2019-08-12T00:00:002019Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.31359039Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Fardo DW, Flanagan ME, Halliday G, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murray ME, Nag S, Seeley WW, Sperling RA, White CL, Schneider JABrain : a journal of neurologyReply: LATE to the PART-y. Brain. 2019 09 01; 142(9):e48.Brain2019-09-01T00:00:002019Reply: LATE to the PART-y.Authorship 11798171431397865Gatchel JR, Rabin JS, Buckley RF, Locascio JJ, Quiroz YT, Yang HS, Vannini P, Amariglio RE, Rentz DM, Properzi M, Donovan NJ, Blacker D, Johnson KA, Sperling RA, Marshall GAJAMA network openLongitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults. JAMA Netw Open. 2019 08 02; 2(8):e198964.JAMA Netw Open2019-08-02T00:00:002019Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults.Authorship 11898171231530865Mukhopadhyay S, Liang Y, Hur H, Villegas G, Calenda G, Reis A, Millen L, Barnable P, Mamkina L, Kumar N, Kalir T, Sperling R, Teleshova NScientific reportsComparative transcriptome analysis of the human endocervix and ectocervix during the proliferative and secretory phases of the menstrual cycle. Sci Rep. 2019 09 17; 9(1):13494.Sci Rep2019-09-17T00:00:002019Comparative transcriptome analysis of the human endocervix and ectocervix during the proliferative and secretory phases of the menstrual cycle.23708142Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A, Morris MC, Evans DA, Johnson K, Sperling RA, Schneider JA, Bennett DA, De Jager PLNature neuroscienceCD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.Nat Neurosci2013-05-23T00:00:002013CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.Authorship 1623726Authorship 12006241431673597Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio REAlzheimer's & dementia (Amsterdam, Netherlands)Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimers Dement (Amst). 2019 Dec; 11:670-678.Alzheimers Dement (Amst)2019-09-25T00:00:002019Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study.31696223d'Oleire Uquillas F, Jacobs HIL, Schultz AP, Hanseeuw BJ, Buckley RF, Sepulcre J, Pascual-Leone A, Donovan NJ, Johnson KA, Sperling RA, Vannini PCerebral cortex (New York, N.Y. : 1991)Functional and Pathological Correlates of Judgments of Learning in Cognitively Unimpaired Older Adults. Cereb Cortex. 2020 03 14; 30(3):1974-1983.Cereb Cortex2020-03-14T00:00:002020Functional and Pathological Correlates of Judgments of Learning in Cognitively Unimpaired Older Adults.Authorship 120303710Authorship 12019571031686034Arboleda-Velasquez JF, Lopera F, O'Hare M, Delgado-Tirado S, Marino C, Chmielewska N, Saez-Torres KL, Amarnani D, Schultz AP, Sperling RA, Leyton-Cifuentes D, Chen K, Baena A, Aguillon D, Rios-Romenets S, Giraldo M, Guzmán-Vélez E, Norton DJ, Pardilla-Delgado E, Artola A, Sanchez JS, Acosta-Uribe J, Lalli M, Kosik KS, Huentelman MJ, Zetterberg H, Blennow K, Reiman RA, Luo J, Chen Y, Thiyyagura P, Su Y, Jun GR, Naymik M, Gai X, Bootwalla M, Ji J, Shen L, Miller JB, Kim LA, Tariot PN, Johnson KA, Reiman EM, Quiroz YTNature medicineResistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019 11; 25(11):1680-1683.Nat Med2019-11-04T00:00:002019Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.31711955Schultz AP, Buckley RF, Hampton OL, Scott MR, Properzi MJ, Peña-Gómez C, Pruzin JJ, Yang HS, Johnson KA, Sperling RA, Chhatwal JPNeuroImage. ClinicalLongitudinal degradation of the default/salience network axis in symptomatic individuals with elevated amyloid burden. Neuroimage Clin. 2020; 26:102052.Neuroimage Clin2019-10-22T00:00:002019Longitudinal degradation of the default/salience network axis in symptomatic individuals with elevated amyloid burden.Authorship 120538610true1Assistant Professor of NeurologyAssistant Professor of Neurologytrue1Professor of NeurologyProfessor of Neurologytrue1J. David and Virginia Wimberly Professor of NeurologyJ. David and Virginia Wimberly Professor of Neurologytrue1John B. Penney, Jr. Professor of NeurologyJohn B. Penney, Jr. Professor of Neurologytrue1Associate Professor of NeurologyAssociate Professor of Neurologytrue1Joseph P. and Rose F. Kennedy Professor of Child Neurology and Mental RetardationJoseph P. and Rose F. Kennedy Professor of Child Neurology and Mental Retardationtrue1Professor of NeurologyProfessor of Neurologytrue1Vincent and Stella Coates Professor of Neurologic Diseases in the Department of NeurologyVincent and Stella Coates Professor of Neurologic Diseases in the Department of Neurology31795044Vannini P, d'Oleire Uquillas F, Jacobs HIL, Sepulcre J, Gatchel J, Amariglio RE, Hanseeuw B, Papp KV, Hedden T, Rentz DM, Pascual-Leone A, Johnson KA, Sperling RANeuroImage. ClinicalDecreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults. Neuroimage Clin. 2019; 24:102097.Neuroimage Clin2019-11-18T00:00:002019Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults.Authorship 12074629Authorship 12091501331759879Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio REAlzheimer's & dementia : the journal of the Alzheimer's AssociationClinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimers Dement. 2020 03; 16(3):552-560.Alzheimers Dement2020-01-04T00:00:002020Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.Authorship 12106223Authorship 1211295531827267Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJNature reviews. NeurologyCerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020 01; 16(1):30-42.Nat Rev Neurol2019-12-11T00:00:002019Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.31826979Jack CR, Holtzman DM, Sperling RScience translational medicineDementia is not synonymous with Alzheimer's disease. Sci Transl Med. 2019 12 11; 11(522).Sci Transl Med2019-12-11T00:00:002019Dementia is not synonymous with Alzheimer's disease.Authorship 12140611631874859Gatchel JR, Lopera F, Norton DJ, Baena A, Guzman-Velez E, Sanchez JS, d'Oleire Uquillas F, Schultz A, Vannini P, Artola A, Amariglio RE, Rentz DM, Tariot PN, Reiman EM, Johnson KA, Sperling RA, Marshall GA, Quiroz YTJournal of neurology, neurosurgery, and psychiatryAssociation of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2020 03; 91(3):330-332.J Neurol Neurosurg Psychiatry2019-12-24T00:00:002019Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease.Authorship 155748Authorship 1561772Authorship 1227955532057937Putcha D, Dickerson BC, Brickhouse M, Johnson KA, Sperling RA, Papp KVNeuropsychologiaWord retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum. Neuropsychologia. 2020 03 16; 140:107391.Neuropsychologia2020-02-10T00:00:002020Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum.32101313Biddle KD, Jacobs HIL, d'Oleire Uquillas F, Zide BS, Kirn DR, Properzi MR, Rentz DM, Johnson KA, Sperling RA, Donovan NJJAMA network openAssociations of Widowhood and ß-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults. JAMA Netw Open. 2020 02 05; 3(2):e200121.JAMA Netw Open2020-02-05T00:00:002020Associations of Widowhood and ß-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults.Authorship 1229401932273431Jacobs HIL, Augustinack JC, Schultz AP, Hanseeuw BJ, Locascio J, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KANeurologyThe presubiculum links incipient amyloid and tau pathology to memory function in older persons. Neurology. 2020 05 05; 94(18):e1916-e1928.Neurology2020-04-09T00:00:002020The presubiculum links incipient amyloid and tau pathology to memory function in older persons.Authorship 12387341Authorship 12380169Authorship 12393631632250387Sperling RA, Donohue MC, Raman R, Sun CK, Yaari R, Holdridge K, Siemers E, Johnson KA, Aisen PSJAMA neurologyAssociation of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals. JAMA Neurol. 2020 06 01; 77(6):735-745.JAMA Neurol2020-06-01T00:00:002020Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.32249013Rabin JS, Shirzadi Z, Swardfager W, MacIntosh BJ, Schultz A, Yang HS, Buckley RF, Gatchel JR, Kirn D, Pruzin JJ, Hedden T, Lipsman N, Rentz DM, Black SE, Johnson KA, Sperling RA, Chhatwal JPNeurobiology of agingAmyloid-beta burden predicts prospective decline in body mass index in clinically normal adults. Neurobiol Aging. 2020 09; 93:124-130.Neurobiol Aging2020-03-07T00:00:002020Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.32315118Insel PS, Donohue MC, Sperling R, Hansson O, Mattsson-Carlgren NAnnals of clinical and translational neurologyThe A4 study: ß-amyloid and cognition in 4432 cognitively unimpaired adults. Ann Clin Transl Neurol. 2020 05; 7(5):776-785.Ann Clin Transl Neurol2020-04-21T00:00:002020The A4 study: ß-amyloid and cognition in 4432 cognitively unimpaired adults.Authorship 12419813Authorship 12472371032417775Amariglio RE, Buckley RF, Rabin JS, Papp KV, Quiroz YT, Mormino EC, Sparks KP, Johnson KA, Rentz DM, Sperling RAJournal of Alzheimer's disease : JADExamining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study. J Alzheimers Dis. 2020; 75(4):1437-1446.J Alzheimers Dis2020-01-01T00:00:002020Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study.Authorship 1250857832463066Aisen PS, Cummings J, Doody R, Kramer L, Salloway S, Selkoe DJ, Sims J, Sperling RA, Vellas BThe journal of prevention of Alzheimer's diseaseThe Future of Anti-Amyloid Trials. J Prev Alzheimers Dis. 2020; 7(3):146-151.J Prev Alzheimers Dis2020-01-01T00:00:002020The Future of Anti-Amyloid Trials.32512123Scott MR, Hampton OL, Buckley RF, Chhatwal JP, Hanseeuw BJ, Jacobs HI, Properzi MJ, Sanchez JS, Johnson KA, Sperling RA, Schultz APNeuroImageInferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults. Neuroimage. 2020 10 15; 220:116991.Neuroimage2020-06-05T00:00:002020Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.Authorship 181097832526197Yang HS, White CC, Klein HU, Yu L, Gaiteri C, Ma Y, Felsky D, Mostafavi S, Petyuk VA, Sperling RA, Ertekin-Taner N, Schneider JA, Bennett DA, De Jager PLNeuronGenetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. 2020 08 05; 107(3):496-508.e6.Neuron2020-06-10T00:00:002020Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology.Authorship 125491110Authorship 125487536Authorship 12553261032522711Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J, Flores S, Keefe S, Dincer A, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal J, Cruchaga C, Ewers M, Fox NN, Ghetti B, Goate A, Graff-Radford NR, Hassenstab JJ, Hornbeck R, Jack C, Johnson K, Joseph-Mathurin N, Karch CM, Koeppe RA, Lee AKW, Levin J, Masters C, McDade E, Perrin RJ, Rowe CC, Salloway S, Saykin AJ, Sperling R, Su Y, Villemagne VL, Vöglein J, Weiner M, Xiong C, Fagan AM, Morris JC, Bateman RJ, Benzinger TLS, Jucker M, Gordon BANeurobiology of diseaseSerum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiol Dis. 2020 08; 142:104960.Neurobiol Dis2020-06-06T00:00:002020Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease.Authorship 12600572132568366Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, Johnson SC, Yang HS, Johnson K, Aisen P, Resnick SM, Sperling R, De Jager PL, Schneider J, Bennett DA, Schrag M, Vardarajan B, Hohman TJ, Mayeux RJAMA neurologyAssociation Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. JAMA Neurol. 2020 10 01; 77(10):1288-1298.JAMA Neurol2020-10-01T00:00:002020Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.Authorship 12636501332611637Guzmán-Vélez E, Martínez J, Papp K, Baena A, Vila-Castelar C, Artola A, Schultz AP, Bocanegra Y, Sanchez J, Rentz D, Tariot PN, Reiman EM, Sperling R, Johnson KA, Lopera F, Quiroz YTNeurologyAssociative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers. Neurology. 2020 09 08; 95(10):e1312-e1321.Neurology2020-07-01T00:00:002020Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.32799367Buckley RF, Scott MR, Jacobs HIL, Schultz AP, Properzi MJ, Amariglio RE, Hohman TJ, Mayblyum DV, Rubinstein ZB, Manning L, Hanseeuw BJ, Mormino EC, Rentz DM, Johnson KA, Sperling RAAnnals of neurologySex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline. Ann Neurol. 2020 11; 88(5):921-932.Ann Neurol2020-08-31T00:00:002020Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.Authorship 12762153Authorship 12784859Authorship 12780941532825838Norton DJ, Parra MA, Sperling RA, Baena A, Guzman-Velez E, Jin DS, Andrea N, Khang J, Schultz A, Rentz DM, Pardilla-Delgado E, Fuller J, Johnson K, Reiman EM, Lopera F, Quiroz YTAlzheimer's research & therapyVisual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer's disease. Alzheimers Res Ther. 2020 08 21; 12(1):99.Alzheimers Res Ther2020-08-21T00:00:002020Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer's disease.32777010Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish JJAMA neurologyShort-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. JAMA Neurol. 2020 12 01; 77(12):1504-1513.JAMA Neurol2020-12-01T00:00:002020Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment.Authorship 12794624432844198Dumitrescu L, Mahoney ER, Mukherjee S, Lee ML, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski C, Hernandez Saucedo H, Widaman KF, Buckley R, Properzi M, Mormino E, Yang HS, Harrison T, Hedden T, Nho K, Andrews SJ, Tommet D, Hadad N, Sanders RE, Ruderfer DM, Gifford KA, Moore AM, Cambronero F, Zhong X, Raghavan NS, Vardarajan B, Pericak-Vance MA, Farrer LA, Wang LS, Cruchaga C, Schellenberg G, Cox NJ, Haines JL, Keene CD, Saykin AJ, Larson EB, Sperling RA, Mayeux R, Bennett DA, Schneider JA, Crane PK, Jefferson AL, Hohman TJBrain : a journal of neurologyGenetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain. 2020 08 01; 143(8):2561-2575.Brain2020-08-01T00:00:002020Genetic variants and functional pathways associated with resilience to Alzheimer's disease.32942175Hampton OL, Buckley RF, Manning LK, Scott MR, Properzi MJ, Peña-Gómez C, Jacobs HIL, Chhatwal JP, Johnson KA, Sperling RA, Schultz APNeuroImage. ClinicalResting-state functional connectivity and amyloid burden influence longitudinal cortical thinning in the default mode network in preclinical Alzheimer's disease. Neuroimage Clin. 2020; 28:102407.Neuroimage Clin2020-09-02T00:00:002020Resting-state functional connectivity and amyloid burden influence longitudinal cortical thinning in the default mode network in preclinical Alzheimer's disease.32957039Sarkis RA, Beers L, Farah E, Al-Akaidi M, Zhang Y, Locascio JJ, Properzi MJ, Schultz AP, Chhatwal JP, Johnson KA, Sperling RA, B Pennell P, Marshall GAClinical neurophysiology : official journal of the International Federation of Clinical NeurophysiologyThe neurophysiology and seizure outcomes of late onset unexplained epilepsy. Clin Neurophysiol. 2020 11; 131(11):2667-2672.Clin Neurophysiol2020-09-19T00:00:002020The neurophysiology and seizure outcomes of late onset unexplained epilepsy.Authorship 12833998Authorship 12877492Authorship 12840727Authorship 12838233Authorship 128741411Authorship 128747811Authorship 12878818Authorship 12888601032920622Langford O, Raman R, Sperling RA, Cummings J, Sun CK, Jimenez-Maggiora G, Aisen PS, Donohue MCThe journal of prevention of Alzheimer's diseasePredicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials. J Prev Alzheimers Dis. 2020; 7(4):213-218.J Prev Alzheimers Dis2020-01-01T00:00:002020Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials.32919366Rabin JS, Neal TE, Nierle HE, Sikkes SAM, Buckley RF, Amariglio RE, Papp KV, Rentz DM, Schultz AP, Johnson KA, Sperling RA, Hedden TNeuroImage. ClinicalMultiple markers contribute to risk of progression from normal to mild cognitive impairment. Neuroimage Clin. 2020; 28:102400.Neuroimage Clin2020-08-28T00:00:002020Multiple markers contribute to risk of progression from normal to mild cognitive impairment.32912283Vila-Castelar C, Muñoz N, Papp KV, Amariglio RE, Baena A, Guzmán-Vélez E, Bocanegra Y, Sanchez JS, Reiman EM, Johnson KA, Sperling RA, Lopera F, Rentz DM, Quiroz YTAlzheimer's research & therapyThe Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease. Alzheimers Res Ther. 2020 09 10; 12(1):104.Alzheimers Res Ther2020-09-10T00:00:002020The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease.32920623Walter S, Clanton TB, Langford OG, Rafii MS, Shaffer EJ, Grill JD, Jimenez-Maggiora GA, Sperling RA, Cummings JL, Aisen PSThe journal of prevention of Alzheimer's diseaseRecruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD). J Prev Alzheimers Dis. 2020; 7(4):219-225.J Prev Alzheimers Dis2020-01-01T00:00:002020Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).32920625Walter S, Langford OG, Clanton TB, Jimenez-Maggiora GA, Raman R, Rafii MS, Shaffer EJ, Sperling RA, Cummings JL, Aisen PSThe journal of prevention of Alzheimer's diseaseThe Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years. J Prev Alzheimers Dis. 2020; 7(4):234-241.J Prev Alzheimers Dis2020-01-01T00:00:002020The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.32920621Aisen PS, Sperling RA, Cummings J, Donohue MC, Langford O, Jimenez-Maggiora GA, Rissman RA, Rafii MS, Walter S, Clanton T, Raman RThe journal of prevention of Alzheimer's diseaseThe Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview. J Prev Alzheimers Dis. 2020; 7(4):208-212.J Prev Alzheimers Dis2020-01-01T00:00:002020The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview.32920624Jimenez-Maggiora GA, Bruschi S, Raman R, Langford O, Donohue M, Rafii MS, Sperling RA, Cummings JL, Aisen PSThe journal of prevention of Alzheimer's diseaseTRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology. J Prev Alzheimers Dis. 2020; 7(4):226-233.J Prev Alzheimers Dis2020-01-01T00:00:002020TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology.Authorship 128938611Authorship 194785Authorship 12953451333046162Jutten RJ, Sikkes SAM, Amariglio RE, Buckley RF, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, Teunissen CE, Van Berckel BNM, Van der Flier WM, Scheltens P, Sperling RA, Papp KVJournal of the International Neuropsychological Society : JINSIdentifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's Disease. J Int Neuropsychol Soc. 2021 05; 27(5):426-438.J Int Neuropsychol Soc2020-10-13T00:00:002020Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's Disease.true1Assistant Professor of NeurologyAssistant Professor of NeurologyAuthorship 13001241633121534Dubbelman MA, Jutten RJ, Tomaszewski Farias SE, Amariglio RE, Buckley RF, Visser PJ, Rentz DM, Johnson KA, Properzi MJ, Schultz A, Donovan N, Gatchell JR, Teunissen CE, Van Berckel BNM, Van der Flier WM, Sperling RA, Papp KV, Scheltens P, Marshall GA, Sikkes SAMAlzheimer's research & therapyDecline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuum. Alzheimers Res Ther. 2020 10 29; 12(1):138.Alzheimers Res Ther2020-10-29T00:00:002020Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuum.33199430Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, Jacobs HIL, Hanseeuw BJ, Rentz DM, Villemagne VL, Papp KV, Mormino EC, Betensky RA, Johnson KA, Sperling RA, Buckley RFNeurologyDefining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation. Neurology. 2021 01 26; 96(4):e619-e631.Neurology2020-11-16T00:00:002020Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation.Authorship 130307215Authorship 13036848Authorship 13039381233247134Chhatwal JP, Schultz AP, Dang Y, Ostaszewski B, Liu L, Yang HS, Johnson KA, Sperling RA, Selkoe DJNature communicationsPlasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals. Nat Commun. 2020 11 27; 11(1):6024.Nat Commun2020-11-27T00:00:002020Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals.33163609Marshall GA, Sikkes SAM, Amariglio RE, Gatchel JR, Rentz DM, Johnson KA, Langford O, Sun CK, Donohue MC, Raman R, Aisen PS, Sperling RA, Galasko DRAlzheimer's & dementia (Amsterdam, Netherlands)Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study. Alzheimers Dement (Amst). 2020; 12(1):e12118.Alzheimers Dement (Amst)2020-10-30T00:00:002020Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study.33336226Papp KV, Rentz DM, Maruff P, Sun CK, Raman R, Donohue MC, Schembri A, Stark C, Yassa MA, Wessels AM, Yaari R, Holdridge KC, Aisen PS, Sperling RAThe journal of prevention of Alzheimer's diseaseThe Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial. J Prev Alzheimers Dis. 2021; 8(1):59-67.J Prev Alzheimers Dis2021-01-01T00:00:002021The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial.Authorship 13101681433451357Sanchez JS, Hanseeuw BJ, Lopera F, Sperling RA, Baena A, Bocanegra Y, Aguillon D, Guzmán-Vélez E, Pardilla-Delgado E, Ramirez-Gomez L, Vila-Castelar C, Martinez JE, Fox-Fuller JT, Ramos C, Ochoa-Escudero M, Alvarez S, Jacobs HIL, Schultz AP, Gatchel JR, Becker JA, Katz SR, Mayblyum DV, Price JC, Reiman EM, Johnson KA, Quiroz YTAlzheimer's research & therapyLongitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study. Alzheimers Res Ther. 2021 01 15; 13(1):27.Alzheimers Res Ther2021-01-15T00:00:002021Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study.33472953Sanchez JS, Becker JA, Jacobs HIL, Hanseeuw BJ, Jiang S, Schultz AP, Properzi MJ, Katz SR, Beiser A, Satizabal CL, O'Donnell A, DeCarli C, Killiany R, El Fakhri G, Normandin MD, Gómez-Isla T, Quiroz YT, Rentz DM, Sperling RA, Seshadri S, Augustinack J, Price JC, Johnson KAScience translational medicineThe cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography. Sci Transl Med. 2021 01 20; 13(577).Sci Transl Med2021-01-20T00:00:002021The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.Authorship 13229244Authorship 132153519Authorship 13227919Authorship 1321787133426266Samaroo A, Amariglio RE, Burnham S, Sparks P, Properzi M, Schultz AP, Buckley R, Johnson KA, Sperling RA, Rentz DM, Papp KVAlzheimer's & dementia (Amsterdam, Netherlands)Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease. Alzheimers Dement (Amst). 2020; 12(1):e12132.Alzheimers Dement (Amst)2021-01-05T00:00:002021Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease.33464300Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano GJAMA neurologyFindings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial. JAMA Neurol. 2021 03 01; 78(3):293-301.JAMA Neurol2021-03-01T00:00:002021Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial.Authorship 13268341133527648Guzmán-Vélez E, Zetterberg H, Fox-Fuller JT, Vila-Castelar C, Sanchez JS, Baena A, Garcia-Ospina G, Aguillon D, Pardilla-Delgado E, Gatchel JR, Sperling RA, Johnson K, Reiman EM, Blennow K, Lopera F, Quiroz YTAlzheimer's & dementia : the journal of the Alzheimer's AssociationAssociations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease. Alzheimers Dement. 2021 05; 17(5):813-821.Alzheimers Dement2021-02-01T00:00:002021Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.Authorship 1329326333568538Deters KD, Napolioni V, Sperling RA, Greicius MD, Mayeux R, Hohman T, Mormino ECNeurologyAmyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study. Neurology. 2021 03 16; 96(11):e1491-e1500.Neurology2021-02-10T00:00:002021Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.Authorship 13317717Authorship 1332222933589537Rentz DM, Papp KV, Mayblyum DV, Sanchez JS, Klein H, Souillard-Mandar W, Sperling RA, Johnson KANeurologyAssociation of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults. Neurology. 2021 04 06; 96(14):e1844-e1854.Neurology2021-02-15T00:00:002021Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults.33582276Schwarz CG, Kremers WK, Wiste HJ, Gunter JL, Vemuri P, Spychalla AJ, Kantarci K, Schultz AP, Sperling RA, Knopman DS, Petersen RC, Jack CRNeuroImageChanging the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives. Neuroimage. 2021 05 01; 231:117845.Neuroimage2021-02-11T00:00:002021Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives.Authorship 13331571233610961Belloy ME, Eger SJ, Le Guen Y, Napolioni V, Deters KD, Yang HS, Scelsi MA, Porter T, James SN, Wong A, Schott JM, Sperling RA, Laws SM, Mormino EC, He Z, Han SS, Altmann A, Greicius MDNeurobiology of agingKL*VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE*4 carriers. Neurobiol Aging. 2021 05; 101:123-129.Neurobiol Aging2021-01-23T00:00:002021KL*VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE*4 carriers.Authorship 1592615Authorship 13453831133778148Sato K, Ihara R, Suzuki K, Niimi Y, Toda T, Jimenez-Maggiora G, Langford O, Donohue MC, Raman R, Aisen PS, Sperling RA, Iwata A, Iwatsubo TAlzheimer's & dementia (New York, N. Y.)Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study. Alzheimers Dement (N Y). 2021; 7(1):e12135.Alzheimers Dement (N Y)2021-03-24T00:00:002021Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study.Authorship 13497481033862301Vannini P, Gagliardi GP, Kuppe M, Dossett ML, Donovan NJ, Gatchel JR, Quiroz YT, Premnath PY, Amariglio R, Sperling RA, Marshall GAJournal of psychiatric researchStress, resilience, and coping strategies in a sample of community-dwelling older adults during COVID-19. J Psychiatr Res. 2021 06; 138:176-185.J Psychiatr Res2021-04-02T00:00:002021Stress, resilience, and coping strategies in a sample of community-dwelling older adults during COVID-19.33952655Mayblyum DV, Becker JA, Jacobs HIL, Buckley RF, Schultz AP, Sepulcre J, Sanchez JS, Rubinstein ZB, Katz SR, Moody KA, Vannini P, Papp KV, Rentz DM, Price JC, Sperling RA, Johnson KA, Hanseeuw BJNeurologyComparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease. Neurology. 2021 Jun 14; 96(24):e2933-e2943.Neurology2021-06-14T00:00:002021Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease.Authorship 13521951533997742Babulal GM, Torres VL, Acosta D, Agüero C, Aguilar-Navarro S, Amariglio R, Ussui JA, Baena A, Bocanegra Y, Brucki SMD, Bustin J, Cabrera DM, Custodio N, Diaz MM, Peñailillo LD, Franco I, Gatchel JR, Garza-Naveda AP, González Lara M, Gutiérrez-Gutiérrez L, Guzmán-Vélez E, Hanseeuw BJ, Jimenez-Velazquez IZ, Rodríguez TL, Llibre-Guerra J, Marquine MJ, Martinez J, Medina LD, Miranda-Castillo C, Morlett Paredes A, Munera D, Nuñez-Herrera A, de Oliveira MO, Palmer-Cancel SJ, Pardilla-Delgado E, Perales-Puchalt J, Pluim C, Ramirez-Gomez L, Rentz DM, Rivera-Fernández C, Rosselli M, Serrano CM, Suing-Ortega MJ, Slachevsky A, Soto-Añari M, Sperling RA, Torrente F, Thumala D, Vannini P, Vila-Castelar C, Yañez-Escalante T, Quiroz YTEClinicalMedicineThe impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America. EClinicalMedicine. 2021 May; 35:100848.EClinicalMedicine2021-04-27T00:00:002021The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America.Authorship 135653846Authorship 13630263Authorship 13620927Authorship 13626731634101781Amariglio RE, Sikkes SAM, Marshall GA, Buckley RF, Gatchel JR, Johnson KA, Rentz DM, Donohue MC, Raman R, Sun CK, Yaari R, Holdridge KC, Sims JR, Grill JD, Aisen PS, Sperling RAThe journal of prevention of Alzheimer's diseaseItem-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data. J Prev Alzheimers Dis. 2021; 8(3):257-262.J Prev Alzheimers Dis2021-01-01T00:00:002021Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data.34101785Berkness T, Carrillo MC, Sperling R, Petersen R, Aisen P, Flournoy C, Snyder H, Raman R, Grill JDThe journal of prevention of Alzheimer's diseaseThe Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD): A Novel Clinical Trials Training Program. J Prev Alzheimers Dis. 2021; 8(3):286-291.J Prev Alzheimers Dis2021-01-01T00:00:002021The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD): A Novel Clinical Trials Training Program.34101788Aisen PS, Bateman RJ, Carrillo M, Doody R, Johnson K, Sims JR, Sperling R, Vellas BThe journal of prevention of Alzheimer's diseasePlatform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force. J Prev Alzheimers Dis. 2021; 8(3):306-312.J Prev Alzheimers Dis2021-01-01T00:00:002021Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force.Authorship 1756735Authorship 1769855Authorship 136982114Authorship 13724731034228129Raman R, Quiroz YT, Langford O, Choi J, Ritchie M, Baumgartner M, Rentz D, Aggarwal NT, Aisen P, Sperling R, Grill JDJAMA network openDisparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial. JAMA Netw Open. 2021 07 01; 4(7):e2114364.JAMA Netw Open2021-07-01T00:00:002021Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.34160128Yang HS, Zhang C, Carlyle BC, Zhen SY, Trombetta BA, Schultz AP, Pruzin JJ, Fitzpatrick CD, Yau WW, Kirn DR, Rentz DM, Arnold SE, Johnson KA, Sperling RA, Chhatwal JP, Tanzi REAlzheimer's & dementia : the journal of the Alzheimer's AssociationPlasma IL-12/IFN-? axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 2022 04; 18(4):645-653.Alzheimers Dement2021-06-23T00:00:002021Plasma IL-12/IFN-? axis predicts cognitive trajectories in cognitively unimpaired older adults.Authorship 1910253Authorship 13817111034359011Vannini P, Gagliardi GP, Kuppe M, Dossett ML, Donovan NJ, Gatchel JR, Quiroz YT, Premnath PY, Amariglio R, Sperling RA, Marshall GAJournal of psychiatric researchCorrigendum to "Stress, resilience, and coping strategies in a sample of community-dwelling older adults during COVID-19" [J. Psychiatr. Res. 138 (2021) 176-185]. J Psychiatr Res. 2021 Oct; 142:167-170.J Psychiatr Res2021-08-03T00:00:002021Corrigendum to "Stress, resilience, and coping strategies in a sample of community-dwelling older adults during COVID-19" [J. Psychiatr. Res. 138 (2021) 176-185].Authorship 1621345Authorship 13886661734430703Ngolab J, Donohue M, Belsha A, Salazar J, Cohen P, Jaiswal S, Tan V, Gessert D, Korouri S, Aggarwal NT, Alber J, Johnson K, Jicha G, van Dyck C, Lah J, Salloway S, Sperling RA, Aisen PS, Rafii MS, Rissman RAAlzheimer's & dementia (Amsterdam, Netherlands)Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. Alzheimers Dement (Amst). 2021; 13(1):e12199.Alzheimers Dement (Amst)2021-08-17T00:00:002021Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial.34550726Jacobs HIL, Becker JA, Kwong K, Engels-Domínguez N, Prokopiou PC, Papp KV, Properzi M, Hampton OL, d'Oleire Uquillas F, Sanchez JS, Rentz DM, El Fakhri G, Normandin MD, Price JC, Bennett DA, Sperling RA, Johnson KAScience translational medicineIn vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline. Sci Transl Med. 2021 Sep 22; 13(612):eabj2511.Sci Transl Med2021-09-22T00:00:002021In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline.34541287Fox-Fuller JT, Torrico-Teave H, d'Oleire Uquillas F, Chen K, Su Y, Chen Y, Brickhouse M, Sanchez JS, Aguero C, Jacobs HIL, Hampton O, Guzmán-Vélez E, Vila-Castelar C, Aguirre-Acevedo DC, Baena A, Artola A, Martinez J, Pluim CF, Alvarez S, Ochoa-Escudero M, Reiman EM, Sperling RA, Lopera F, Johnson KA, Dickerson BC, Quiroz YTAlzheimer's & dementia (Amsterdam, Netherlands)Cortical thickness across the lifespan in a Colombian cohort with autosomal-dominant Alzheimer's disease: A cross-sectional study. Alzheimers Dement (Amst). 2021; 13(1):e12233.Alzheimers Dement (Amst)2021-09-14T00:00:002021Cortical thickness across the lifespan in a Colombian cohort with autosomal-dominant Alzheimer's disease: A cross-sectional study.Authorship 139642422Authorship 139690916Authorship 1396893934548654McDade E, Voytyuk I, Aisen P, Bateman RJ, Carrillo MC, De Strooper B, Haass C, Reiman EM, Sperling R, Tariot PN, Yan R, Masters CL, Vassar R, Lichtenthaler SFNature reviews. NeurologyThe case for low-level BACE1 inhibition for the prevention of Alzheimer disease. Nat Rev Neurol. 2021 11; 17(11):703-714.Nat Rev Neurol2021-09-21T00:00:002021The case for low-level BACE1 inhibition for the prevention of Alzheimer disease.Authorship 139826418Authorship 14005491534588623Rodriguez-Vieitez E, Montal V, Sepulcre J, Lois C, Hanseeuw B, Vilaplana E, Schultz AP, Properzi MJ, Scott MR, Amariglio R, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini PMolecular psychiatryAssociation of cortical microstructure with amyloid-ß and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. Mol Psychiatry. 2021 12; 26(12):7813-7822.Mol Psychiatry2021-09-29T00:00:002021Association of cortical microstructure with amyloid-ß and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.34621977Papp KV, Samaroo A, Chou HC, Buckley R, Schneider OR, Hsieh S, Soberanes D, Quiroz Y, Properzi M, Schultz A, García-Magariño I, Marshall GA, Burke JG, Kumar R, Snyder N, Johnson K, Rentz DM, Sperling RA, Amariglio REAlzheimer's & dementia (Amsterdam, Netherlands)Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease. Alzheimers Dement (Amst). 2021; 13(1):e12243.Alzheimers Dement (Amst)2021-09-30T00:00:002021Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease.Authorship 14048371634661109Spira AP, Zipunnikov V, Raman R, Choi J, Di J, Bai J, Carlsson CM, Mintzer JE, Marshall GA, Porsteinsson AP, Yaari R, Wanigatunga SK, Kim J, Wu MN, Aisen PS, Sperling RA, Rosenberg PBSleep advances : a journal of the Sleep Research SocietyBrain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies. Sleep Adv. 2021; 2(1):zpab015.Sleep Adv2021-09-19T00:00:002021Brain amyloid burden, sleep, and 24-hour rest/activity rhythms: screening findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration Studies.34792589Wang L, Laurentiev J, Yang J, Lo YC, Amariglio RE, Blacker D, Sperling RA, Marshall GA, Zhou LJAMA network openDevelopment and Validation of a Deep Learning Model for Earlier Detection of Cognitive Decline From Clinical Notes in Electronic Health Records. JAMA Netw Open. 2021 11 01; 4(11):e2135174.JAMA Netw Open2021-11-01T00:00:002021Development and Validation of a Deep Learning Model for Earlier Detection of Cognitive Decline From Clinical Notes in Electronic Health Records.Authorship 1414397735065037Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, Sung YJ, Lee JH, Klunk WE, Hofmann A, Noble JM, Graff-Radford N, Mori H, Salloway SM, Masters CL, Martins R, Karch CM, Xiong C, Cruchaga C, Perrin RJ, Gordon BA, Benzinger TLS, Fox NC, Schofield PR, Fagan AM, Goate AM, Morris JC, Bateman RJ, Johnson KA, Sperling RAThe Lancet. NeurologyVariant-dependent heterogeneity in amyloid ß burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. Lancet Neurol. 2022 02; 21(2):140-152.Lancet Neurol2022-02-01T00:00:002022Variant-dependent heterogeneity in amyloid ß burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.35005192Grober E, Papp KV, Rentz DM, Sperling RA, Johnson KA, Amariglio RE, Schultz A, Lipton RB, Ezzati AAlzheimer's & dementia (Amsterdam, Netherlands)Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system. Alzheimers Dement (Amst). 2021; 13(1):e12224.Alzheimers Dement (Amst)2021-12-31T00:00:002021Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system.Authorship 14261504Authorship 142765939Authorship 1430031160Authorship 14303291235095476Jutten RJ, Rentz DM, Fu JF, Mayblyum DV, Amariglio RE, Buckley RF, Properzi MJ, Maruff P, Stark CE, Yassa MA, Johnson KA, Sperling RA, Papp KVFrontiers in aging neuroscienceMonthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease. Front Aging Neurosci. 2021; 13:800126.Front Aging Neurosci2022-01-13T00:00:002022Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease.35099509Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Flier WM, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Frings L, Frisoni GB, Fröhlich L, Gabryelewicz T, Gertz HJ, Gill KD, Gkatzima O, Gómez-Tortosa E, Grimmer T, Guedj E, Habeck CG, Hampel H, Handels R, Hansson O, Hausner L, Hellwig S, Heneka MT, Herukka SK, Hildebrandt H, Hodges J, Hort J, Huang CC, Iriondo AJ, Itoh Y, Ivanoiu A, Jagust WJ, Jessen F, Johannsen P, Johnson KA, Kandimalla R, Kapaki EN, Kern S, Kilander L, Klimkowicz-Mrowiec A, Klunk WE, Koglin N, Kornhuber J, Kramberger MG, Kuo HC, Van Laere K, Landau SM, Landeau B, Lee DY, de Leon M, Leyton CE, Lin KJ, Lleó A, Löwenmark M, Madsen K, Maier W, Marcusson J, Marquié M, Martinez-Lage P, Maserejian N, Mattsson N, de Mendonça A, Meyer PT, Miller BL, Minatani S, Mintun MA, Mok VCT, Molinuevo JL, Morbelli SD, Morris JC, Mroczko B, Na DL, Newberg A, Nobili F, Nordberg A, Olde Rikkert MGM, de Oliveira CR, Olivieri P, Orellana A, Paraskevas G, Parchi P, Pardini M, Parnetti L, Peters O, Poirier J, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Reiman EM, Rinne JO, Rodrigue KM, Rodríguez-Rodriguez E, Roe CM, Rosa-Neto P, Rosen HJ, Rot U, Rowe CC, Rüther E, Ruiz A, Sabri O, Sakhardande J, Sánchez-Juan P, Sando SB, Santana I, Sarazin M, Scheltens P, Schröder J, Selnes P, Seo SW, Silva D, Skoog I, Snyder PJ, Soininen H, Sollberger M, Sperling RA, Spiru L, Stern Y, Stomrud E, Takeda A, Teichmann M, Teunissen CE, Thompson LI, Tomassen J, Tsolaki M, Vandenberghe R, Verbeek MM, Verhey FRJ, Villemagne V, Villeneuve S, Vogelgsang J, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Yen TC, Zboch M, Zetterberg HJAMA neurologyPrevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. 2022 03 01; 79(3):228-243.JAMA Neurol2022-03-01T00:00:002022Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.35213372Jacobs HIL, O'Donnell A, Satizabal CL, Lois C, Kojis D, Hanseeuw BJ, Thibault E, Sanchez JS, Buckley RF, Yang Q, DeCarli C, Killiany R, Sargurupremraj M, Sperling RA, Johnson KA, Beiser AS, Seshadri SJournal of Alzheimer's disease : JADAssociations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study. J Alzheimers Dis. 2022; 86(4):1603-1609.J Alzheimers Dis2022-01-01T00:00:002022Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.35298083Jacobs HIL, Becker JA, Kwong K, Munera D, Ramirez-Gomez L, Engels-Domínguez N, Sanchez JS, Vila-Castelar C, Baena A, Sperling RA, Johnson KA, Lopera F, Quiroz YTAlzheimer's & dementia : the journal of the Alzheimer's AssociationWaning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease. Alzheimers Dement. 2023 01; 19(1):169-180.Alzheimers Dement2022-03-17T00:00:002022Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.35322012Prokopiou PC, Engels-Domínguez N, Papp KV, Scott MR, Schultz AP, Schneider C, Farrell ME, Buckley RF, Quiroz YT, El Fakhri G, Rentz DM, Sperling RA, Johnson KA, Jacobs HILNature communicationsLower novelty-related locus coeruleus function is associated with Aß-related cognitive decline in clinically healthy individuals. Nat Commun. 2022 03 23; 13(1):1571.Nat Commun2022-03-23T00:00:002022Lower novelty-related locus coeruleus function is associated with Aß-related cognitive decline in clinically healthy individuals.Authorship 14341631435338074Farrell ME, Papp KV, Buckley RF, Jacobs HIL, Schultz AP, Properzi MJ, Vannini P, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RANeurologyAssociation of Emerging ß-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults. Neurology. 2022 04 12; 98(15):e1512-e1524.Neurology2022-03-25T00:00:002022Association of Emerging ß-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.35380901Guzmán-Vélez E, Diez I, Schoemaker D, Pardilla-Delgado E, Vila-Castelar C, Fox-Fuller JT, Baena A, Sperling RA, Johnson KA, Lopera F, Sepulcre J, Quiroz YTProceedings of the National Academy of Sciences of the United States of AmericaAmyloid-ß and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease. Proc Natl Acad Sci U S A. 2022 04 12; 119(15):e2113641119.Proc Natl Acad Sci U S A2022-04-05T00:00:002022Amyloid-ß and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease.Authorship 143737610Authorship 143772311Authorship 14426464Authorship 14415708Authorship 14385373Authorship 144260312Authorship 14403655Authorship 14368291535291556Willey B, Mimmack K, Gagliardi G, Dossett ML, Wang S, Udeogu OJ, Donovan NJ, Gatchel JR, Quiroz YT, Amariglio R, Liu CH, Hyun S, ElTohamy A, Rentz D, Sperling RA, Marshall GA, Vannini PEClinicalMedicineRacial and socioeconomic status differences in stress, posttraumatic growth, and mental health in an older adult cohort during the COVID-19 pandemic. EClinicalMedicine. 2022 Mar; 45:101343.EClinicalMedicine2022-03-13T00:00:002022Racial and socioeconomic status differences in stress, posttraumatic growth, and mental health in an older adult cohort during the COVID-19 pandemic.35155730Petersen KK, Grober E, Lipton RB, Sperling RA, Buckley RF, Aisen PS, Ezzati AAlzheimer's & dementia (Amsterdam, Netherlands)Impact of sex and APOE e4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults. Alzheimers Dement (Amst). 2022; 14(1):e12271.Alzheimers Dement (Amst)2022-02-09T00:00:002022Impact of sex and APOE e4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults.35213373Weinstein G, O'Donnell A, Davis-Plourde K, Zelber-Sagi S, Ghosh S, DeCarli CS, Thibault EG, Sperling RA, Johnson KA, Beiser AS, Seshadri SJournal of Alzheimer's disease : JADNon-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-ß and Tau Pathology in Middle-Aged Adults: The Framingham Study. J Alzheimers Dis. 2022; 86(3):1371-1383.J Alzheimers Dis2022-01-01T00:00:002022Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-ß and Tau Pathology in Middle-Aged Adults: The Framingham Study.35173601Munro CE, Buckley R, Vannini P, DeMuro C, Sperling R, Rentz DM, Johnson K, Gatchel JR, Amariglio RFrontiers in aging neuroscienceLongitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer's Disease Biomarkers and Mood Symptoms. Front Aging Neurosci. 2021; 13:806432.Front Aging Neurosci2022-01-31T00:00:002022Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer's Disease Biomarkers and Mood Symptoms.35197359Grober E, Lipton RB, Sperling RA, Papp KV, Johnson KA, Rentz DM, Veroff AE, Aisen PS, Ezzati ANeurologyAssociations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study. Neurology. 2022 03 29; 98(13):e1327-e1336.Neurology2022-02-23T00:00:002022Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.35388223Bethlehem RAI, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, Adler S, Alexopoulos GS, Anagnostou E, Areces-Gonzalez A, Astle DE, Auyeung B, Ayub M, Bae J, Ball G, Baron-Cohen S, Beare R, Bedford SA, Benegal V, Beyer F, Blangero J, Blesa Cábez M, Boardman JP, Borzage M, Bosch-Bayard JF, Bourke N, Calhoun VD, Chakravarty MM, Chen C, Chertavian C, Chetelat G, Chong YS, Cole JH, Corvin A, Costantino M, Courchesne E, Crivello F, Cropley VL, Crosbie J, Crossley N, Delarue M, Delorme R, Desrivieres S, Devenyi GA, Di Biase MA, Dolan R, Donald KA, Donohoe G, Dunlop K, Edwards AD, Elison JT, Ellis CT, Elman JA, Eyler L, Fair DA, Feczko E, Fletcher PC, Fonagy P, Franz CE, Galan-Garcia L, Gholipour A, Giedd J, Gilmore JH, Glahn DC, Goodyer IM, Grant PE, Groenewold NA, Gunning FM, Gur RE, Gur RC, Hammill CF, Hansson O, Hedden T, Heinz A, Henson RN, Heuer K, Hoare J, Holla B, Holmes AJ, Holt R, Huang H, Im K, Ipser J, Jack CR, Jackowski AP, Jia T, Johnson KA, Jones PB, Jones DT, Kahn RS, Karlsson H, Karlsson L, Kawashima R, Kelley EA, Kern S, Kim KW, Kitzbichler MG, Kremen WS, Lalonde F, Landeau B, Lee S, Lerch J, Lewis JD, Li J, Liao W, Liston C, Lombardo MV, Lv J, Lynch C, Mallard TT, Marcelis M, Markello RD, Mathias SR, Mazoyer B, McGuire P, Meaney MJ, Mechelli A, Medic N, Misic B, Morgan SE, Mothersill D, Nigg J, Ong MQW, Ortinau C, Ossenkoppele R, Ouyang M, Palaniyappan L, Paly L, Pan PM, Pantelis C, Park MM, Paus T, Pausova Z, Paz-Linares D, Pichet Binette A, Pierce K, Qian X, Qiu J, Qiu A, Raznahan A, Rittman T, Rodrigue A, Rollins CK, Romero-Garcia R, Ronan L, Rosenberg MD, Rowitch DH, Salum GA, Satterthwaite TD, Schaare HL, Schachar RJ, Schultz AP, Schumann G, Schöll M, Sharp D, Shinohara RT, Skoog I, Smyser CD, Sperling RA, Stein DJ, Stolicyn A, Suckling J, Sullivan G, Taki Y, Thyreau B, Toro R, Traut N, Tsvetanov KA, Turk-Browne NB, Tuulari JJ, Tzourio C, Vachon-Presseau É, Valdes-Sosa MJ, Valdes-Sosa PA, Valk SL, van Amelsvoort T, Vandekar SN, Vasung L, Victoria LW, Villeneuve S, Villringer A, Vértes PE, Wagstyl K, Wang YS, Warfield SK, Warrier V, Westman E, Westwater ML, Whalley HC, Witte AV, Yang N, Yeo B, Yun H, Zalesky A, Zar HJ, Zettergren A, Zhou JH, Ziauddeen H, Zugman A, Zuo XN, Bullmore ET, Alexander-Bloch AFNatureBrain charts for the human lifespan. Nature. 2022 04; 604(7906):525-533.Nature2022-04-06T00:00:002022Brain charts for the human lifespan.Authorship 144618512Authorship 1446575159Authorship 14479895Authorship 144617410Authorship 14475158Authorship 14472072Authorship 1449046835473760Rabin JS, Pruzin J, Scott M, Yang HS, Hampton O, Hsieh S, Schultz AP, Buckley RF, Hedden T, Rentz D, Johnson KA, Sperling RA, Chhatwal JPNeurologyAssociation of ß-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy. Neurology. 2022 Jul 18; 99(3):e270-e280.Neurology2022-07-18T00:00:002022Association of ß-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy.35435938Young CB, Winer JR, Younes K, Cody KA, Betthauser TJ, Johnson SC, Schultz A, Sperling RA, Greicius MD, Cobos I, Poston KL, Mormino ECJAMA neurologyDivergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease. JAMA Neurol. 2022 06 01; 79(6):592-603.JAMA Neurol2022-06-01T00:00:002022Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.35471588Buckley RF, O'Donnell A, McGrath ER, Jacobs HIL, Lois C, Satizabal CL, Ghosh S, Rubinstein ZB, Murabito JM, Sperling RA, Johnson KA, Seshadri S, Beiser ASAnnals of neurologyMenopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study. Ann Neurol. 2022 07; 92(1):11-22.Ann Neurol2022-05-17T00:00:002022Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study.35470142Petersen KK, Lipton RB, Grober E, Davatzikos C, Sperling RA, Ezzati ANeurologyPredicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data. Neurology. 2022 06 14; 98(24):e2425-e2435.Neurology2022-04-25T00:00:002022Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data.35440022Assunção SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, Atri A, Cummings JAlzheimer's research & therapyMeaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease. Alzheimers Res Ther. 2022 04 19; 14(1):54.Alzheimers Res Ther2022-04-19T00:00:002022Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.Authorship 145072447Authorship 14508901335542998Papp KV, Rofael H, Veroff AE, Donohue MC, Wang S, Randolph C, Grober E, Brashear HR, Novak G, Ernstrom K, Raman R, Aisen PS, Sperling R, Romano G, Henley DThe journal of prevention of Alzheimer's diseaseSensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial. J Prev Alzheimers Dis. 2022; 9(2):255-261.J Prev Alzheimers Dis2022-01-01T00:00:002022Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.35552371Eissman JM, Dumitrescu L, Mahoney ER, Smith AN, Mukherjee S, Lee ML, Scollard P, Choi SE, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski CC, Hernandez Saucedo H, Widaman KF, Buckley RF, Properzi MJ, Mormino EC, Yang HS, Harrison TM, Hedden T, Nho K, Andrews SJ, Tommet D, Hadad N, Sanders RE, Ruderfer DM, Gifford KA, Zhong X, Raghavan NS, Vardarajan BN, Pericak-Vance MA, Farrer LA, Wang LS, Cruchaga C, Schellenberg GD, Cox NJ, Haines JL, Keene CD, Saykin AJ, Larson EB, Sperling RA, Mayeux R, Cuccaro ML, Bennett DA, Schneider JA, Crane PK, Jefferson AL, Hohman TJBrain : a journal of neurologySex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain. 2022 07 29; 145(7):2541-2554.Brain2022-07-29T00:00:002022Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.35670654Shirzadi Z, Yau WW, Schultz SA, Schultz AP, Scott MR, Goubran M, Mojiri-Forooshani P, Joseph-Mathurin N, Kantarci K, Preboske G, Wermer MJH, Jack C, Benzinger T, Taddei K, Sohrabi HR, Sperling RA, Johnson KA, Bateman RJ, Martins RN, Greenberg SM, Chhatwal JPAnnals of neurologyProgressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy. Ann Neurol. 2022 09; 92(3):358-363.Ann Neurol2022-06-25T00:00:002022Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy.35838824Sepulveda-Falla D, Sanchez JS, Almeida MC, Boassa D, Acosta-Uribe J, Vila-Castelar C, Ramirez-Gomez L, Baena A, Aguillon D, Villalba-Moreno ND, Littau JL, Villegas A, Beach TG, White CL, Ellisman M, Krasemann S, Glatzel M, Johnson KA, Sperling RA, Reiman EM, Arboleda-Velasquez JF, Kosik KS, Lopera F, Quiroz YTActa neuropathologicaDistinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia. Acta Neuropathol. 2022 09; 144(3):589-601.Acta Neuropathol2022-07-15T00:00:002022Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia.true1Assistant Professor of NeurologyAssistant Professor of Neurologytrue1Associate Professor of NeurologyAssociate Professor of Neurology35895837Montal V, Diez I, Kim CM, Orwig W, Bueichekú E, Gutiérrez-Zúñiga R, Bejanin A, Pegueroles J, Dols-Icardo O, Vannini P, El-Fakhri G, Johnson KA, Sperling RA, Fortea J, Sepulcre JScience translational medicineNetwork Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Sci Transl Med. 2022 07 27; 14(655):eabn7273.Sci Transl Med2022-07-27T00:00:002022Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes.35880989Yau WW, Shirzadi Z, Yang HS, Ikoba AP, Rabin JS, Properzi MJ, Kirn DR, Schultz AP, Rentz DM, Johnson KA, Sperling RA, Chhatwal JPAnnals of neurologyTau Mediates Synergistic Influence of Vascular Risk and Aß on Cognitive Decline. Ann Neurol. 2022 11; 92(5):745-755.Ann Neurol2022-08-13T00:00:002022Tau Mediates Synergistic Influence of Vascular Risk and Aß on Cognitive Decline.35821672Pruzin JJ, Klein H, Rabin JS, Schultz AP, Kirn DR, Yang HS, Buckley RF, Scott MR, Properzi M, Rentz DM, Johnson KA, Sperling RA, Chhatwal JPAlzheimer's & dementia (Amsterdam, Netherlands)Physical activity is associated with increased resting-state functional connectivity in networks predictive of cognitive decline in clinically unimpaired older adults. Alzheimers Dement (Amst). 2022; 14(1):e12319.Alzheimers Dement (Amst)2022-07-07T00:00:002022Physical activity is associated with increased resting-state functional connectivity in networks predictive of cognitive decline in clinically unimpaired older adults.Authorship 146475211Authorship 146099419Authorship 145830516Authorship 146879512Authorship 146242013Authorship 14667238Authorship 146130311Authorship 14613049Authorship 14614311435871328Baradaran H, Peloso GM, Polak JF, Killiany RJ, Ghosh S, DeCarli CS, Thibault EG, Sperling RA, Johnson KA, Beiser A, Romero JR, Seshadri SJournal of Alzheimer's disease : JADAssociation of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-ß Burden. J Alzheimers Dis. 2022; 89(1):223-232.J Alzheimers Dis2022-01-01T00:00:002022Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-ß Burden.35841239Raman R, Aisen PS, Carillo MC, Detke M, Grill JD, Okonkwo OC, Rivera-Mindt M, Sabbagh M, Vellas B, Weiner M, Sperling RThe journal of prevention of Alzheimer's diseaseTackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report. J Prev Alzheimers Dis. 2022; 9(3):388-392.J Prev Alzheimers Dis2022-01-01T00:00:002022Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report.35862098Hampton OL, Mukherjee S, Properzi MJ, Schultz AP, Crane PK, Gibbons LE, Hohman TJ, Maruff P, Lim YY, Amariglio RE, Papp KV, Johnson KA, Rentz DM, Sperling RA, Buckley RFNeuropsychologyHarmonizing the preclinical Alzheimer cognitive composite for multicohort studies. Neuropsychology. 2023 May; 37(4):436-449.Neuropsychology2022-07-21T00:00:002022Harmonizing the preclinical Alzheimer cognitive composite for multicohort studies.35841244Reynolds GO, Manning L, Kirn D, Klein H, Hampton O, Burke O, Buckley R, Rentz D, Sperling R, Marshall GA, Amariglio REThe journal of prevention of Alzheimer's diseaseSubjective Cognitive Decline in a Registry Sample: Relation to Psychiatric History, Loneliness, and Personality. J Prev Alzheimers Dis. 2022; 9(3):435-440.J Prev Alzheimers Dis2022-01-01T00:00:002022Subjective Cognitive Decline in a Registry Sample: Relation to Psychiatric History, Loneliness, and Personality.Authorship 150169512Authorship 14816715Authorship 14956017Authorship 14867508Authorship 149559811Authorship 14824822Authorship 1483615159Authorship 14955996Authorship 148893814Authorship 1493104236357681Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, Stomrud E, Tideman P, Ohlsson T, Jögi J, Johnson K, Sperling R, Dore V, Masters CL, Rowe C, Visser D, van Berckel BNM, van der Flier WM, Baker S, Jagust WJ, Wiste HJ, Petersen RC, Jack CR, Hansson ONature medicineAmyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022 11; 28(11):2381-2387.Nat Med2022-11-10T00:00:002022Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.35908251Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, Salloway S, Sperling R, Zetterberg H, Teunissen CEAlzheimer's & dementia : the journal of the Alzheimer's AssociationThe Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease. Alzheimers Dement. 2022 12; 18(12):2669-2686.Alzheimers Dement2022-07-31T00:00:002022The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.36281665Yaari R, Holdridge KC, Choi J, Donohue MC, Kantarci K, Jack CR, Zuk SM, Sims JR, Johnson KA, Aisen PS, Sperling RAThe journal of prevention of Alzheimer's diseaseAmyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid. J Prev Alzheimers Dis. 2022; 9(4):617-624.J Prev Alzheimers Dis2022-01-01T00:00:002022Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid.36281670Rhodus EK, Aisen P, Grill JD, Rentz DM, Petersen RC, Sperling RA, Salloway SP, Pierce D, Raman RThe journal of prevention of Alzheimer's diseaseAlzheimer's Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer's Clinical Trial Consortium Sites. J Prev Alzheimers Dis. 2022; 9(4):665-671.J Prev Alzheimers Dis2022-01-01T00:00:002022Alzheimer's Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer's Clinical Trial Consortium Sites.35971310Rafii MS, Sperling RA, Donohue MC, Zhou J, Roberts C, Irizarry MC, Dhadda S, Sethuraman G, Kramer LD, Swanson CJ, Li D, Krause S, Rissman RA, Walter S, Raman R, Johnson KA, Aisen PSAlzheimer's & dementia : the journal of the Alzheimer's AssociationThe AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease. Alzheimers Dement. 2023 04; 19(4):1227-1233.Alzheimers Dement2022-08-15T00:00:002022The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.35907254Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, Provost K, Soucy JP, Buckley RF, Benzinger TLS, Morris JC, Villemagne VL, Doré V, Sperling RA, Johnson KA, Rowe CC, Gordon BA, Poirier J, Breitner JCS, Villeneuve SJAMA neurologyAssociation of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. JAMA Neurol. 2022 10 01; 79(10):975-985.JAMA Neurol2022-10-01T00:00:002022Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment.35969392Grill JD, Sperling RA, Raman RJAMA neurologyWhat Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials? JAMA Neurol. 2022 11 01; 79(11):1097-1098.JAMA Neurol2022-11-01T00:00:002022What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?36151472Bethlehem RAI, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, Adler S, Alexopoulos GS, Anagnostou E, Areces-Gonzalez A, Astle DE, Auyeung B, Ayub M, Bae J, Ball G, Baron-Cohen S, Beare R, Bedford SA, Benegal V, Beyer F, Blangero J, Blesa Cábez M, Boardman JP, Borzage M, Bosch-Bayard JF, Bourke N, Calhoun VD, Chakravarty MM, Chen C, Chertavian C, Chetelat G, Chong YS, Cole JH, Corvin A, Costantino M, Courchesne E, Crivello F, Cropley VL, Crosbie J, Crossley N, Delarue M, Delorme R, Desrivieres S, Devenyi GA, Di Biase MA, Dolan R, Donald KA, Donohoe G, Dunlop K, Edwards AD, Elison JT, Ellis CT, Elman JA, Eyler L, Fair DA, Feczko E, Fletcher PC, Fonagy P, Franz CE, Galan-Garcia L, Gholipour A, Giedd J, Gilmore JH, Glahn DC, Goodyer IM, Grant PE, Groenewold NA, Gunning FM, Gur RE, Gur RC, Hammill CF, Hansson O, Hedden T, Heinz A, Henson RN, Heuer K, Hoare J, Holla B, Holmes AJ, Holt R, Huang H, Im K, Ipser J, Jack CR, Jackowski AP, Jia T, Johnson KA, Jones PB, Jones DT, Kahn RS, Karlsson H, Karlsson L, Kawashima R, Kelley EA, Kern S, Kim KW, Kitzbichler MG, Kremen WS, Lalonde F, Landeau B, Lee S, Lerch J, Lewis JD, Li J, Liao W, Liston C, Lombardo MV, Lv J, Lynch C, Mallard TT, Marcelis M, Markello RD, Mathias SR, Mazoyer B, McGuire P, Meaney MJ, Mechelli A, Medic N, Misic B, Morgan SE, Mothersill D, Nigg J, Ong MQW, Ortinau C, Ossenkoppele R, Ouyang M, Palaniyappan L, Paly L, Pan PM, Pantelis C, Park MM, Paus T, Pausova Z, Paz-Linares D, Pichet Binette A, Pierce K, Qian X, Qiu J, Qiu A, Raznahan A, Rittman T, Rodrigue A, Rollins CK, Romero-Garcia R, Ronan L, Rosenberg MD, Rowitch DH, Salum GA, Satterthwaite TD, Schaare HL, Schachar RJ, Schultz AP, Schumann G, Schöll M, Sharp D, Shinohara RT, Skoog I, Smyser CD, Sperling RA, Stein DJ, Stolicyn A, Suckling J, Sullivan G, Taki Y, Thyreau B, Toro R, Traut N, Tsvetanov KA, Turk-Browne NB, Tuulari JJ, Tzourio C, Vachon-Presseau É, Valdes-Sosa MJ, Valdes-Sosa PA, Valk SL, van Amelsvoort T, Vandekar SN, Vasung L, Victoria LW, Villeneuve S, Villringer A, Vértes PE, Wagstyl K, Wang YS, Warfield SK, Warrier V, Westman E, Westwater ML, Whalley HC, Witte AV, Yang N, Yeo B, Yun H, Zalesky A, Zar HJ, Zettergren A, Zhou JH, Ziauddeen H, Zugman A, Zuo XN, Bullmore ET, Alexander-Bloch AFNaturePublisher Correction: Brain charts for the human lifespan. Nature. 2022 Oct; 610(7931):E6.Nature2022-10-01T00:00:002022Publisher Correction: Brain charts for the human lifespan.36281685Dubbelman MA, Sanchez J, Schultz AP, Rentz DM, Amariglio RE, Sikkes SAM, Sperling RA, Johnson KA, Marshall GAThe journal of prevention of Alzheimer's diseaseEveryday Functioning and Entorhinal and Inferior Temporal Tau Burden in Cognitively Normal Older Adults. J Prev Alzheimers Dis. 2022; 9(4):801-808.J Prev Alzheimers Dis2022-01-01T00:00:002022Everyday Functioning and Entorhinal and Inferior Temporal Tau Burden in Cognitively Normal Older Adults.35962782Insel PS, Young CB, Aisen PS, Johnson KA, Sperling RA, Mormino EC, Donohue MCBrain : a journal of neurologyTau positron emission tomography in preclinical Alzheimer's disease. Brain. 2023 02 13; 146(2):700-711.Brain2023-02-13T00:00:002023Tau positron emission tomography in preclinical Alzheimer's disease.Authorship 19836612Authorship 15123387Authorship 15129752036571821Aguillon D, Langella S, Chen Y, Sanchez JS, Su Y, Vila-Castelar C, Vasquez D, Zetterberg H, Hansson O, Dage JL, Janelidze S, Chen K, Fox-Fuller JT, Aduen P, Martinez JE, Garcia G, Baena A, Guzman C, Johnson KA, Sperling RA, Blennow K, Reiman EM, Lopera F, Quiroz YTAlzheimer's & dementia : the journal of the Alzheimer's AssociationPlasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease. Alzheimers Dement. 2023 06; 19(6):2585-2594.Alzheimers Dement2022-12-26T00:00:002022Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.36597122Young CB, Johns E, Kennedy G, Belloy ME, Insel PS, Greicius MD, Sperling RA, Johnson KA, Poston KL, Mormino ECMolecular neurodegenerationAPOE effects on regional tau in preclinical Alzheimer's disease. Mol Neurodegener. 2023 01 04; 18(1):1.Mol Neurodegener2023-01-04T00:00:002023APOE effects on regional tau in preclinical Alzheimer's disease.Authorship 15220651336710683Winston CN, Langford O, Levin N, Raman R, Yarasheski K, West T, Abdel-Latif S, Donohue M, Nakamura A, Toba K, Masters CL, Doecke J, Sperling RA, Aisen PS, Rissman RAJournal of Alzheimer's disease : JADEvaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease. J Alzheimers Dis. 2023; 92(1):95-107.J Alzheimers Dis2023-01-01T00:00:002023Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.Authorship 1534474636950699Young CB, Mormino EC, Poston KL, Johnson KA, Rentz DM, Sperling RA, Papp KVAlzheimer's & dementia (Amsterdam, Netherlands)Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi-site cohort. Alzheimers Dement (Amst). 2023 Jan-Mar; 15(1):e12414.Alzheimers Dement (Amst)2023-03-20T00:00:002023Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi-site cohort.37020050Van Egroo M, Riphagen JM, Ashton NJ, Janelidze S, Sperling RA, Johnson KA, Yang HS, Bennett DA, Blennow K, Hansson O, Zetterberg H, Jacobs HILMolecular psychiatryUltra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau. Mol Psychiatry. 2023 06; 28(6):2412-2422.Mol Psychiatry2023-04-05T00:00:002023Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau.37010830Coughlan GT, Betthauser TJ, Boyle R, Koscik RL, Klinger HM, Chibnik LB, Jonaitis EM, Yau WW, Wenzel A, Christian BT, Gleason CE, Saelzler UG, Properzi MJ, Schultz AP, Hanseeuw BJ, Manson JE, Rentz DM, Johnson KA, Sperling R, Johnson SC, Buckley RFJAMA neurologyAssociation of Age at Menopause and Hormone Therapy Use With Tau and ß-Amyloid Positron Emission Tomography. JAMA Neurol. 2023 05 01; 80(5):462-473.JAMA Neurol2023-05-01T00:00:002023Association of Age at Menopause and Hormone Therapy Use With Tau and ß-Amyloid Positron Emission Tomography.Authorship 190069537212093Gonzalez C, Mimmack KJ, Amariglio RE, Becker JA, Chhatwal JP, Fitzpatrick CD, Gatchel JR, Johnson KA, Katz ZS, Kuppe MK, Locascio JJ, Udeogu OJ, Papp KV, Premnath P, Properzi MJ, Rentz DM, Schultz AP, Sperling RA, Vannini P, Wang S, Marshall GAJournal of Alzheimer's disease : JADAssociations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings. J Alzheimers Dis. 2023; 94(1):217-226.J Alzheimers Dis2023-01-01T00:00:002023Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.37188781Lopera F, Marino C, Chandrahas AS, O'Hare M, Villalba-Moreno ND, Aguillon D, Baena A, Sanchez JS, Vila-Castelar C, Ramirez Gomez L, Chmielewska N, Oliveira GM, Littau JL, Hartmann K, Park K, Krasemann S, Glatzel M, Schoemaker D, Gonzalez-Buendia L, Delgado-Tirado S, Arevalo-Alquichire S, Saez-Torres KL, Amarnani D, Kim LA, Mazzarino RC, Gordon H, Bocanegra Y, Villegas A, Gai X, Bootwalla M, Ji J, Shen L, Kosik KS, Su Y, Chen Y, Schultz A, Sperling RA, Johnson K, Reiman EM, Sepulveda-Falla D, Arboleda-Velasquez JF, Quiroz YTNature medicineResilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man. Nat Med. 2023 05; 29(5):1243-1252.Nat Med2023-05-15T00:00:002023Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.37291760Schultz SA, Shirzadi Z, Schultz AP, Liu L, Fitzpatrick CD, McDade E, Barthelemy NR, Renton A, Esposito B, Joseph-Mathurin N, Cruchaga C, Chen CD, Goate A, Allegri RF, Benzinger TLS, Berman S, Chui HC, Fagan AM, Farlow MR, Fox NC, Gordon BA, Day GS, Graff-Radford NR, Hassenstab JJ, Hanseeuw BJ, Hofmann A, Jack CR, Jucker M, Karch CM, Koeppe RA, Lee JH, Levey AI, Levin J, Martins RN, Mori H, Morris JC, Noble J, Perrin RJ, Rosa-Neto P, Salloway SP, Sanchez-Valle R, Schofield PR, Xiong C, Johnson KA, Bateman RJ, Sperling RA, Chhatwal JPAging cellLocation of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. 2023 08; 22(8):e13871.Aging Cell2023-06-08T00:00:002023Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.37276136Rabin LA, Sikkes SAM, Tommet D, Jones RN, Crane PK, Elbulok-Charcape MM, Dubbelman MA, Koscik R, Amariglio RE, Buckley RF, Boada M, Chételat G, Dubois B, Ellis KA, Gifford KA, Jefferson AL, Jessen F, Johnson S, Katz MJ, Lipton RB, Luck T, Margioti E, Maruff P, Molinuevo JL, Perrotin A, Petersen RC, Rami L, Reisberg B, Rentz DM, Riedel-Heller SG, Risacher SL, Rodriguez-Gomez O, Sachdev PS, Saykin AJ, Scarmeas N, Smart C, Snitz BE, Sperling RA, Taler V, van der Flier WM, van Harten AC, Wagner M, Wolfsgruber SNeuropsychologyLinking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative. Neuropsychology. 2023 May; 37(4):463-499.Neuropsychology2023-05-01T00:00:002023Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative.37491329Prokopiou PC, Engels-Domínguez N, Schultz AP, Sepulcre J, Koops EA, Papp KV, Marshall GA, Normandin MD, El Fakhri G, Rentz D, Sperling RA, Johnson KA, Jacobs HILNeurologyAssociation of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease. Neurology. 2023 09 19; 101(12):e1206-e1217.Neurology2023-07-25T00:00:002023Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease.Authorship 15581811Authorship 155296316Authorship 157146617Authorship 155452815Authorship 156912838Authorship 157038346Authorship 156910137Authorship 154331423Authorship 157055211Authorship 15664098Authorship 15630665Authorship 15590105Authorship 156550418Authorship 15568626Authorship 15608621937101235Ali M, Archer DB, Gorijala P, Western D, Timsina J, Fernández MV, Wang TC, Satizabal CL, Yang Q, Beiser AS, Wang R, Chen G, Gordon B, Benzinger TLS, Xiong C, Morris JC, Bateman RJ, Karch CM, McDade E, Goate A, Seshadri S, Mayeux RP, Sperling RA, Buckley RF, Johnson KA, Won HH, Jung SH, Kim HR, Seo SW, Kim HJ, Mormino E, Laws SM, Fan KH, Kamboh MI, Vemuri P, Ramanan VK, Yang HS, Wenzel A, Rajula HSR, Mishra A, Dufouil C, Debette S, Lopez OL, DeKosky ST, Tao F, Nagle MW, Hohman TJ, Sung YJ, Dumitrescu L, Cruchaga CActa neuropathologica communicationsLarge multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease. Acta Neuropathol Commun. 2023 04 26; 11(1):68.Acta Neuropathol Commun2023-04-26T00:00:002023Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease.37333223Yang HS, Teng L, Kang D, Menon V, Ge T, Finucane HK, Schultz AP, Properzi M, Klein HU, Chibnik LB, Schneider JA, Bennett DA, Hohman TJ, Mayeux RP, Johnson KA, De Jager PL, Sperling RAmedRxiv : the preprint server for health sciencesCell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. medRxiv. 2023 Jun 05.medRxiv2023-06-05T00:00:002023Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease.36993271Nho K, Risacher SL, Apostolova L, Bice PJ, Brosch J, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, Sperling R, Hooli B, Shcherbinin S, Svaldi D, Jack CR, Jagust WJ, Landau S, Vasanthakumar A, Waring JF, Doré V, Laws SM, Masters CL, Porter T, Rowe CC, Villemagne VL, Dumitrescu L, Hohman TJ, Libby JB, Mormino E, Buckley RF, Johnson K, Yang HS, Petersen RC, Ramanan VK, Vemuri P, Cohen AD, Fan KH, Kamboh MI, Lopez OL, Bennett DA, Ali M, Benzinger T, Cruchaga C, Hobbs D, De Jager PL, Fujita M, Jadhav V, Lamb BT, Tsai AP, Castanho I, Mill J, Weiner MW, Saykin AJmedRxiv : the preprint server for health sciencesNovel CYP1B1-RMDN2 Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET. medRxiv. 2023 Mar 22.medRxiv2023-03-22T00:00:002023Novel CYP1B1-RMDN2 Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET.37304049Reynolds G, Buckley R, Papp K, Schultz SA, Rentz D, Sperling R, Amariglio RAlzheimer's & dementia (Amsterdam, Netherlands)Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data. Alzheimers Dement (Amst). 2023 Apr-Jun; 15(2):e12435.Alzheimers Dement (Amst)2023-06-07T00:00:002023Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data.37458272Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PSThe New England journal of medicineTrial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med. 2023 Sep 21; 389(12):1096-1107.N Engl J Med2023-07-17T00:00:002023Trial of Solanezumab in Preclinical Alzheimer's Disease.37131229Kirn DR, Grill JD, Aisen P, Ernstrom K, Gale S, Heidebrink J, Jicha G, Jimenez-Maggiora G, Johnson L, Peskind E, McCann K, Shaffer E, Sultzer D, Wang S, Sperling R, Raman RAlzheimer's research & therapyCentralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment. Alzheimers Res Ther. 2023 05 02; 15(1):88.Alzheimers Res Ther2023-05-02T00:00:002023Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment.37182868Nallapu BT, Petersen KK, Lipton RB, Grober E, Sperling RA, Ezzati AJournal of Alzheimer's disease : JADAssociation of Alcohol Consumption with Cognition in Older Population: The A4 Study. J Alzheimers Dis. 2023; 93(4):1381-1393.J Alzheimers Dis2023-01-01T00:00:002023Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.37218387Robinson T, Klinger H, Buckley R, Deters KD, Quiroz YT, Rentz D, Rabin JS, Sperling RA, Amariglio REAlzheimer's & dementia : the journal of the Alzheimer's AssociationSubjective cognitive decline across ethnoracial groups in the A4 study. Alzheimers Dement. 2023 09; 19(9):4084-4093.Alzheimers Dement2023-05-23T00:00:002023Subjective cognitive decline across ethnoracial groups in the A4 study.Authorship 158376114Authorship 15890431237528163Gagliardi G, Rodriguez-Vieitez E, Montal V, Sepulcre J, Diez I, Lois C, Hanseeuw B, Schultz AP, Properzi MJ, Papp KV, Marshall GA, Fortea J, Johnson KA, Sperling RA, Vannini PCommunications medicineCortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Commun Med (Lond). 2023 Aug 01; 3(1):106.Commun Med (Lond)2023-08-01T00:00:002023Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid.37728659Scott MR, Edwards NC, Properzi MJ, Jacobs HI, Price JC, Lois C, Farrell ME, Hanseeuw BJ, Thibault EG, Rentz DM, Johnson KA, Sperling RA, Schultz AP, Buckley RFJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and MetabolismContribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal. J Cereb Blood Flow Metab. 2024 Jan; 44(1):131-141.J Cereb Blood Flow Metab2023-09-20T00:00:002023Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal.Authorship 1597440537830926Grill JD, Flournoy C, Dhadda S, Ernstrom K, Sperling R, Molina-Henry D, Tranotti K, Harris R, Kanekiyo M, Gee M, Irizarry M, Kramer L, Aisen P, Raman RAnnals of neurologyEligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease. Ann Neurol. 2024 Feb; 95(2):288-298.Ann Neurol2023-10-25T00:00:002023Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease.true1Professor of RadiologyProfessor of Radiology37843849Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, Levey AI, Gordon BA, Schofield PR, Salloway SP, Perrin RJ, McDade E, Levin J, Cruchaga C, Allegri RF, Fox NC, Goate A, Day GS, Koeppe R, Chui HC, Berman S, Mori H, Sanchez-Valle R, Lee JH, Rosa-Neto P, Ruthirakuhan M, Wu CY, Swardfager W, Benzinger TLS, Sohrabi HR, Martins RN, Bateman RJ, Johnson KA, Sperling RA, Greenberg SM, Schultz AP, Chhatwal JPJAMA neurologyEtiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. JAMA Neurol. 2023 Dec 01; 80(12):1353-1363.JAMA Neurol2023-12-01T00:00:002023Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.Authorship 16006742Authorship 160162543Authorship 1601837137899618Sperling RAThe journal of prevention of Alzheimer's diseaseEditorial: Are We There Yet (and How Do We Get There…)? J Prev Alzheimers Dis. 2023; 10(S1):S1-S2.J Prev Alzheimers Dis2023-01-01T00:00:002023Editorial: Are We There Yet (and How Do We Get There…)?37848035Boxer AL, Sperling RCellAccelerating Alzheimer's therapeutic development: The past and future of clinical trials. Cell. 2023 10 26; 186(22):4757-4772.Cell2023-10-16T00:00:002023Accelerating Alzheimer's therapeutic development: The past and future of clinical trials.37968130Hanseeuw BJ, Jacobs HIL, Schultz AP, Buckley RF, Farrell ME, Guehl NJ, Becker JA, Properzi M, Sanchez JS, Quiroz YT, Vannini P, Sepulcre J, Yang HS, Chhatwal JP, Gatchel J, Marshall GA, Amariglio R, Papp K, Rentz DM, Normandin M, Price JC, Healy BC, El Fakhri G, Sperling RA, Johnson KANeurologyAssociation of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults. Neurology. 2023 Dec 12; 101(24):e2533-e2544.Neurology2023-11-08T00:00:002023Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.Authorship 16050572037932961Rissman RA, Langford O, Raman R, Donohue MC, Abdel-Latif S, Meyer MR, Wente-Roth T, Kirmess KM, Ngolab J, Winston CN, Jimenez-Maggiora G, Rafii MS, Sachdev P, West T, Yarasheski KE, Braunstein JB, Irizarry M, Johnson KA, Aisen PS, Sperling RAAlzheimer's & dementia : the journal of the Alzheimer's AssociationPlasma Aß42/Aß40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease. Alzheimers Dement. 2024 Feb; 20(2):1214-1224.Alzheimers Dement2023-11-06T00:00:002023Plasma Aß42/Aß40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.Authorship 16112132Authorship 160820712Authorship 16087278Authorship 160862817Authorship 16105767Authorship 161046424Authorship 16105831138036535Yang HS, Teng L, Kang D, Menon V, Ge T, Finucane HK, Schultz AP, Properzi M, Klein HU, Chibnik LB, Schneider JA, Bennett DA, Hohman TJ, Mayeux RP, Johnson KA, De Jager PL, Sperling RANature communicationsCell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. Nat Commun. 2023 Nov 30; 14(1):7659.Nat Commun2023-11-30T00:00:002023Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease.37991080Papp KV, Jutten RJ, Soberanes D, Weizenbaum E, Hsieh S, Molinare C, Buckley R, Betensky RA, Marshall GA, Johnson KA, Rentz DM, Sperling R, Amariglio REAnnals of neurologyEarly Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing. Ann Neurol. 2024 Mar; 95(3):507-517.Ann Neurol2023-12-19T00:00:002023Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing.38012286Stern AM, Sperling RANature agingTangles, not TANGO: targeting tau aggregates. Nat Aging. 2023 Dec; 3(12):1472-1473.Nat Aging2023-12-01T00:00:002023Tangles, not TANGO: targeting tau aggregates.37971861Jutten RJ, Amariglio RE, Maruff P, Properzi MJ, Rentz DM, Johnson KA, Sperling RA, Papp KVNeuropsychologyIncreased intraindividual variability in reaction time performance is associated with emerging cognitive decline in cognitively unimpaired adults. Neuropsychology. 2024 Feb; 38(2):184-197.Neuropsychology2023-11-16T00:00:002023Increased intraindividual variability in reaction time performance is associated with emerging cognitive decline in cognitively unimpaired adults.38038976Bonomi S, Lu R, Schindler SE, Bui Q, Lah JJ, Wolk D, Gleason CE, Sperling R, Roberson ED, Levey AI, Shaw L, Van Hulle C, Benzinger T, Adams M, Manzanares C, Qiu D, Hassenstab J, Moulder KL, Balls-Berry JE, Johnson K, Johnson SC, Murchison CF, Luo J, Gremminger E, Agboola F, Grant EA, Hornbeck R, Massoumzadeh P, Keefe S, Dierker D, Gray J, Henson RL, Streitz M, Mechanic-Hamilton D, Morris JC, Xiong CAnnals of neurologyRelationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals. Ann Neurol. 2024 Mar; 95(3):495-506.Ann Neurol2023-12-19T00:00:002023Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.37971862Weizenbaum EL, Soberanes D, Hsieh S, Molinare CP, Buckley RF, Betensky RA, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, Sperling RA, Amariglio RE, Papp KVNeuropsychologyCapturing learning curves with the multiday Boston Remote Assessment of Neurocognitive Health (BRANCH): Feasibility, reliability, and validity. Neuropsychology. 2024 Feb; 38(2):198-210.Neuropsychology2023-11-16T00:00:002023Capturing learning curves with the multiday Boston Remote Assessment of Neurocognitive Health (BRANCH): Feasibility, reliability, and validity.Authorship 1614344838111596Dubbelman MA, Hall TC, Levesque IM, Mimmack KJ, Sikkes SAM, Fischer SH, Rentz DM, Sperling RA, Papp KV, Amariglio RE, Marshall GAAlzheimer's & dementia (Amsterdam, Netherlands)Using a digital tool to detect early changes in everyday functioning in older adults: A pilot study of the Assessment of Smartphone Everyday Tasks (ASSET). Alzheimers Dement (Amst). 2023 Oct-Dec; 15(4):e12506.Alzheimers Dement (Amst)2023-12-17T00:00:002023Using a digital tool to detect early changes in everyday functioning in older adults: A pilot study of the Assessment of Smartphone Everyday Tasks (ASSET).Authorship 16185143138170841Sexton CE, Bitan G, Bowles KR, Brys M, Buée L, Maina MB, Clelland CD, Cohen AD, Crary JF, Dage JL, Diaz K, Frost B, Gan L, Goate AM, Golbe LI, Hansson O, Karch CM, Kolb HC, La Joie R, Lee SE, Matallana D, Miller BL, Onyike CU, Quiroz YT, Rexach JE, Rohrer JD, Rommel A, Sadri-Vakili G, Schindler SE, Schneider JA, Sperling RA, Teunissen CE, Weninger SC, Worley SL, Zheng H, Carrillo MCAlzheimer's & dementia : the journal of the Alzheimer's AssociationNovel avenues of tau research. Alzheimers Dement. 2024 Jan 03.Alzheimers Dement2024-01-03T00:00:002024Novel avenues of tau research.Authorship 1621505738230716Ruthirakuhan M, Wood Alexander M, Cogo-Moreira H, Robinson T, Amariglio R, Buckley RF, Sperling RA, Swardfager W, Black SE, Rabin JSThe journal of prevention of Alzheimer's diseaseInvestigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aß Status Groups in the A4 Study. J Prev Alzheimers Dis. 2024; 11(1):48-55.J Prev Alzheimers Dis2024-01-01T00:00:002024Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aß Status Groups in the A4 Study.Authorship 16234172838265159Agarwal K, Backler W, Bayram E, Bloom L, Boeve BF, Cha JH, Denslow M, Ferman TJ, Galasko D, Galvin JE, Gomperts SN, Irizarry MC, Kantarci K, Kaushik H, Kietlinski M, Koenig A, Leverenz JB, McKeith I, McLean PJ, Montine TJ, Moose SO, O'Brien JT, Panier V, Ramanathan S, Ringel MS, Scholz SW, Small J, Sperling RA, Taylor A, Taylor JP, Ward RA, Witten L, Hyman BTAlzheimer's & dementia : the journal of the Alzheimer's AssociationLewy body dementia: Overcoming barriers and identifying solutions. Alzheimers Dement. 2024 Jan 24.Alzheimers Dement2024-01-24T00:00:002024Lewy body dementia: Overcoming barriers and identifying solutions.Authorship 16272251738315899Yang HS, Yau WW, Carlyle BC, Trombetta BA, Zhang C, Shirzadi Z, Schultz AP, Pruzin JJ, Fitzpatrick CD, Kirn DR, Rabin JS, Buckley RF, Hohman TJ, Rentz DM, Tanzi RE, Johnson KA, Sperling RA, Arnold SE, Chhatwal JPBrain : a journal of neurologyPlasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease. Brain. 2024 Feb 05.Brain2024-02-05T00:00:002024Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.Authorship 16291912038429551Therriault J, Schindler SE, Salvadó G, Pascoal TA, Benedet AL, Ashton NJ, Karikari TK, Apostolova L, Murray ME, Verberk I, Vogel JW, La Joie R, Gauthier S, Teunissen C, Rabinovici GD, Zetterberg H, Bateman RJ, Scheltens P, Blennow K, Sperling R, Hansson O, Jack CR, Rosa-Neto PNature reviews. NeurologyBiomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Rev Neurol. 2024 Mar 01.Nat Rev Neurol2024-03-01T00:00:002024Biomarker-based staging of Alzheimer disease: rationale and clinical applications.38452039Shirzadi Z, Boyle R, Yau WW, Coughlan G, Fu JF, Properzi MJ, Buckley RF, Yang HS, Scanlon CE, Hsieh S, Amariglio RE, Papp K, Rentz D, Price JC, Johnson KA, Sperling RA, Chhatwal JP, Schultz APJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and MetabolismVascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study. J Cereb Blood Flow Metab. 2024 Mar 07; 271678X241237624.J Cereb Blood Flow Metab2024-03-07T00:00:002024Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study.Authorship 163450714Authorship 16348321638443298Burling JE, Katz Z, Yuan Z, Munro C, Mimmack K, Ma G, Hanseeuw BJ, Papp KV, Amariglio RE, Vannini P, Rentz DM, Quiroz YT, Johnson KA, Sperling RA, Blacker D, Marshall GA, Yang HS, Gatchel JRThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric PsychiatryStudy Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study. Am J Geriatr Psychiatry. 2024 Jan 28.Am J Geriatr Psychiatry2024-01-28T00:00:002024Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.Authorship 1606252Authorship 308901Authorship 2466898Authorship 6335717Authorship 6393438Authorship 6440001Authorship 6433171Authorship 6435777Authorship 6492167Authorship 6603707Authorship 6632291Authorship 6568321Authorship 6429312Authorship 6538681Authorship 6419874Authorship 64665915Authorship 6496734Authorship 6552891Authorship 6584539Authorship 6618716Authorship 6602574Authorship 6430305Authorship 639956195Authorship 6666336Authorship 6394184Authorship 66687011Authorship 66756438Authorship 6394126Authorship 6433661Authorship 6427162Authorship 6446363Authorship 6539721Authorship 6433655Authorship 6431414Authorship 64550213Authorship 35449Authorship 6499256Authorship 66177910Authorship 66406426Authorship 6565748Authorship 6609601Authorship 66176321Authorship 6553976Authorship 6589458Authorship 6666683Authorship 6443748Authorship 64719911Authorship 6629912Authorship 64598814Authorship 6544252Authorship 6551442Authorship 6662314Authorship 6542655Authorship 6420678Authorship 6663692Authorship 64944517Authorship 6658349Authorship 6501584Authorship 6541039Authorship 65646810Authorship 6600236Authorship 6628119Authorship 66467310Authorship 66822916Authorship 6338364Authorship 66323510Authorship 6573174Authorship 64374510Authorship 64515312Authorship 6514481Authorship 6541884Authorship 6653621Authorship 6420896Authorship 64863113Authorship 6497846Authorship 65296511Authorship 660833122633529Fleisher AS, Chen K, Liu X, Ayutyanont N, Roontiva A, Thiyyagura P, Protas H, Joshi AD, Sabbagh M, Sadowsky CH, Sperling RA, Clark CM, Mintun MA, Pontecorvo MJ, Coleman RE, Doraiswamy PM, Johnson KA, Carpenter AP, Skovronsky DM, Reiman EMNeurobiology of agingApolipoprotein E e4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging. 2013 Jan; 34(1):1-12.Neurobiol Aging2012-05-24T00:00:002012Apolipoprotein E e4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.21321398Yang W, Lui RL, Gao JH, Chan TF, Yau ST, Sperling RA, Huang XJournal of Alzheimer's disease : JADIndependent component analysis-based classification of Alzheimer's disease MRI data. J Alzheimers Dis. 2011; 24(4):775-83.J Alzheimers Dis2011-01-01T00:00:002011Independent component analysis-based classification of Alzheimer's disease MRI data.21696834Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel HTrends in neurosciencesNeuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci. 2011 Aug; 34(8):430-42.Trends Neurosci2011-06-21T00:00:002011Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.22232352Sperling R, Johnson KArchives of neurologyTo sleep, perchance to delay dementia. Arch Neurol. 2012 Jan; 69(1):118-20.Arch Neurol2012-01-01T00:00:002012To sleep, perchance to delay dementia.23801740Sepulcre J, Sabuncu MR, Becker A, Sperling R, Johnson KABrain : a journal of neurologyIn vivo characterization of the early states of the amyloid-beta network. Brain. 2013 Jul; 136(Pt 7):2239-52.Brain2013-07-01T00:00:002013In vivo characterization of the early states of the amyloid-beta network.22100665Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, Obisesan TO, Rusinek H, Scharre D, Sperling R, Weiner MW, Green RCNeuroImageThe ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage. 2012 Feb 15; 59(4):4196-200.Neuroimage2011-11-04T00:00:002011The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors.22529247Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AMArchives of neurologyAmyloid-ß--associated clinical decline occurs only in the presence of elevated P-tau. Arch Neurol. 2012 Jun; 69(6):709-13.Arch Neurol2012-06-01T00:00:002012Amyloid-ß--associated clinical decline occurs only in the presence of elevated P-tau.21784356Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NLAlzheimer's & dementia : the journal of the Alzheimer's AssociationSteps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement. 2011 Jul; 7(4):474-485.e4.Alzheimers Dement2011-07-01T00:00:002011Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.22570135DeCarli C, Kawas C, Morrison JH, Reuter-Lorenz PA, Sperling RA, Wright CBThe journals of gerontology. Series A, Biological sciences and medical sciencesSession II: Mechanisms of age-related cognitive change and targets for intervention: neural circuits, networks, and plasticity. J Gerontol A Biol Sci Med Sci. 2012 Jun; 67(7):747-53.J Gerontol A Biol Sci Med Sci2012-05-08T00:00:002012Session II: Mechanisms of age-related cognitive change and targets for intervention: neural circuits, networks, and plasticity.11115219Saag K, van der Heijde D, Fisher C, Samara A, DeTora L, Bolognese J, Sperling R, Daniels BArchives of family medicineRofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group. Arch Fam Med. 2000 Nov-Dec; 9(10):1124-34.Arch Fam Med2000-11-01T00:00:002000Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group.21514247Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CHAlzheimer's & dementia : the journal of the Alzheimer's AssociationIntroduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):257-62.Alzheimers Dement2011-04-21T00:00:002011Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.23876113Salmon DP, Ferris SH, Thomas RG, Sano M, Cummings JL, Sperling RA, Petersen RC, Aisen PSNeuropsychologyAge and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly. Neuropsychology. 2013 Jul; 27(4):391-401.Neuropsychology2013-07-01T00:00:002013Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.22878163Sperling RA, Johnson KA, Doraiswamy PM, Reiman EM, Fleisher AS, Sabbagh MN, Sadowsky CH, Carpenter A, Davis MD, Lu M, Flitter M, Joshi AD, Clark CM, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJNeurobiology of agingAmyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging. 2013 Mar; 34(3):822-31.Neurobiol Aging2012-08-09T00:00:002012Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.22078171Sperling RNeurobiology of agingPotential of functional MRI as a biomarker in early Alzheimer's disease. Neurobiol Aging. 2011 Dec; 32 Suppl 1:S37-43.Neurobiol Aging2011-12-01T00:00:002011Potential of functional MRI as a biomarker in early Alzheimer's disease.22474610Johnson KA, Fox NC, Sperling RA, Klunk WECold Spring Harbor perspectives in medicineBrain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. 2012 Apr; 2(4):a006213.Cold Spring Harb Perspect Med2012-04-01T00:00:002012Brain imaging in Alzheimer disease.11413252Sperling RJournal of neurology, neurosurgery, and psychiatryThe volumes of memory. J Neurol Neurosurg Psychiatry. 2001 Jul; 71(1):5.J Neurol Neurosurg Psychiatry2001-07-01T00:00:002001The volumes of memory.22172609Sperling RA, Johnson KAThe Lancet. NeurologyDementia: new criteria but no new treatments. Lancet Neurol. 2012 Jan; 11(1):4-5.Lancet Neurol2012-01-01T00:00:002012Dementia: new criteria but no new treatments.23932342Johnson KA, Sperling RA, Sepulcre JBiological psychiatryFunctional connectivity in Alzheimer's disease: measurement and meaning. Biol Psychiatry. 2013 Sep 01; 74(5):318-9.Biol Psychiatry2013-09-01T00:00:002013Functional connectivity in Alzheimer's disease: measurement and meaning.20587006Sperling R, Johnson KAlzheimer's research & therapyPro: Can biomarkers be gold standards in Alzheimer's disease? Alzheimers Res Ther. 2010 Jun 25; 2(3):17.Alzheimers Res Ther2010-06-25T00:00:002010Pro: Can biomarkers be gold standards in Alzheimer's disease?22305802Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman MThe Lancet. NeurologyAmyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012 Mar; 11(3):241-9.Lancet Neurol2012-02-03T00:00:002012Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.22786606Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, Pontecorvo MJNeurologyAmyloid-ß assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology. 2012 Oct 16; 79(16):1636-44.Neurology2012-07-11T00:00:002012Amyloid-ß assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.22959699Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley RW, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, van Deerlin V, Stern Y, Weir D, Wolk DA, Trojanowski JQAlzheimer's & dementia : the journal of the Alzheimer's AssociationAdvancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimers Dement. 2012 Sep; 8(5):445-52.Alzheimers Dement2012-09-01T00:00:002012Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.23183885Sperling RA, Karlawish J, Johnson KANature reviews. NeurologyPreclinical Alzheimer disease-the challenges ahead. Nat Rev Neurol. 2013 01; 9(1):54-8.Nat Rev Neurol2012-11-27T00:00:002012Preclinical Alzheimer disease-the challenges ahead.21917766Salloway S, Sperling R, Keren R, Porsteinsson AP, van Dyck CH, Tariot PN, Gilman S, Arnold D, Abushakra S, Hernandez C, Crans G, Liang E, Quinn G, Bairu M, Pastrak A, Cedarbaum JMNeurologyA phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. Neurology. 2011 Sep 27; 77(13):1253-62.Neurology2011-09-14T00:00:002011A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.22133718Sperling RA, Jack CR, Aisen PSScience translational medicineTesting the right target and right drug at the right stage. Sci Transl Med. 2011 Nov 30; 3(111):111cm33.Sci Transl Med2011-11-30T00:00:002011Testing the right target and right drug at the right stage.23558480Sperling R, Johnson KContinuum (Minneapolis, Minn.)Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria. Continuum (Minneap Minn). 2013 Apr; 19(2 Dementia):325-38.Continuum (Minneap Minn)2013-04-01T00:00:002013Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria.22344847Vannini P, Hedden T, Sullivan C, Sperling RAHuman brain mappingDifferential functional response in the posteromedial cortices and hippocampus to stimulus repetition during successful memory encoding. Hum Brain Mapp. 2013 Jul; 34(7):1568-78.Hum Brain Mapp2012-02-17T00:00:002012Differential functional response in the posteromedial cortices and hippocampus to stimulus repetition during successful memory encoding.23411394Carrillo MC, Brashear HR, Logovinsky V, Ryan JM, Feldman HH, Siemers ER, Abushakra S, Hartley DM, Petersen RC, Khachaturian AS, Sperling RAAlzheimer's & dementia : the journal of the Alzheimer's AssociationCan we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease. Alzheimers Dement. 2013 Mar; 9(2):123-131.e1.Alzheimers Dement2013-02-12T00:00:002013Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.21414553Khachaturian ZS, Petersen RC, Snyder PJ, Khachaturian AS, Aisen P, de Leon M, Greenberg BD, Kukull W, Maruff P, Sperling RA, Stern Y, Touchon J, Vellas B, Andrieu S, Weiner MW, Carrillo MC, Bain LJAlzheimer's & dementia : the journal of the Alzheimer's AssociationDeveloping a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010. Alzheimers Dement. 2011 Mar; 7(2):127-32.Alzheimers Dement2011-03-01T00:00:002011Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.21514248Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CHAlzheimer's & dementia : the journal of the Alzheimer's AssociationToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):280-92.Alzheimers Dement2011-04-21T00:00:002011Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.23809364Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen PAlzheimer's & dementia : the journal of the Alzheimer's AssociationDesigning drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013 Jul; 9(4):438-44.Alzheimers Dement2013-07-01T00:00:002013Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.Authorship 198567223884042Chhatwal JP, Schultz AP, Johnson K, Benzinger TL, Jack C, Ances BM, Sullivan CA, Salloway SP, Ringman JM, Koeppe RA, Marcus DS, Thompson P, Saykin AJ, Correia S, Schofield PR, Rowe CC, Fox NC, Brickman AM, Mayeux R, McDade E, Bateman R, Fagan AM, Goate AM, Xiong C, Buckles VD, Morris JC, Sperling RANeurologyImpaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology. 2013 Aug 20; 81(8):736-44.Neurology2013-07-24T00:00:002013Impaired default network functional connectivity in autosomal dominant Alzheimer disease.Authorship 5549121Authorship 67686838Authorship 6757842024016464Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, Farlow M, Fox N, Ghetti B, Goate AM, Heinrichs D, Hornbeck R, Jack C, Jucker M, Klunk WE, Marcus DS, Martins RN, Masters CM, Mayeux R, McDade E, Morris JC, Oliver A, Ringman JM, Rossor MN, Salloway S, Schofield PR, Snider J, Snyder P, Sperling RA, Stewart C, Thomas RG, Xiong C, Bateman RJRevue neurologiquePreclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris). 2013 Oct; 169(10):737-43.Rev Neurol (Paris)2013-09-06T00:00:002013Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.23897875Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack CR, Jagust WJ, Johnson KA, Rowe CC, Sperling RA, Thies W, Wahlund LO, Weiner MW, Pasqualetti P, Decarli CNeurologyImaging markers for Alzheimer disease: which vs how. Neurology. 2013 Jul 30; 81(5):487-500.Neurology2013-07-30T00:00:002013Imaging markers for Alzheimer disease: which vs how.Authorship 6798662Authorship 6788982Authorship 68083117Authorship 6801792723578674Barakos J, Sperling R, Salloway S, Jack C, Gass A, Fiebach JB, Tampieri D, Melançon D, Miaux Y, Rippon G, Black R, Lu Y, Brashear HR, Arrighi HM, Morris KA, Grundman MAJNR. American journal of neuroradiologyMR imaging features of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol. 2013 Oct; 34(10):1958-65.AJNR Am J Neuroradiol2013-04-11T00:00:002013MR imaging features of amyloid-related imaging abnormalities.24049139Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, Schofield PR, Sperling RA, Cairns NJ, Marcus DS, Xiong C, Bateman RJ, Morris JC, Rossor MN, Ourselin S, Fox NCNeurologyThe pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology. 2013 Oct 15; 81(16):1425-33.Neurology2013-09-18T00:00:002013The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.23375563Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun MA, Pontecorvo MJ, Skovronsky DMAlzheimer's & dementia : the journal of the Alzheimer's AssociationFlorbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 2013 Oct; 9(5 Suppl):S72-83.Alzheimers Dement2013-01-30T00:00:002013Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.Authorship 684178724179292Ward AM, McLaren DG, Schultz AP, Chhatwal J, Boot BP, Hedden T, Sperling RASleepDaytime sleepiness is associated with decreased default mode network connectivity in both young and cognitively intact elderly subjects. Sleep. 2013 Nov 01; 36(11):1609-15.Sleep2013-11-01T00:00:002013Daytime sleepiness is associated with decreased default mode network connectivity in both young and cognitively intact elderly subjects.Authorship 34824511Authorship 69343633Authorship 6935441024194552Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, Christensen JJ, Ercole L, Hornbeck RC, Farrar AM, Aldea P, Jasielec MS, Owen CJ, Xie X, Mayeux R, Brickman A, McDade E, Klunk W, Mathis CA, Ringman J, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Salloway S, Correia S, Schofield PR, Masters CL, Rowe C, Villemagne VL, Martins R, Ourselin S, Rossor MN, Fox NC, Cash DM, Weiner MW, Holtzman DM, Buckles VD, Moulder K, Morris JCProceedings of the National Academy of Sciences of the United States of AmericaRegional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):E4502-9.Proc Natl Acad Sci U S A2013-11-05T00:00:002013Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.24247857Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, Pepin LC, Becker JA, Amariglio RE, Rentz DM, Sperling RA, Johnson KAThe Journal of neuropsychiatry and clinical neurosciencesApathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci. 2013; 25(4):302-7.J Neuropsychiatry Clin Neurosci2013-01-01T00:00:002013Apathy is associated with increased amyloid burden in mild cognitive impairment.Authorship 2357282Authorship 704295224450891Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HRThe New England journal of medicineTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med. 2014 Jan 23; 370(4):322-33.N Engl J Med2014-01-23T00:00:002014Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.24585367Serrano-Pozo A, Qian J, Monsell SE, Blacker D, Gómez-Isla T, Betensky RA, Growdon JH, Johnson KA, Frosch MP, Sperling RA, Hyman BTAnnals of neurologyMild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol. 2014 Apr; 75(4):597-601.Ann Neurol2014-04-08T00:00:002014Mild to moderate Alzheimer dementia with insufficient neuropathological changes.Authorship 3269912Authorship 7123442Authorship 7099571Authorship 71382411Authorship 7212146Authorship 7119122Authorship 7199116Authorship 7184711523526685Werring DJ, Sperling RAnnals of neurologyInflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA? Ann Neurol. 2013 Apr; 73(4):439-41.Ann Neurol2013-04-01T00:00:002013Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?23404748Ward AM, Schultz AP, Huijbers W, Van Dijk KR, Hedden T, Sperling RAHuman brain mappingThe parahippocampal gyrus links the default-mode cortical network with the medial temporal lobe memory system. Hum Brain Mapp. 2014 Mar; 35(3):1061-73.Hum Brain Mapp2013-02-13T00:00:002013The parahippocampal gyrus links the default-mode cortical network with the medial temporal lobe memory system.24719099Huijbers W, Mormino EC, Wigman SE, Ward AM, Vannini P, McLaren DG, Becker JA, Schultz AP, Hedden T, Johnson KA, Sperling RAThe Journal of neuroscience : the official journal of the Society for NeuroscienceAmyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. J Neurosci. 2014 Apr 09; 34(15):5200-10.J Neurosci2014-04-09T00:00:002014Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults.24648338Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, Aisen PScience translational medicineThe A4 study: stopping AD before symptoms begin? Sci Transl Med. 2014 Mar 19; 6(228):228fs13.Sci Transl Med2014-03-19T00:00:002014The A4 study: stopping AD before symptoms begin?24598588Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, Marcus D, Cairns NJ, Buckles VD, Ladenson JH, Morris JC, Holtzman DMScience translational medicineLongitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med. 2014 Mar 05; 6(226):226ra30.Sci Transl Med2014-03-05T00:00:002014Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.24724181Salloway S, Sperling R, Brashear HRThe New England journal of medicinePhase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. N Engl J Med. 2014 04 10; 370(15):1460.N Engl J Med2014-04-10T00:00:002014Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.24655282Cohen SI, Rajah L, Yoon CH, Buell AK, White DA, Sperling RA, Vendruscolo M, Terentjev EM, Dobson CM, Weitz DA, Knowles TPPhysical review lettersSpatial propagation of protein polymerization. Phys Rev Lett. 2014 Mar 07; 112(9):098101.Phys Rev Lett2014-03-04T00:00:002014Spatial propagation of protein polymerization.Authorship 1659173Authorship 72615310Authorship 7279071Authorship 72589976930188Sperling R, Havron A, Sperling JAnnals of the New York Academy of SciencesPhotochemical cross-linking between proteins and nucleic acids as a probe of nucleoprotein interactions. Ann N Y Acad Sci. 1980; 346:386-8.Ann N Y Acad Sci1980-01-01T00:00:001980Photochemical cross-linking between proteins and nucleic acids as a probe of nucleoprotein interactions.24754377Feldman HH, Haas M, Gandy S, Schoepp DD, Cross AJ, Mayeux R, Sperling RA, Fillit H, van de Hoef DL, Dougal S, Nye JSAnnals of the New York Academy of SciencesAlzheimer's disease research and development: a call for a new research roadmap. Ann N Y Acad Sci. 2014 Apr; 1313:1-16.Ann N Y Acad Sci2014-04-01T00:00:002014Alzheimer's disease research and development: a call for a new research roadmap.Authorship 730798924748674Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RANeurologyAmyloid and APOE e4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology. 2014 May 20; 82(20):1760-7.Neurology2014-04-18T00:00:002014Amyloid and APOE e4 interact to influence short-term decline in preclinical Alzheimer disease.Authorship 737766524257331Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris SAlzheimer's research & therapyPromising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther. 2013; 5(6):58.Alzheimers Res Ther2013-11-21T00:00:002013Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review.Authorship 250054Authorship 2101599Authorship 7422882124928124Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, Moreno S, Reiman EM, Ringman JM, Salloway S, Schofield PR, Sperling R, Tariot PN, Xiong C, Morris JC, Bateman RJNeurologySymptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014 Jul 15; 83(3):253-60.Neurology2014-06-13T00:00:002014Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.Authorship 352314323890751Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GAThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric PsychiatryRegional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am J Geriatr Psychiatry. 2014 Nov; 22(11):1168-79.Am J Geriatr Psychiatry2013-07-24T00:00:002013Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum.24698445Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, Hyman BT, Locascio JJ, Johnson KA, Sperling RA, Marshall GA, Rentz DMThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric PsychiatrySubjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1642-51.Am J Geriatr Psychiatry2014-02-26T00:00:002014Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease.Authorship 7465112Authorship 7471908Authorship 7493907Authorship 7473362Authorship 7525089Authorship 753528824815535Papp KV, Amariglio RE, Dekhtyar M, Roy K, Wigman S, Bamfo R, Sherman J, Sperling RA, Rentz DMThe Clinical neuropsychologistDevelopment of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory. Clin Neuropsychol. 2014; 28(5):771-85.Clin Neuropsychol2014-05-12T00:00:002014Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory.24685624Marshall GA, Lorius N, Locascio JJ, Hyman BT, Rentz DM, Johnson KA, Sperling RAJournal of Alzheimer's disease : JADRegional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum. J Alzheimers Dis. 2014; 41(3):719-28.J Alzheimers Dis2014-01-01T00:00:002014Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.24705405Marder TJ, Flores VL, Bolo NR, Hoogenboom WS, Simonson DC, Jacobson AM, Foote SE, Shenton ME, Sperling RA, Musen GDiabetesTask-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline. Diabetes. 2014 Sep; 63(9):3112-9.Diabetes2014-04-04T00:00:002014Task-induced brain activity patterns in type 2 diabetes: a potential biomarker for cognitive decline.24898635Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, Rentz DM, Sperling RA, Johnson KA, Marshall GAJournal of Alzheimer's disease : JADRegional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum. J Alzheimers Dis. 2014; 42(1):291-300.J Alzheimers Dis2014-01-01T00:00:002014Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.24886908Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, Weiner M, Aisen PSJAMA neurologyThe preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014 Aug; 71(8):961-70.JAMA Neurol2014-08-01T00:00:002014The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.24852459McLaren DG, Sperling RA, Atri ANeuroImageFlexible modulation of network connectivity related to cognition in Alzheimer's disease. Neuroimage. 2014 Oct 15; 100:544-57.Neuroimage2014-05-20T00:00:002014Flexible modulation of network connectivity related to cognition in Alzheimer's disease.Authorship 7569389Authorship 756828925069482Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, Ourselin S, Schofield PR, Masters CL, Martins RN, Weiner MW, Thompson PM, Fox NC, Koeppe RA, Jack CR, Mathis CA, Oliver A, Blazey TM, Moulder K, Buckles V, Hornbeck R, Chhatwal J, Schultz AP, Goate AM, Fagan AM, Cairns NJ, Marcus DS, Morris JC, Ances BMJAMA neurologyFunctional connectivity in autosomal dominant and late-onset Alzheimer disease. JAMA Neurol. 2014 Sep; 71(9):1111-22.JAMA Neurol2014-09-01T00:00:002014Functional connectivity in autosomal dominant and late-onset Alzheimer disease.25212917Zoller AS, Gaal IM, Royer CA, Locascio JJ, Amariglio RE, Blacker D, Okereke OI, Johnson KA, Sperling RA, Rentz DM, Marshall GACurrent Alzheimer researchSIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. Curr Alzheimer Res. 2014; 11(8):785-91.Curr Alzheimer Res2014-01-01T00:00:002014SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment.Authorship 759551224614494Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJMolecular psychiatryFlorbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Mol Psychiatry. 2014 Sep; 19(9):1044-51.Mol Psychiatry2014-03-11T00:00:002014Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.25150630Schultz AP, Chhatwal JP, Huijbers W, Hedden T, van Dijk KR, McLaren DG, Ward AM, Wigman S, Sperling RANeuroImageTemplate based rotation: a method for functional connectivity analysis with a priori templates. Neuroimage. 2014 Nov 15; 102 Pt 2:620-36.Neuroimage2014-08-21T00:00:002014Template based rotation: a method for functional connectivity analysis with a priori templates.Authorship 7632047Authorship 7660063725341459Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, Klunk W, Knopman D, Kukull WA, Lamb B, Logsdon RG, Maruff P, Mesulam M, Mobley W, Mohs R, Morgan D, Nixon RA, Paul S, Petersen R, Plassman B, Potter W, Reiman E, Reisberg B, Sano M, Schindler R, Schneider LS, Snyder PJ, Sperling RA, Yaffe K, Bain LJ, Thies WH, Carrillo MCAlzheimer's & dementia : the journal of the Alzheimer's Association2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease. Alzheimers Dement. 2014 Oct; 10(5 Suppl):S430-52.Alzheimers Dement2014-10-01T00:00:0020142014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.Authorship 795474Authorship 769575825222039Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RAJAMA neurologySynergistic effect of ß-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014 Nov; 71(11):1379-85.JAMA Neurol2014-11-01T00:00:002014Synergistic effect of ß-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.Authorship 771085725274110Marshall GA, Zoller AS, Kelly KE, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DMCurrent Alzheimer researchEveryday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res. 2014; 11(9):853-61.Curr Alzheimer Res2014-01-01T00:00:002014Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment.Authorship 77214010Authorship 7737626Authorship 7725669Authorship 7742083125256133Samieri C, Proust-Lima C, M Glymour M, Okereke OI, Amariglio RE, Sperling RA, Rentz DM, Grodstein FAlzheimer's & dementia : the journal of the Alzheimer's AssociationSubjective cognitive concerns, episodic memory, and the APOE e4 allele. Alzheimers Dement. 2014 Nov; 10(6):752-759.e1.Alzheimers Dement2014-09-23T00:00:002014Subjective cognitive concerns, episodic memory, and the APOE e4 allele.24798886Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner MAlzheimer's & dementia : the journal of the Alzheimer's AssociationA conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014 Nov; 10(6):844-52.Alzheimers Dement2014-05-03T00:00:002014A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.Authorship 775892625113793Ward AM, Mormino EC, Huijbers W, Schultz AP, Hedden T, Sperling RANeurobiology of agingRelationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits. Neurobiol Aging. 2015 Jan; 36(1):265-72.Neurobiol Aging2014-07-03T00:00:002014Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits.Authorship 5627477Authorship 5166973Authorship 41780011Authorship 3693222Authorship 4774617Authorship 5117574Authorship 272057Authorship 2555105Authorship 5050467Authorship 2346423Authorship 929514Authorship 714477Authorship 81212Authorship 2627992Authorship 1931437Authorship 2227127Authorship 342735Authorship 2224312Authorship 3538886Authorship 1689287Authorship 7883545Authorship 7869173Authorship 8011389Authorship 7926661Authorship 7945098Authorship 8021787Authorship 7943797Authorship 79157123Authorship 8029742Authorship 7972315Authorship 8055679Authorship 79990111Authorship 801230325442939Sperling R, Mormino E, Johnson KNeuronThe evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron. 2014 Nov 05; 84(3):608-22.Neuron2014-11-05T00:00:002014The evolution of preclinical Alzheimer's disease: implications for prevention trials.25775167Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MWJAMA neurologyPredicting Reduction of Cerebrospinal Fluid ß-Amyloid 42 in Cognitively Healthy Controls. JAMA Neurol. 2015 May; 72(5):554-60.JAMA Neurol2015-05-01T00:00:002015Predicting Reduction of Cerebrospinal Fluid ß-Amyloid 42 in Cognitively Healthy Controls.25540951Stephenson D, Perry D, Bens C, Bain LJ, Berry D, Krams M, Sperling R, Dilts D, Luthman J, Hanna D, McKew J, Temple R, Fields FO, Salloway S, Katz RExpert review of neurotherapeuticsCharting a path toward combination therapy for Alzheimer's disease. Expert Rev Neurother. 2015 Jan; 15(1):107-13.Expert Rev Neurother2014-12-26T00:00:002014Charting a path toward combination therapy for Alzheimer's disease.25716491Guercio BJ, Donovan NJ, Ward A, Schultz A, Lorius N, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GAThe Journal of neuropsychiatry and clinical neurosciencesApathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. J Neuropsychiatry Clin Neurosci. 2015; 27(1):e22-7.J Neuropsychiatry Clin Neurosci2014-11-10T00:00:002014Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals.25678559Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, Amariglio RE, Marshall GA, Rentz DM, Johnson KA, Sperling RABrain : a journal of neurologyAmyloid-ß deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain. 2015 Apr; 138(Pt 4):1023-35.Brain2015-02-11T00:00:002015Amyloid-ß deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.25545807Replogle JM, Chan G, White CC, Raj T, Winn PA, Evans DA, Sperling RA, Chibnik LB, Bradshaw EM, Schneider JA, Bennett DA, De Jager PLAnnals of neurologyA TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol. 2015 Mar; 77(3):469-77.Ann Neurol2015-03-01T00:00:002015A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology.25969699Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy M, Karlawish JAlzheimer's research & therapyDevelopment of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimers Res Ther. 2015; 7(1):26.Alzheimers Res Ther2015-05-12T00:00:002015Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants.25708309Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens CExpert review of neurotherapeuticsBuilding a roadmap for developing combination therapies for Alzheimer's disease. Expert Rev Neurother. 2015 Mar; 15(3):327-33.Expert Rev Neurother2015-03-01T00:00:002015Building a roadmap for developing combination therapies for Alzheimer's disease.25934852Growdon ME, Schultz AP, Dagley AS, Amariglio RE, Hedden T, Rentz DM, Johnson KA, Sperling RA, Albers MW, Marshall GANeurologyOdor identification and Alzheimer disease biomarkers in clinically normal elderly. Neurology. 2015 May 26; 84(21):2153-60.Neurology2015-05-01T00:00:002015Odor identification and Alzheimer disease biomarkers in clinically normal elderly.25706191Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RAJAMA neurologyTracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument. JAMA Neurol. 2015 Apr; 72(4):446-54.JAMA Neurol2015-04-01T00:00:002015Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument.25485714Su Y, Blazey TM, Snyder AZ, Raichle ME, Marcus DS, Ances BM, Bateman RJ, Cairns NJ, Aldea P, Cash L, Christensen JJ, Friedrichsen K, Hornbeck RC, Farrar AM, Owen CJ, Mayeux R, Brickman AM, Klunk W, Price JC, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Schofield PR, Buckles V, Morris JC, Benzinger TLSNeuroImagePartial volume correction in quantitative amyloid imaging. Neuroimage. 2015 Feb 15; 107:55-64.Neuroimage2014-12-05T00:00:002014Partial volume correction in quantitative amyloid imaging.26064192Doody RS, Raman R, Sperling RA, Seimers E, Sethuraman G, Mohs R, Farlow M, Iwatsubo T, Vellas B, Sun X, Ernstrom K, Thomas RG, Aisen PSAlzheimer's research & therapyPeripheral and central effects of ?-secretase inhibition by semagacestat in Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):36.Alzheimers Res Ther2015-06-10T00:00:002015Peripheral and central effects of ?-secretase inhibition by semagacestat in Alzheimer's disease.24787033Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, Marshall GAAlzheimer disease and associated disordersVascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Dis Assoc Disord. 2015 Jan-Mar; 29(1):18-25.Alzheimer Dis Assoc Disord2015-01-01T00:00:002015Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum.Authorship 2920721Authorship 3150252Authorship 4190882Authorship 4628448Authorship 495027126121081Quiroz YT, Schultz AP, Chen K, Protas HD, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, Giraldo M, Tirado V, Ramírez DL, Tariot PN, Dickerson BC, Sperling RA, Lopera F, Reiman EMJAMA neurologyBrain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. JAMA Neurol. 2015 Aug; 72(8):912-9.JAMA Neurol2015-08-01T00:00:002015Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.Authorship 8095817Authorship 809714426002757Papp KV, Amariglio RE, Mormino EC, Hedden T, Dekhytar M, Johnson KA, Sperling RA, Rentz DMNeuropsychologiaFree and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease. Neuropsychologia. 2015 Jul; 73:169-75.Neuropsychologia2015-05-19T00:00:002015Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.26125043Hayes SM, Salat DH, Forman DE, Sperling RA, Verfaellie MAnnals of clinical and translational neurologyCardiorespiratory fitness is associated with white matter integrity in aging. Ann Clin Transl Neurol. 2015 Jun; 2(6):688-98.Ann Clin Transl Neurol2015-04-24T00:00:002015Cardiorespiratory fitness is associated with white matter integrity in aging.Authorship 2930651Authorship 81401214Authorship 814971726048028Amariglio RE, Mormino EC, Pietras AC, Marshall GA, Vannini P, Johnson KA, Sperling RA, Rentz DMNeurologySubjective cognitive concerns, amyloid-ß, and neurodegeneration in clinically normal elderly. Neurology. 2015 Jul 07; 85(1):56-62.Neurology2015-06-05T00:00:002015Subjective cognitive concerns, amyloid-ß, and neurodegeneration in clinically normal elderly.26062627Gidicsin CM, Maye JE, Locascio JJ, Pepin LC, Philiossaint M, Becker JA, Younger AP, Dekhtyar M, Schultz AP, Amariglio RE, Marshall GA, Rentz DM, Hedden T, Sperling RA, Johnson KANeurologyCognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers. Neurology. 2015 Jul 07; 85(1):48-55.Neurology2015-06-10T00:00:002015Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers.25854929Munro CE, Donovan NJ, Guercio BJ, Wigman SE, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GAJournal of Alzheimer's disease : JADNeuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment. J Alzheimers Dis. 2015; 46(3):727-35.J Alzheimers Dis2015-01-01T00:00:002015Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment.25697700Donovan NJ, Hsu DC, Dagley AS, Schultz AP, Amariglio RE, Mormino EC, Okereke OI, Rentz DM, Johnson KA, Sperling RA, Marshall GAJournal of Alzheimer's disease : JADDepressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. J Alzheimers Dis. 2015; 46(1):63-73.J Alzheimers Dis2015-01-01T00:00:002015Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.Authorship 816646626025290Reijmer YD, Schultz AP, Leemans A, O'Sullivan MJ, Gurol ME, Sperling R, Greenberg SM, Viswanathan A, Hedden TNeuroImageDecoupling of structural and functional brain connectivity in older adults with white matter hyperintensities. Neuroimage. 2015 Aug 15; 117:222-9.Neuroimage2015-05-27T00:00:002015Decoupling of structural and functional brain connectivity in older adults with white matter hyperintensities.Authorship 81868615Authorship 819001726017560Marshall GA, Zoller AS, Lorius N, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DMCurrent Alzheimer researchFunctional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment. Curr Alzheimer Res. 2015; 12(5):493-502.Curr Alzheimer Res2015-01-01T00:00:002015Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment.26159796Auriel E, Westover MB, Bianchi MT, Reijmer Y, Martinez-Ramirez S, Ni J, Van Etten E, Frosch MP, Fotiadis P, Schwab K, Vashkevich A, Boulouis G, Younger AP, Johnson KA, Sperling RA, Hedden T, Gurol ME, Viswanathan A, Greenberg SMStrokeEstimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging. Stroke. 2015 Aug; 46(8):2129-35.Stroke2015-07-09T00:00:002015Estimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging.Authorship 82448821Authorship 8315689Authorship 82850316Authorship 830906426208959Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HRNeurologyAmyloid-ß 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials. Neurology. 2015 Aug 25; 85(8):692-700.Neurology2015-07-24T00:00:002015Amyloid-ß 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.26220940Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, Moghekar A, Albert M, Hu WT, Monge Argilés JA, Gorostidi A, Teunissen CE, De Deyn PP, Hyman BT, Molinuevo JL, Frisoni GB, Linazasoro G, de Leon MJ, van der Flier WM, Scheltens P, Blennow K, Shaw LM, Trojanowski JQBrain : a journal of neurologyAlzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. Brain. 2015 Sep; 138(Pt 9):2701-15.Brain2015-07-27T00:00:002015Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.26245925Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, Sperling R, Salloway S, Schofield PR, Masters CL, Martins RN, Rossor MN, Jucker M, Danek A, Förster S, Lane CA, Morris JC, Benzinger TL, Bateman RJNeurologyCerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. 2015 Sep 01; 85(9):790-8.Neurology2015-08-05T00:00:002015Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease.Authorship 83675110Authorship 8369549Authorship 8364621026401564Guercio BJ, Donovan NJ, Munro CE, Aghjayan SL, Wigman SE, Locascio JJ, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GAJournal of Alzheimer's disease : JADThe Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment. J Alzheimers Dis. 2015; 47(2):421-32.J Alzheimers Dis2015-01-01T00:00:002015The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.Authorship 84034033Authorship 8403692Authorship 839406325827242Shaw EE, Schultz AP, Sperling RA, Hedden TBrain connectivityFunctional Connectivity in Multiple Cortical Networks Is Associated with Performance Across Cognitive Domains in Older Adults. Brain Connect. 2015 Oct; 5(8):505-16.Brain Connect2015-06-23T00:00:002015Functional Connectivity in Multiple Cortical Networks Is Associated with Performance Across Cognitive Domains in Older Adults.26302229Salloway S, Sperling RJAMA neurologyUnderstanding Conflicting Neuropathological Findings in Patients Clinically Diagnosed as Having Alzheimer Dementia. JAMA Neurol. 2015 Oct; 72(10):1106-8.JAMA Neurol2015-10-01T00:00:002015Understanding Conflicting Neuropathological Findings in Patients Clinically Diagnosed as Having Alzheimer Dementia.26402085Rabin LA, Smart CM, Crane PK, Amariglio RE, Berman LM, Boada M, Buckley RF, Chételat G, Dubois B, Ellis KA, Gifford KA, Jefferson AL, Jessen F, Katz MJ, Lipton RB, Luck T, Maruff P, Mielke MM, Molinuevo JL, Naeem F, Perrotin A, Petersen RC, Rami L, Reisberg B, Rentz DM, Riedel-Heller SG, Risacher SL, Rodriguez O, Sachdev PS, Saykin AJ, Slavin MJ, Snitz BE, Sperling RA, Tandetnik C, van der Flier WM, Wagner M, Wolfsgruber S, Sikkes SAJournal of Alzheimer's disease : JADSubjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. J Alzheimers Dis. 2015 Sep 24; 48 Suppl 1:S63-86.J Alzheimers Dis2015-09-24T00:00:002015Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies.Authorship 84590617Authorship 8434421326297855Hyman BT, Growdon JH, Albers MW, Buckner RL, Chhatwal J, Gomez-Isla MT, Haass C, Hudry E, Jack CR, Johnson KA, Khachaturian ZS, Kim DY, Martin JB, Nitsch RM, Rosen BR, Selkoe DJ, Sperling RA, St George-Hyslop P, Tanzi RE, Yap L, Young AB, Phelps CH, McCaffrey PGAlzheimer's & dementia : the journal of the Alzheimer's AssociationMassachusetts Alzheimer's Disease Research Center: progress and challenges. Alzheimers Dement. 2015 Oct; 11(10):1241-5.Alzheimers Dement2015-08-19T00:00:002015Massachusetts Alzheimer's Disease Research Center: progress and challenges.26414614Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, Cuerdon NE, Ryan KJ, Johnson KA, Schneider JA, Bennett DA, Chibnik LB, Sperling RA, Bradshaw EM, De Jager PLNature neuroscienceCD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015 Nov; 18(11):1556-8.Nat Neurosci2015-09-28T00:00:002015CD33 modulates TREM2: convergence of Alzheimer loci.Authorship 847971826581790Hayes SM, Alosco ML, Hayes JP, Cadden M, Peterson KM, Allsup K, Forman DE, Sperling RA, Verfaellie MJournal of the International Neuropsychological Society : JINSPhysical Activity Is Positively Associated with Episodic Memory in Aging. J Int Neuropsychol Soc. 2015 Nov; 21(10):780-90.J Int Neuropsychol Soc2015-11-01T00:00:002015Physical Activity Is Positively Associated with Episodic Memory in Aging.Authorship 4375396Authorship 855366726416539Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman RJ, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo MC, Weninger SNature reviews. NeurologyCAP--advancing the evaluation of preclinical Alzheimer disease treatments. Nat Rev Neurol. 2016 Jan; 12(1):56-61.Nat Rev Neurol2015-09-29T00:00:002015CAP--advancing the evaluation of preclinical Alzheimer disease treatments.Authorship 5335841Authorship 8593283Authorship 8601174Authorship 860233426639975Malishkevich A, Marshall GA, Schultz AP, Sperling RA, Aharon-Peretz J, Gozes IJournal of Alzheimer's disease : JADBlood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers. J Alzheimers Dis. 2016; 50(1):249-60.J Alzheimers Dis2016-01-01T00:00:002016Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.26542307Rieckmann A, Hedden T, Younger AP, Sperling RA, Johnson KA, Buckner RLHuman brain mappingDopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity. Hum Brain Mapp. 2016 Feb; 37(2):621-31.Hum Brain Mapp2015-11-06T00:00:002015Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity.Authorship 86385610Authorship 8665026Authorship 8713242425316342Hedden T, Schultz AP, Rieckmann A, Mormino EC, Johnson KA, Sperling RA, Buckner RLCerebral cortex (New York, N.Y. : 1991)Multiple Brain Markers are Linked to Age-Related Variation in Cognition. Cereb Cortex. 2016 Apr; 26(4):1388-400.Cereb Cortex2014-10-14T00:00:002014Multiple Brain Markers are Linked to Age-Related Variation in Cognition.26782335Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJNature reviews. NeurologySuspected non-Alzheimer disease pathophysiology--concept and controversy. Nat Rev Neurol. 2016 Feb; 12(2):117-24.Nat Rev Neurol2016-01-18T00:00:002016Suspected non-Alzheimer disease pathophysiology--concept and controversy.26505746Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K, Marshall G, Albers M, Mauro S, Pepin L, Alverio J, Judge K, Philiossaint M, Shoup T, Yokell D, Dickerson B, Gomez-Isla T, Hyman B, Vasdev N, Sperling RAnnals of neurologyTau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016 Jan; 79(1):110-9.Ann Neurol2015-12-15T00:00:002015Tau positron emission tomographic imaging in aging and early Alzheimer disease.Authorship 87230830Authorship 8722971126987701Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jönsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu C, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg HThe Lancet. NeurologyDefeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016 Apr; 15(5):455-532.Lancet Neurol2016-04-01T00:00:002016Defeating Alzheimer's disease and other dementias: a priority for European science and society.26973104Maye JE, Betensky RA, Gidicsin CM, Locascio J, Becker JA, Pepin L, Carmasin J, Rentz DM, Marshall GA, Blacker D, Sperling RA, Johnson KANeurobiology of agingMaternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring. Neurobiol Aging. 2016 Apr; 40:61-67.Neurobiol Aging2015-12-28T00:00:002015Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.25843019Dagley A, LaPoint M, Huijbers W, Hedden T, McLaren DG, Chatwal JP, Papp KV, Amariglio RE, Blacker D, Rentz DM, Johnson KA, Sperling RA, Schultz APNeuroImageHarvard Aging Brain Study: Dataset and accessibility. Neuroimage. 2017 01; 144(Pt B):255-258.Neuroimage2015-04-03T00:00:002015Harvard Aging Brain Study: Dataset and accessibility.Authorship 87336621Authorship 8734743127012484Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CRAlzheimer's & dementia : the journal of the Alzheimer's AssociationPreclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016 Mar; 12(3):292-323.Alzheimers Dement2016-03-01T00:00:002016Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.27010959Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, McDade E, Ringman JM, Thompson PM, Saykin AJ, Ghetti B, Sperling RA, Johnson KA, Salloway SP, Schofield PR, Masters CL, Villemagne VL, Fox NC, Förster S, Chen K, Reiman EM, Xiong C, Marcus DS, Weiner MW, Morris JC, Bateman RJ, Benzinger TLPloS oneQuantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(3):e0152082.PLoS One2016-03-24T00:00:002016Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.Authorship 877634527103054Rabinovici GD, Karlawish J, Knopman D, Snyder HM, Sperling R, Carrillo MCAlzheimer's & dementia : the journal of the Alzheimer's AssociationTesting and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary. Alzheimers Dement. 2016 Apr; 12(4):510-5.Alzheimers Dement2016-04-01T00:00:002016Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.Authorship 88013610Authorship 879945327143434Rieckmann A, Van Dijk KR, Sperling RA, Johnson KA, Buckner RL, Hedden TNeurobiology of agingAccelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer's disease. Neurobiol Aging. 2016 06; 42:177-88.Neurobiol Aging2016-03-21T00:00:002016Accelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer's disease.26915497Greve DN, Salat DH, Bowen SL, Izquierdo-Garcia D, Schultz AP, Catana C, Becker JA, Svarer C, Knudsen GM, Sperling RA, Johnson KANeuroImageDifferent partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging. Neuroimage. 2016 05 15; 132:334-343.Neuroimage2016-02-23T00:00:002016Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging.Authorship 88160011Authorship 88182212Authorship 8807905Authorship 8817941027017906Hendrix JA, Bateman RJ, Brashear HR, Duggan C, Carrillo MC, Bain LJ, DeMattos R, Katz RG, Ostrowitzki S, Siemers E, Sperling R, Vitolo OVAlzheimer's & dementia : the journal of the Alzheimer's AssociationChallenges, solutions, and recommendations for Alzheimer's disease combination therapy. Alzheimers Dement. 2016 05; 12(5):623-30.Alzheimers Dement2016-03-24T00:00:002016Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.26988427Molinuevo JL, Cami J, Carné X, Carrillo MC, Georges J, Isaac MB, Khachaturian Z, Kim SY, Morris JC, Pasquier F, Ritchie C, Sperling R, Karlawish JAlzheimer's & dementia : the journal of the Alzheimer's AssociationEthical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimers Dement. 2016 05; 12(5):614-22.Alzheimers Dement2016-03-15T00:00:002016Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.27157073Weninger S, Carrillo MC, Dunn B, Aisen PS, Bateman RJ, Kotz JD, Langbaum JB, Mills SL, Reiman EM, Sperling R, Santacruz AM, Tariot PN, Welsh-Bohmer KAAlzheimer's & dementia : the journal of the Alzheimer's AssociationCollaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials. Alzheimers Dement. 2016 05; 12(5):631-2.Alzheimers Dement2016-05-01T00:00:002016Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.27188934Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JLNature reviews. Disease primersAlzheimer's disease. Nat Rev Dis Primers. 2015 10 15; 1:15056.Nat Rev Dis Primers2015-10-15T00:00:002015Alzheimer's disease.Authorship 88294213Authorship 8831652427016429Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, Ryan NS, Förster S, Laske C, Schofield PR, Sperling RA, Salloway S, Correia S, Jack C, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AMAnnals of neurologyWhite matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016 Jun; 79(6):929-39.Ann Neurol2016-04-27T00:00:002016White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.Authorship 8870221727180034Fotiadis P, van Rooden S, van der Grond J, Schultz A, Martinez-Ramirez S, Auriel E, Reijmer Y, van Opstal AM, Ayres A, Schwab KM, Hedden T, Rosand J, Viswanathan A, Wermer M, Terwindt G, Sperling RA, Polimeni JR, Johnson KA, van Buchem MA, Greenberg SM, Gurol METhe Lancet. NeurologyCortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. Lancet Neurol. 2016 07; 15(8):811-819.Lancet Neurol2016-05-11T00:00:002016Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.Authorship 888115826595826Papp KV, Mormino EC, Amariglio RE, Munro C, Dagley A, Schultz AP, Johnson KA, Sperling RA, Rentz DMNeuropsychologyBiomarker validation of a decline in semantic processing in preclinical Alzheimer's disease. Neuropsychology. 2016 07; 30(5):624-30.Neuropsychology2015-11-23T00:00:002015Biomarker validation of a decline in semantic processing in preclinical Alzheimer's disease.2Assistant Professor1Associate Professor0Full ProfessorAuthorship 890784727413148Sepulcre J, Schultz AP, Sabuncu M, Gomez-Isla T, Chhatwal J, Becker A, Sperling R, Johnson KAThe Journal of neuroscience : the official journal of the Society for NeuroscienceIn Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain. J Neurosci. 2016 07 13; 36(28):7364-74.J Neurosci2016-07-13T00:00:002016In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain.Authorship 8953892Authorship 8953381327385740Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MRNeurologyPolygenic risk of Alzheimer disease is associated with early- and late-life processes. Neurology. 2016 Aug 02; 87(5):481-8.Neurology2016-07-06T00:00:002016Polygenic risk of Alzheimer disease is associated with early- and late-life processes.27371494Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois BNeurologyA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016 Aug 02; 87(5):539-47.Neurology2016-07-01T00:00:002016A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.Authorship 5584951227162047Donovan NJ, Wu Q, Rentz DM, Sperling RA, Marshall GA, Glymour MMInternational journal of geriatric psychiatryLoneliness, depression and cognitive function in older U.S. adults. Int J Geriatr Psychiatry. 2017 05; 32(5):564-573.Int J Geriatr Psychiatry2016-05-09T00:00:002016Loneliness, depression and cognitive function in older U.S. adults.Authorship 8964498Authorship 8972101327340843Hsu DC, Mormino EC, Schultz AP, Amariglio RE, Donovan NJ, Rentz DM, Johnson KA, Sperling RA, Marshall GAJournal of Alzheimer's disease : JADLower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly. J Alzheimers Dis. 2016 06 18; 53(3):1097-105.J Alzheimers Dis2016-06-18T00:00:002016Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.27504496Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, Cuerdon NE, Ryan KJ, Johnson KA, Schneider JA, Bennett DA, Chibnik LB, Sperling RA, De Jager PL, Bradshaw EMNeurology. GeneticsTrans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci. Neurol Genet. 2016 Aug; 2(4):e90.Neurol Genet2016-07-26T00:00:002016Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci.Authorship 9108521127473132Chhatwal JP, Schultz AP, Marshall GA, Boot B, Gomez-Isla T, Dumurgier J, LaPoint M, Scherzer C, Roe AD, Hyman BT, Sperling RA, Johnson KANeurologyTemporal T807 binding correlates with CSF tau and phospho-tau in normal elderly. Neurology. 2016 Aug 30; 87(9):920-6.Neurology2016-07-29T00:00:002016Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly.2021-03-31SPERLING, REISA A.2009-12-01Mentoring Imaging Research in Early ADK24AG0350072010-03-31GOTTLIEB, GARY L1984-12-01General Clinical Research CenterM01RR0026352006-01-31SPERLING, REISA A.2000-02-01FACE-NAME ASSOCIATION: FMRI STUDIES IN AGING &MILD ADK23NS0021892008-07-31BLACKER, DEBORAH L.1984-08-01Age-related changes of cognition in health and diseaseP01AG0049532018-02-28MOBLEY, WILLIAM C1997-07-01Alzheimer's Disease Cooperative StudyU19AG0104832019-03-31HYMAN, BRADLEY T.1984-09-28Massachusetts Alzheimer's Disease Research CenterP50AG0051342024-04-30AISEN, PAUL S.;JOHNSON, KEITH A.;SPERLING, REISA A.2016-08-15The A3 Study: Ante-Amyloid Prevention of Alzheimer's diseaseR01AG0540292025-12-31JOHNSON, KEITH A.;SPERLING, REISA A.2010-07-15Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain StudyP01AG0366942018-03-31SPERLING, REISA A.2006-05-01Evolution of memory related fMRI activation over the course of MCI and ADR01AG027435Principal InvestigatorCo-Principal InvestigatorCo-Principal InvestigatorCo-Principal InvestigatorCo-Principal InvestigatorCo-Principal InvestigatorCo-Principal InvestigatorPrincipal InvestigatorCo-Principal InvestigatorAuthorship 92074913Authorship 9253824Authorship 9196186Authorship 9219038Authorship 9226583Authorship 92238823Authorship 9226314Authorship 9224641Authorship 92146412Authorship 92316711Authorship 9269484Authorship 9281666Authorship 9216297Authorship 9210817Authorship 9243005Authorship 9283548Authorship 922270110725484Irwin KL, Moorman AC, O'Sullivan MJ, Sperling R, Koestler ME, Soto I, Rice R, Brodman M, Yasin S, Droese A, Zhang D, Schwartz DA, Byers RHObstetrics and gynecologyInfluence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet Gynecol. 2000 Apr; 95(4):525-34.Obstet Gynecol2000-04-01T00:00:002000Influence of human immunodeficiency virus infection on pelvic inflammatory disease.27751558Shah H, Albanese E, Duggan C, Rudan I, Langa KM, Carrillo MC, Chan KY, Joanette Y, Prince M, Rossor M, Saxena S, Snyder HM, Sperling R, Varghese M, Wang H, Wortmann M, Dua TThe Lancet. NeurologyResearch priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 2016 Nov; 15(12):1285-1294.Lancet Neurol2016-10-11T00:00:002016Research priorities to reduce the global burden of dementia by 2025.26665121Marshall GA, Dekhtyar M, Bruno JM, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DMThe journal of prevention of Alzheimer's diseaseThe Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease. J Prev Alzheimers Dis. 2015 Dec; 2(4):242-253.J Prev Alzheimers Dis2015-12-01T00:00:002015The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease.2619871Arad-Dann H, Isenberg D, Ovadia E, Shoenfeld Y, Sperling J, Sperling RJournal of autoimmunityAutoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease. J Autoimmun. 1989 Dec; 2(6):877-88.J Autoimmun1989-12-01T00:00:001989Autoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease.27696605Dhilla Albers A, Asafu-Adjei J, Delaney MK, Kelly KE, Gomez-Isla T, Blacker D, Johnson KA, Sperling RA, Hyman BT, Betensky RA, Hastings L, Albers MWAnnals of neurologyEpisodic memory of odors stratifies Alzheimer biomarkers in normal elderly. Ann Neurol. 2016 12; 80(6):846-857.Ann Neurol2016-11-23T00:00:002016Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.23559893Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, Albert MS, Wagster MV, Schinka JA, Cullum CM, Farias ST, Balota D, Rao S, Loewenstein D, Budson AE, Brandt J, Manly JJ, Barnes L, Strutt A, Gollan TH, Ganguli M, Babcock D, Litvan I, Kramer JH, Ferman TJAlzheimer's & dementia : the journal of the Alzheimer's AssociationAssessment of cognition in early dementia. Alzheimers Dement. 2011 May 01; 7(3):e60-e76.Alzheimers Dement2011-05-01T00:00:002011Assessment of cognition in early dementia.27702899Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BTProceedings of the National Academy of Sciences of the United States of AmericaBayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease. Proc Natl Acad Sci U S A. 2016 10 18; 113(42):E6535-E6544.Proc Natl Acad Sci U S A2016-10-04T00:00:002016Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.9894173Sperling RInfectious diseases in obstetrics and gynecologyZidovudine. Infect Dis Obstet Gynecol. 1998; 6(5):197-203.Infect Dis Obstet Gynecol1998-01-01T00:00:001998Zidovudine.26247003Sperling RA, Amariglio RE, Marshall GA, Rentz DMThe journal of prevention of Alzheimer's diseaseEstablishing Clinical Relevance in Preclinical Alzheimer's Disease. J Prev Alzheimers Dis. 2015 Jun; 2(2):85-87.J Prev Alzheimers Dis2015-06-01T00:00:002015Establishing Clinical Relevance in Preclinical Alzheimer's Disease.27738998Rentz DM, Mormino EC, Papp KV, Betensky RA, Sperling RA, Johnson KABrain imaging and behaviorCognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance. Brain Imaging Behav. 2017 04; 11(2):383-390.Brain Imaging Behav2017-04-01T00:00:002017Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance.27548655Mormino EC, Papp KV, Rentz DM, Schultz AP, LaPoint M, Amariglio R, Hanseeuw B, Marshall GA, Hedden T, Johnson KA, Sperling RAJAMA neurologyHeterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals. JAMA Neurol. 2016 Oct 01; 73(10):1185-1191.JAMA Neurol2016-10-01T00:00:002016Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.27724996Aghjayan SL, Buckley RF, Vannini P, Rentz DM, Jackson JD, Sperling RA, Johnson KA, Amariglio REInternational psychogeriatricsThe influence of demographic factors on subjective cognitive concerns and beta-amyloid. Int Psychogeriatr. 2017 04; 29(4):645-652.Int Psychogeriatr2016-10-11T00:00:002016The influence of demographic factors on subjective cognitive concerns and beta-amyloid.27514526Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, Sperling R, Amariglio RJournal of molecular neuroscience : MNA Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease. J Mol Neurosci. 2016 Nov; 60(3):354-361.J Mol Neurosci2016-08-11T00:00:002016A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease.23585777Marshall GA, Amariglio RE, Sperling RA, Rentz DMNeurodegenerative disease managementActivities of daily living: where do they fit in the diagnosis of Alzheimer's disease? Neurodegener Dis Manag. 2012 Oct 01; 2(5):483-491.Neurodegener Dis Manag2012-10-01T00:00:002012Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?23139856Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, Oliver A, Quaid K, Ringman JM, Rossor MN, Salloway S, Schofield PR, Selsor NJ, Sperling RA, Weiner MW, Xiong C, Moulder KL, Buckles VDClinical investigationDeveloping an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond). 2012 Oct 01; 2(10):975-984.Clin Investig (Lond)2012-10-01T00:00:002012Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.26478889Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, Jack CR, Sperling R, Cummings J, Blennow K, O'Bryant S, Frisoni GB, Khachaturian A, Kivipelto M, Klunk W, Broich K, Andrieu S, de Schotten MT, Mangin JF, Lammertsma AA, Johnson K, Teipel S, Drzezga A, Bokde A, Colliot O, Bakardjian H, Zetterberg H, Dubois B, Vellas B, Schneider LS, Hampel HThe journal of prevention of Alzheimer's diseaseThe Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. J Prev Alzheimers Dis. 2014 Dec; 1(3):181-202.J Prev Alzheimers Dis2014-12-01T00:00:002014The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.Authorship 93110516Authorship 92997321Authorship 9295474Authorship 9347494Authorship 9369658Authorship 93223314Authorship 9338787Authorship 9371911027806159Donovan NJ, Okereke OI, Vannini P, Amariglio RE, Rentz DM, Marshall GA, Johnson KA, Sperling RAJAMA psychiatryAssociation of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults. JAMA Psychiatry. 2016 Dec 01; 73(12):1230-1237.JAMA Psychiatry2016-12-01T00:00:002016Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.27649320Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, McDade E, Ringman JM, Thompson PM, Saykin AJ, Ghetti B, Sperling RA, Johnson KA, Salloway SP, Schofield PR, Masters CL, Villemagne VL, Fox NC, Förster S, Chen K, Reiman EM, Xiong C, Marcus DS, Weiner MW, Morris JC, Bateman RJ, Benzinger TLPloS oneCorrection: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(9):e0163669.PLoS One2016-09-20T00:00:002016Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.27825022Molinuevo JL, Rabin LA, Amariglio R, Buckley R, Dubois B, Ellis KA, Ewers M, Hampel H, Klöppel S, Rami L, Reisberg B, Saykin AJ, Sikkes S, Smart CM, Snitz BE, Sperling R, van der Flier WM, Wagner M, Jessen FAlzheimer's & dementia : the journal of the Alzheimer's AssociationImplementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017 Mar; 13(3):296-311.Alzheimers Dement2016-11-05T00:00:002016Implementation of subjective cognitive decline criteria in research studies.27213625Tarrant SD, Bardach SH, Bates K, Nichols H, Towner J, Tamatha C, Caban-Holt A, Van-Eldik LJ, Murphy RR, Sperling R, Jicha GAAlzheimer disease and associated disordersThe Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease. Alzheimer Dis Assoc Disord. 2017 Apr-Jun; 31(2):141-145.Alzheimer Dis Assoc Disord2017-04-01T00:00:002017The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease.27421609Hanseeuw BJ, Schultz AP, Betensky RA, Sperling RA, Johnson KAAlzheimer's & dementia : the journal of the Alzheimer's AssociationDecreased hippocampal metabolism in high-amyloid mild cognitive impairment. Alzheimers Dement. 2016 12; 12(12):1288-1296.Alzheimers Dement2016-07-13T00:00:002016Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.26998469Rentz DM, Dekhtyar M, Sherman J, Burnham S, Blacker D, Aghjayan SL, Papp KV, Amariglio RE, Schembri A, Chenhall T, Maruff P, Aisen P, Hyman BT, Sperling RAThe journal of prevention of Alzheimer's diseaseThe Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials. J Prev Alzheimers Dis. 2016 Mar; 3(1):8-12.J Prev Alzheimers Dis2016-03-01T00:00:002016The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials.27654968Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson KJAMA neurologyTau Positron Emission Tomographic Imaging in the Lewy Body Diseases. JAMA Neurol. 2016 Nov 01; 73(11):1334-1341.JAMA Neurol2016-11-01T00:00:002016Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.Authorship 938500112094276Sperling R, Schnabel M, Sauerwein B, Von Garrel T, Gotzen L, Stiletto RZentralblatt fur Chirurgie[Evaluation and results of the gliding nail in the elderly patient]. Zentralbl Chir. 2002 Jun; 127(6):507-13.Zentralbl Chir2002-06-01T00:00:002002[Evaluation and results of the gliding nail in the elderly patient].Authorship 939276926247004Vellas B, Bateman R, Blennow K, Frisoni G, Johnson K, Katz R, Langbaum J, Marson D, Sperling R, Wessels A, Salloway S, Doody R, Aisen PThe journal of prevention of Alzheimer's diseaseEndpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2015 Jun; 2(2):128-135.J Prev Alzheimers Dis2015-06-01T00:00:002015Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force.Authorship 941672527989841Williams VJ, Hayes JP, Forman DE, Salat DH, Sperling RA, Verfaellie M, Hayes SMNeuroImageCardiorespiratory fitness is differentially associated with cortical thickness in young and older adults. Neuroimage. 2017 02 01; 146:1084-1092.Neuroimage2016-10-28T00:00:002016Cardiorespiratory fitness is differentially associated with cortical thickness in young and older adults.Authorship 945436828029725Prckovska V, Huijbers W, Schultz A, Ortiz-Teran L, Peña-Gomez C, Villoslada P, Johnson K, Sperling R, Sepulcre JHuman brain mappingEpicenters of dynamic connectivity in the adaptation of the ventral visual system. Hum Brain Mapp. 2017 04; 38(4):1965-1976.Hum Brain Mapp2016-12-28T00:00:002016Epicenters of dynamic connectivity in the adaptation of the ventral visual system.Authorship 948484927578492Huijbers W, Papp KV, LaPoint M, Wigman SE, Dagley A, Hedden T, Rentz DM, Schultz AP, Sperling RACerebral cortex (New York, N.Y. : 1991)Age-Related Increases in Tip-of-the-tongue are Distinct from Decreases in Remembering Names: A Functional MRI Study. Cereb Cortex. 2017 09 01; 27(9):4339-4349.Cereb Cortex2017-09-01T00:00:002017Age-Related Increases in Tip-of-the-tongue are Distinct from Decreases in Remembering Names: A Functional MRI Study.Authorship 5375991Authorship 6085160 Fenwood RdBrigham and Women's HospitalBtm60 Fenwood RdBoston02115MA8909457Sandson TA, O'Connor M, Sperling RA, Edelman RR, Warach SNeurologyNoninvasive perfusion MRI in Alzheimer's disease: a preliminary report. Neurology. 1996 Nov; 47(5):1339-42.Neurology1996-11-01T00:00:001996Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report.9859959Pitt J, Schluchter M, Jenson H, Kovacs A, LaRussa P, McIntosh K, Boyer P, Cooper E, Goldfarb J, Hammill H, Hodes D, Peavy H, Sperling R, Tuomala R, Shearer WJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology AssociationMaternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15; 19(5):462-70.J Acquir Immune Defic Syndr Hum Retrovirol1998-12-15T00:00:001998Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group.14568509Sperling R, Chua E, Cocchiarella A, Rand-Giovannetti E, Poldrack R, Schacter DL, Albert MNeuroImagePutting names to faces: successful encoding of associative memories activates the anterior hippocampal formation. Neuroimage. 2003 Oct; 20(2):1400-10.Neuroimage2003-10-01T00:00:002003Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation.11954675Budson AE, Michalska KJ, Rentz DM, Joubert CC, Daffner KR, Schacter DL, Sperling RAAmerican journal of Alzheimer's disease and other dementiasUse of a false recognition paradigm in an Alzheimer's disease clinical trial: a pilot study. Am J Alzheimers Dis Other Demen. 2002 Mar-Apr; 17(2):93-100.Am J Alzheimers Dis Other Demen2002-03-01T00:00:002002Use of a false recognition paradigm in an Alzheimer's disease clinical trial: a pilot study.1334515Weinblatt ME, Kremer JM, Coblyn JS, Helfgott S, Maier AL, Petrillo G, Henson B, Rubin P, Sperling RThe Journal of rheumatologyZileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis. J Rheumatol. 1992 Oct; 19(10):1537-41.J Rheumatol1992-10-01T00:00:001992Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.Authorship 96673612Authorship 9688838Authorship 9680651628283594Papp KV, Rentz DM, Mormino EC, Schultz AP, Amariglio RE, Quiroz Y, Johnson KA, Sperling RANeurologyCued memory decline in biomarker-defined preclinical Alzheimer disease. Neurology. 2017 Apr 11; 88(15):1431-1438.Neurology2017-03-10T00:00:002017Cued memory decline in biomarker-defined preclinical Alzheimer disease.28253478Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, Chhatwal J, Marshall GA, Donovan N, Jackson J, Gatchel JR, Hanseeuw BJ, Schultz AP, Aisen PS, Johnson KA, Sperling RAAlzheimer's & dementia : the journal of the Alzheimer's AssociationEarly and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid ß. Alzheimers Dement. 2017 Sep; 13(9):1004-1012.Alzheimers Dement2017-02-28T00:00:002017Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid ß.28253546Hanseeuw BJ, Betensky RA, Schultz AP, Papp KV, Mormino EC, Sepulcre J, Bark JS, Cosio DM, LaPoint M, Chhatwal JP, Rentz DM, Sperling RA, Johnson KAAnnals of neurologyFluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline. Ann Neurol. 2017 Apr; 81(4):583-596.Ann Neurol2017-04-06T00:00:002017Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.Authorship 9716261128314821Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, Huijbers W, LaPoint M, Buckley RF, Johnson KA, Sperling RAThe Journal of neuroscience : the official journal of the Society for NeurosciencePhases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals. J Neurosci. 2017 04 19; 37(16):4323-4331.J Neurosci2017-03-17T00:00:002017Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.17604356Dickerson BC, Miller SL, Greve DN, Dale AM, Albert MS, Schacter DL, Sperling RAHippocampusPrefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: an event-related functional-anatomic MRI study. Hippocampus. 2007; 17(11):1060-70.Hippocampus2007-01-01T00:00:002007Prefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: an event-related functional-anatomic MRI study.17623735Glanz BI, Holland CM, Gauthier SA, Amunwa EL, Liptak Z, Houtchens MK, Sperling RA, Khoury SJ, Guttmann CR, Weiner HLMultiple sclerosis (Houndmills, Basingstoke, England)Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler. 2007 Sep; 13(8):1004-10.Mult Scler2007-07-10T00:00:002007Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.17697413Rentz DM, Huh TJ, Sardinha LM, Moran EK, Becker JA, Daffner KR, Sperling RA, Johnson KAJournal of the International Neuropsychological Society : JINSIntelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. J Int Neuropsychol Soc. 2007 Sep; 13(5):821-31.J Int Neuropsychol Soc2007-09-01T00:00:002007Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion.18206188Dickerson BC, Sperling RANeuropsychologiaFunctional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia. 2008; 46(6):1624-35.Neuropsychologia2007-12-08T00:00:002007Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies.19211893Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KAThe Journal of neuroscience : the official journal of the Society for NeuroscienceCortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci. 2009 Feb 11; 29(6):1860-73.J Neurosci2009-02-11T00:00:002009Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease.11756667Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, Cocchiarella A, Firth P, Rosen B, Lake S, Lange N, Routledge C, Albert MProceedings of the National Academy of Sciences of the United States of AmericaFunctional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):455-60.Proc Natl Acad Sci U S A2001-12-26T00:00:002001Functional MRI detection of pharmacologically induced memory impairment.Authorship 9755915Authorship 9763479Authorship 975261928366797Sepulcre J, Sabuncu MR, Li Q, El Fakhri G, Sperling R, Johnson KAAlzheimer's & dementia : the journal of the Alzheimer's AssociationTau and amyloid ß proteins distinctively associate to functional network changes in the aging brain. Alzheimers Dement. 2017 Nov; 13(11):1261-1269.Alzheimers Dement2017-03-30T00:00:002017Tau and amyloid ß proteins distinctively associate to functional network changes in the aging brain.28385579Vannini P, Amariglio R, Hanseeuw B, Johnson KA, McLaren DG, Chhatwal J, Pascual-Leone A, Rentz D, Sperling RANeuropsychologiaMemory self-awareness in the preclinical and prodromal stages of Alzheimer's disease. Neuropsychologia. 2017 05; 99:343-349.Neuropsychologia2017-04-03T00:00:002017Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.28381517Vannini P, Hanseeuw B, Munro CE, Amariglio RE, Marshall GA, Rentz DM, Pascual-Leone A, Johnson KA, Sperling RANeurologyHippocampal hypometabolism in older adults with memory complaints and increased amyloid burden. Neurology. 2017 May 02; 88(18):1759-1767.Neurology2017-04-05T00:00:002017Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden.Authorship 977396628410856Gatchel JR, Donovan NJ, Locascio JJ, Becker JA, Rentz DM, Sperling RA, Johnson KA, Marshall GAThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric PsychiatryRegional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease. Am J Geriatr Psychiatry. 2017 Jul; 25(7):683-693.Am J Geriatr Psychiatry2017-01-04T00:00:002017Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.17413017Sperling RAnnals of the New York Academy of SciencesFunctional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann N Y Acad Sci. 2007 Feb; 1097:146-55.Ann N Y Acad Sci2007-02-01T00:00:002007Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease.1569479Johnson KA, Sperling RA, Holman BL, Nagel JS, Growdon JHJournal of nuclear medicine : official publication, Society of Nuclear MedicineCerebral perfusion in progressive supranuclear palsy. J Nucl Med. 1992 May; 33(5):704-9.J Nucl Med1992-05-01T00:00:001992Cerebral perfusion in progressive supranuclear palsy.Authorship 9797601228441426White CC, Yang HS, Yu L, Chibnik LB, Dawe RJ, Yang J, Klein HU, Felsky D, Ramos-Miguel A, Arfanakis K, Honer WG, Sperling RA, Schneider JA, Bennett DA, De Jager PLPLoS medicineIdentification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017 04; 14(4):e1002287.PLoS Med2017-04-25T00:00:002017Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.21259385Putcha D, O'Keefe K, LaViolette P, O'Brien J, Greve D, Rentz DM, Locascio J, Atri A, Sperling RHuman brain mappingReliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults. Hum Brain Mapp. 2011 Dec; 32(12):2027-44.Hum Brain Mapp2011-01-21T00:00:002011Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults.21490054Drzezga A, Becker JA, Van Dijk KR, Sreenivasan A, Talukdar T, Sullivan C, Schultz AP, Sepulcre J, Putcha D, Greve D, Johnson KA, Sperling RABrain : a journal of neurologyNeuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain. 2011 Jun; 134(Pt 6):1635-46.Brain2011-04-13T00:00:002011Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden.23134660Quiroz YT, Stern CE, Reiman EM, Brickhouse M, Ruiz A, Sperling RA, Lopera F, Dickerson BCJournal of neurology, neurosurgery, and psychiatryCortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers. J Neurol Neurosurg Psychiatry. 2013 May; 84(5):556-61.J Neurol Neurosurg Psychiatry2012-11-07T00:00:002012Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.9344010Feske SK, Sperling RA, Schwartz RBJournal of neuroimaging : official journal of the American Society of NeuroimagingExtensive reversible brain magnetic resonance lesions in a patient with HELLP syndrome. J Neuroimaging. 1997 Oct; 7(4):247-50.J Neuroimaging1997-10-01T00:00:001997Extensive reversible brain magnetic resonance lesions in a patient with HELLP syndrome.21437929Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KAAnnals of neurologyAmyloid-ß associated cortical thinning in clinically normal elderly. Ann Neurol. 2011 Jun; 69(6):1032-42.Ann Neurol2011-03-17T00:00:002011Amyloid-ß associated cortical thinning in clinically normal elderly.16980251Rentz DM, Sardinha LM, Huh TJ, Searl MM, Daffner KR, Sperling RAThe Clinical neuropsychologistIQ-based norms for highly intelligent adults. Clin Neuropsychol. 2006 Dec; 20(4):637-48.Clin Neuropsychol2006-12-01T00:00:002006IQ-based norms for highly intelligent adults.Authorship 985180828558094Sepulcre J, Grothe MJ, Sabuncu M, Chhatwal J, Schultz AP, Hanseeuw B, El Fakhri G, Sperling R, Johnson KAJAMA neurologyHierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex. JAMA Neurol. 2017 07 01; 74(7):813-820.JAMA Neurol2017-07-01T00:00:002017Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.Authorship 9867681128592457Buckley RF, Schultz AP, Hedden T, Papp KV, Hanseeuw BJ, Marshall G, Sepulcre J, Smith EE, Rentz DM, Johnson KA, Sperling RA, Chhatwal JPNeurologyFunctional network integrity presages cognitive decline in preclinical Alzheimer disease. Neurology. 2017 Jul 04; 89(1):29-37.Neurology2017-06-07T00:00:002017Functional network integrity presages cognitive decline in preclinical Alzheimer disease.28472627Dekhtyar M, Papp KV, Buckley R, Jacobs HIL, Schultz AP, Johnson KA, Sperling RA, Rentz DMNeuropsychologiaNeuroimaging markers associated with maintenance of optimal memory performance in late-life. Neuropsychologia. 2017 06; 100:164-170.Neuropsychologia2017-05-01T00:00:002017Neuroimaging markers associated with maintenance of optimal memory performance in late-life.14744186Rentz DM, Huh TJ, Faust RR, Budson AE, Scinto LF, Sperling RA, Daffner KRNeuropsychologyUse of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology. 2004 Jan; 18(1):38-49.Neuropsychology2004-01-01T00:00:002004Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals.Authorship 9891399Authorship 9900872Authorship 99016125694918Schumer W, Sperling RJAMAShock and its effect on the cell. JAMA. 1968 Jul 22; 205(4):215-9.JAMA1968-07-22T00:00:001968Shock and its effect on the cell.28616381Vannini P, Hanseeuw B, Munro CE, Amariglio RE, Marshall GA, Rentz DM, Pascual-Leone A, Johnson KA, Sperling RANeuroImage. ClinicalAnosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. Neuroimage Clin. 2017; 15:408-414.Neuroimage Clin2017-05-25T00:00:002017Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.28609533Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PSJAMAAssociation Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons. JAMA. 2017 06 13; 317(22):2305-2316.JAMA2017-06-13T00:00:002017Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.11402113Johnson KA, Lopera F, Jones K, Becker A, Sperling R, Hilson J, Londono J, Siegert I, Arcos M, Moreno S, Madrigal L, Ossa J, Pineda N, Ardila A, Roselli M, Albert MS, Kosik KS, Rios ANeurologyPresenilin-1-associated abnormalities in regional cerebral perfusion. Neurology. 2001 Jun 12; 56(11):1545-51.Neurology2001-06-12T00:00:002001Presenilin-1-associated abnormalities in regional cerebral perfusion.23152607Hedden T, Mormino EC, Amariglio RE, Younger AP, Schultz AP, Becker JA, Buckner RL, Johnson KA, Sperling RA, Rentz DMThe Journal of neuroscience : the official journal of the Society for NeuroscienceCognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci. 2012 Nov 14; 32(46):16233-42.J Neurosci2012-11-14T00:00:002012Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Authorship 99408411Authorship 996389528697559Gatchel JR, Donovan NJ, Locascio JJ, Schultz AP, Becker JA, Chhatwal J, Papp KV, Amariglio RE, Rentz DM, Blacker D, Sperling RA, Johnson KA, Marshall GAJournal of Alzheimer's disease : JADDepressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study. J Alzheimers Dis. 2017; 59(3):975-985.J Alzheimers Dis2017-01-01T00:00:002017Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study.28545932LaPoint MR, Chhatwal JP, Sepulcre J, Johnson KA, Sperling RA, Schultz APNeuroImageThe association between tau PET and retrospective cortical thinning in clinically normal elderly. Neuroimage. 2017 08 15; 157:612-622.Neuroimage2017-05-22T00:00:002017The association between tau PET and retrospective cortical thinning in clinically normal elderly.Authorship 998464719328456Carrillo MC, Blackwell A, Hampel H, Lindborg J, Sperling R, Schenk D, Sevigny JJ, Ferris S, Bennett DA, Craft S, Hsu T, Klunk WAlzheimer's & dementia : the journal of the Alzheimer's AssociationEarly risk assessment for Alzheimer's disease. Alzheimers Dement. 2009 Mar; 5(2):182-96.Alzheimers Dement2009-03-01T00:00:002009Early risk assessment for Alzheimer's disease.8565434Sandson TA, Sperling RA, Price BHComprehensive therapyAlzheimer's disease: an update. Compr Ther. 1995 Sep; 21(9):480-5.Compr Ther1995-09-01T00:00:001995Alzheimer's disease: an update.22218879Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, Morris JC, Nordberg A, Petersen RC, Reiman EM, Selkoe DJ, Sperling RA, Van Laere K, Weiner MW, Drzezga AEuropean journal of nuclear medicine and molecular imagingAß Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2012 Feb; 39(2):209-19.Eur J Nucl Med Mol Imaging2012-02-01T00:00:002012Aß Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.19812343Hedden T, Van Dijk KR, Becker JA, Mehta A, Sperling RA, Johnson KA, Buckner RLThe Journal of neuroscience : the official journal of the Society for NeuroscienceDisruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci. 2009 Oct 07; 29(40):12686-94.J Neurosci2009-10-07T00:00:002009Disruption of functional connectivity in clinically normal older adults harboring amyloid burden.21825241Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, Fischl BArchives of neurologyThe dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol. 2011 Aug; 68(8):1040-8.Arch Neurol2011-08-01T00:00:002011The dynamics of cortical and hippocampal atrophy in Alzheimer disease.20087893Wang L, Negreira A, LaViolette P, Bakkour A, Sperling RA, Dickerson BCHippocampusIntrinsic interhemispheric hippocampal functional connectivity predicts individual differences in memory performance ability. Hippocampus. 2010 Mar; 20(3):345-51.Hippocampus2010-03-01T00:00:002010Intrinsic interhemispheric hippocampal functional connectivity predicts individual differences in memory performance ability.22190237Holtzman DM, Goate A, Kelly J, Sperling RScience translational medicineMapping the road forward in Alzheimer's disease. Sci Transl Med. 2011 Dec 21; 3(114):114ps48.Sci Transl Med2011-12-21T00:00:002011Mapping the road forward in Alzheimer's disease.Authorship 10069535Authorship 100539917Authorship 10060101228459045Cummings J, Aisen P, Barton R, Bork J, Doody R, Dwyer J, Egan JC, Feldman H, Lappin D, Truyen L, Salloway S, Sperling R, Vradenburg GThe journal of prevention of Alzheimer's diseaseRe-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network. J Prev Alzheimers Dis. 2016 Jun; 3(2):114-120.J Prev Alzheimers Dis2016-03-04T00:00:002016Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network.28793924Aisen PS, Cummings J, Jack CR, Morris JC, Sperling R, Frölich L, Jones RW, Dowsett SA, Matthews BR, Raskin J, Scheltens P, Dubois BAlzheimer's research & therapyOn the path to 2025: understanding the Alzheimer's disease continuum. Alzheimers Res Ther. 2017 Aug 09; 9(1):60.Alzheimers Res Ther2017-08-09T00:00:002017On the path to 2025: understanding the Alzheimer's disease continuum.28738187Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway SP, Correia S, Sperling RA, Chhatwal JP, Mayeux RP, Brickman AM, Martins RN, Farlow MR, Ghetti B, Saykin AJ, Jack CR, Schofield PR, McDade E, Weiner MW, Ringman JM, Thompson PM, Masters CL, Rowe CC, Rossor MN, Ourselin S, Fox NCAlzheimer's & dementia : the journal of the Alzheimer's AssociationPresymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement. 2018 01; 14(1):43-53.Alzheimers Dement2017-07-22T00:00:002017Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study.19847046Dickerson BC, Sperling RABehavioural neurologyLarge-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. Behav Neurol. 2009; 21(1):63-75.Behav Neurol2009-01-01T00:00:002009Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging.20188183Wang L, Laviolette P, O'Keefe K, Putcha D, Bakkour A, Van Dijk KR, Pihlajamäki M, Dickerson BC, Sperling RANeuroImageIntrinsic connectivity between the hippocampus and posteromedial cortex predicts memory performance in cognitively intact older individuals. Neuroimage. 2010 Jun; 51(2):910-7.Neuroimage2010-02-24T00:00:002010Intrinsic connectivity between the hippocampus and posteromedial cortex predicts memory performance in cognitively intact older individuals.20373347Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, Sperling RA, Johnson KAAnnals of neurologyCognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010 Mar; 67(3):353-64.Ann Neurol2010-03-01T00:00:002010Cognition, reserve, and amyloid deposition in normal aging.2024-04-30AISEN, PAUL S. ;CUMMINGS, JEFFREY L.;SPERLING, REISA A.2017-05-01Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's DiseaseR01AG053798Co-Principal InvestigatorAuthorship 10087031428878053Norton DJ, Amariglio R, Protas H, Chen K, Aguirre-Acevedo DC, Pulsifer B, Castrillon G, Tirado V, Munoz C, Tariot P, Langbaum JB, Reiman EM, Lopera F, Sperling RA, Quiroz YTNeurologySubjective memory complaints in preclinical autosomal dominant Alzheimer disease. Neurology. 2017 Oct 03; 89(14):1464-1470.Neurology2017-09-06T00:00:002017Subjective memory complaints in preclinical autosomal dominant Alzheimer disease.15897955Dickerson BC, Sperling RANeuroRx : the journal of the American Society for Experimental NeuroTherapeuticsNeuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx. 2005 Apr; 2(2):348-60.NeuroRx2005-04-01T00:00:002005Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.19847047Pihlajamäki M, Sperling RABehavioural neurologyFunctional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals. Behav Neurol. 2009; 21(1):77-91.Behav Neurol2009-01-01T00:00:002009Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals.Authorship 101708522Authorship 10165211028450713Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, Quaid KA, Salloway S, Xiong C, Benzinger T, Buckles V, Masters CL, Sperling R, Bateman RJ, Morris JC, Laske CScientific reportsDecreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Sci Rep. 2017 04 27; 7(1):1225.Sci Rep2017-04-27T00:00:002017Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease.28973551Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, Jackson JD, Mormino EC, Rentz DM, Sperling RA, Johnson KA, Amariglio REJAMA neurologyRegion-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global ß-Amyloid Burden. JAMA Neurol. 2017 12 01; 74(12):1455-1463.JAMA Neurol2017-12-01T00:00:002017Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global ß-Amyloid Burden.16298252Rand-Giovannetti E, Chua EF, Driscoll AE, Schacter DL, Albert MS, Sperling RANeurobiology of agingHippocampal and neocortical activation during repetitive encoding in older persons. Neurobiol Aging. 2006 Jan; 27(1):173-82.Neurobiol Aging2005-03-31T00:00:002005Hippocampal and neocortical activation during repetitive encoding in older persons.12486265Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MSJournal of neurology, neurosurgery, and psychiatryfMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Jan; 74(1):44-50.J Neurol Neurosurg Psychiatry2003-01-01T00:00:002003fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease.15453969Chua EF, Rand-Giovannetti E, Schacter DL, Albert MS, Sperling RAJournal of cognitive neuroscienceDissociating confidence and accuracy: functional magnetic resonance imaging shows origins of the subjective memory experience. J Cogn Neurosci. 2004 Sep; 16(7):1131-42.J Cogn Neurosci2004-09-01T00:00:002004Dissociating confidence and accuracy: functional magnetic resonance imaging shows origins of the subjective memory experience.Authorship 1017752829036824Dumurgier J, Hanseeuw BJ, Hatling FB, Judge KA, Schultz AP, Chhatwal JP, Blacker D, Sperling RA, Johnson KA, Hyman BT, Gómez-Isla TJournal of Alzheimer's disease : JADAlzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. J Alzheimers Dis. 2017; 60(4):1451-1459.J Alzheimers Dis2017-01-01T00:00:002017Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.16303318Chua EF, Schacter DL, Rand-Giovannetti E, Sperling RANeuroImageUnderstanding metamemory: neural correlates of the cognitive process and subjective level of confidence in recognition memory. Neuroimage. 2006 Feb 15; 29(4):1150-60.Neuroimage2005-11-21T00:00:002005Understanding metamemory: neural correlates of the cognitive process and subjective level of confidence in recognition memory.17021177Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RAThe Journal of neuroscience : the official journal of the Society for NeuroscienceAlterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci. 2006 Oct 04; 26(40):10222-31.J Neurosci2006-10-04T00:00:002006Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.20548049Laskowitz DT, Kolls BJNeurologyA phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology. 2010 Jun 15; 74(24):2026; author reply 2026-7.Neurology2010-06-15T00:00:002010A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.Authorship 1023290629088363Jackson JD, Rentz DM, Aghjayan SL, Buckley RF, Meneide TF, Sperling RA, Amariglio REAge and ageingSubjective cognitive concerns are associated with objective memory performance in Caucasian but not African-American persons. Age Ageing. 2017 11 01; 46(6):988-993.Age Ageing2017-11-01T00:00:002017Subjective cognitive concerns are associated with objective memory performance in Caucasian but not African-American persons.Authorship 1024897829124043Marshall GA, Aghjayan SL, Dekhtyar M, Locascio JJ, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DMThe journal of prevention of Alzheimer's diseaseActivities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly. J Prev Alzheimers Dis. 2017; 4(2):81-86.J Prev Alzheimers Dis2017-01-01T00:00:002017Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly.10634454Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, Walsh KL, Corwin C, Daffner KR, Friedman P, Meadows ME, Sperling RA, Growdon JHArchives of neurologyDonepezil therapy in clinical practice: a randomized crossover study. Arch Neurol. 2000 Jan; 57(1):94-9.Arch Neurol2000-01-01T00:00:002000Donepezil therapy in clinical practice: a randomized crossover study.11176944Sperling RA, Guttmann CR, Hohol MJ, Warfield SK, Jakab M, Parente M, Diamond EL, Daffner KR, Olek MJ, Orav EJ, Kikinis R, Jolesz FA, Weiner HLArchives of neurologyRegional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol. 2001 Jan; 58(1):115-21.Arch Neurol2001-01-01T00:00:002001Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.18056553Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker DArchives of general psychiatryClinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry. 2007 Dec; 64(12):1443-50.Arch Gen Psychiatry2007-12-01T00:00:002007Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.29159051d'Oleire Uquillas F, Jacobs HIL, Hanseeuw B, Marshall GA, Properzi M, Schultz AP, LaPoint MR, Johnson KA, Sperling RA, Vannini PNeuroImage. ClinicalInteractive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals. Neuroimage Clin. 2018; 17:388-396.Neuroimage Clin2017-10-31T00:00:002017Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.Authorship 1027817920463288O'Brien JL, O'Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, Sperling RANeurologyLongitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010 Jun 15; 74(24):1969-76.Neurology2010-05-12T00:00:002010Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline.Authorship 103025420Authorship 10295447Authorship 10292541229186281Aisen P, Touchon J, Amariglio R, Andrieu S, Bateman R, Breitner J, Donohue M, Dunn B, Doody R, Fox N, Gauthier S, Grundman M, Hendrix S, Ho C, Isaac M, Raman R, Rosenberg P, Schindler R, Schneider L, Sperling R, Tariot P, Welsh-Bohmer K, Weiner M, Vellas BThe journal of prevention of Alzheimer's diseaseEU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials. J Prev Alzheimers Dis. 2017; 4(2):116-124.J Prev Alzheimers Dis2017-01-01T00:00:002017EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.29188862Touchon J, Rosenbaum J, Aisen P, Andrieu S, Carrillo MC, Ceccaldi M, Dartiques JF, Feldman H, Gabelle A, Isaac M, Fitten LJ, Sperling RA, Vellas B, Tariot P, Weiner MThe journal of nutrition, health & agingEditorial: Collaborative Efforts to Prevent Alzheimer's Disease. J Nutr Health Aging. 2017; 21(10):1072-1074.J Nutr Health Aging2017-01-01T00:00:002017Editorial: Collaborative Efforts to Prevent Alzheimer's Disease.29188853Buckley RF, Sparks KP, Papp KV, Dekhtyar M, Martin C, Burnham S, Sperling RA, Rentz DMThe journal of prevention of Alzheimer's diseaseComputerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries. J Prev Alzheimers Dis. 2017; 4(1):3-11.J Prev Alzheimers Dis2017-01-01T00:00:002017Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries.17604351Chua EF, Schacter DL, Rand-Giovannetti E, Sperling RAHippocampusEvidence for a specific role of the anterior hippocampal region in successful associative encoding. Hippocampus. 2007; 17(11):1071-80.Hippocampus2007-01-01T00:00:002007Evidence for a specific role of the anterior hippocampal region in successful associative encoding.2023-06-30AISEN, PAUL S. ;PETERSEN, RONALD C;SPERLING, REISA A.2017-12-02Alzheimer's Clinical Trials Consortium (ACTC)U24AG057437Co-Principal Investigator23375565Yang T, Hong S, O'Malley T, Sperling RA, Walsh DM, Selkoe DJAlzheimer's & dementia : the journal of the Alzheimer's AssociationNew ELISAs with high specificity for soluble oligomers of amyloid ß-protein detect natural Aß oligomers in human brain but not CSF. Alzheimers Dement. 2013 Mar; 9(2):99-112.Alzheimers Dement2013-01-30T00:00:002013New ELISAs with high specificity for soluble oligomers of amyloid ß-protein detect natural Aß oligomers in human brain but not CSF.22890098Chhatwal JP, Sperling RAJournal of Alzheimer's disease : JADFunctional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis. 2012; 31 Suppl 3:S155-67.J Alzheimers Dis2012-01-01T00:00:002012Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease.Authorship 10329901Authorship 10313234Authorship 103460520Authorship 10343891529199318Sperling R, Cummings J, Donohue M, Aisen PThe journal of prevention of Alzheimer's diseaseGlobal Alzheimer's Platform Trial Ready Cohorts for the Prevention of Alzheimer's Dementia. J Prev Alzheimers Dis. 2016; 3(4):185-187.J Prev Alzheimers Dis2016-01-01T00:00:002016Global Alzheimer's Platform Trial Ready Cohorts for the Prevention of Alzheimer's Dementia.29264389Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino ECAlzheimer's & dementia (New York, N. Y.)Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5. Alzheimers Dement (N Y). 2017 Nov; 3(4):668-677.Alzheimers Dement (N Y)2017-11-10T00:00:002017Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5.29255837Vellas B, Sampaio C, Bateman R, Boxer A, Carrillo MC, Cummings J, Dubois B, Hampel H, Katz R, Khachaturian Z, Gauthier S, Johnson K, Karlawish J, Mintun M, Petersen R, Rafii M, Robert P, Schneider LS, Siemers E, Sperling R, Tariot P, Touchon J, Weiner M, Andrieu S, Aisen PThe journal of prevention of Alzheimer's diseaseEU./U.S. CTAD Task Force on Alzheimer's Trial Populations. J Prev Alzheimers Dis. 2014; 1(2):110-116.J Prev Alzheimers Dis2014-01-01T00:00:002014EU./U.S. CTAD Task Force on Alzheimer's Trial Populations.29210442Aisen P, Touchon J, Andrieu S, Boada M, Doody R, Nosheny RL, Langbaum JB, Schneider L, Hendrix S, Wilcock G, Molinuevo JL, Ritchie C, Ousset PJ, Cummings J, Sperling R, DeKosky ST, Lovestone S, Hampel H, Petersen R, Legrand V, Egan M, Randolph C, Salloway S, Weiner M, Vellas BThe journal of prevention of Alzheimer's diseaseRegistries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis. 2016; 3(2):68-74.J Prev Alzheimers Dis2016-01-01T00:00:002016Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.21951985Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker DThe Journal of clinical psychiatryAlzheimer's disease: implications of the updated diagnostic and research criteria. J Clin Psychiatry. 2011 Sep; 72(9):1190-6.J Clin Psychiatry2011-09-01T00:00:002011Alzheimer's disease: implications of the updated diagnostic and research criteria.18238903Miller SL, Celone K, DePeau K, Diamond E, Dickerson BC, Rentz D, Pihlajamäki M, Sperling RAProceedings of the National Academy of Sciences of the United States of AmericaAge-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci U S A. 2008 Feb 12; 105(6):2181-6.Proc Natl Acad Sci U S A2008-01-31T00:00:002008Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation.18378553Pihlajamäki M, DePeau KM, Blacker D, Sperling RAThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric PsychiatryImpaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. Am J Geriatr Psychiatry. 2008 Apr; 16(4):283-92.Am J Geriatr Psychiatry2008-04-01T00:00:002008Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease.19923550Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman MNeurologyA phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology. 2009 Dec 15; 73(24):2061-70.Neurology2009-11-18T00:00:002009A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.21490323Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell LNeurologyAlzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology. 2011 Apr 19; 76(16):1395-402.Neurology2011-04-13T00:00:002011Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.Authorship 1037140829325447Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RAThe American journal of psychiatryLongitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. Am J Psychiatry. 2018 06 01; 175(6):530-537.Am J Psychiatry2018-01-12T00:00:002018Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults.20363808Vannini P, O'Brien J, O'Keefe K, Pihlajamäki M, Laviolette P, Sperling RACerebral cortex (New York, N.Y. : 1991)What goes down must come up: role of the posteromedial cortices in encoding and retrieval. Cereb Cortex. 2011 Jan; 21(1):22-34.Cereb Cortex2010-04-02T00:00:002010What goes down must come up: role of the posteromedial cortices in encoding and retrieval.21765181Hedden T, Van Dijk KR, Shire EH, Sperling RA, Johnson KA, Buckner RLCerebral cortex (New York, N.Y. : 1991)Failure to modulate attentional control in advanced aging linked to white matter pathology. Cereb Cortex. 2012 May; 22(5):1038-51.Cereb Cortex2011-07-17T00:00:002011Failure to modulate attentional control in advanced aging linked to white matter pathology.2247106Israel E, Dermarkarian R, Rosenberg M, Sperling R, Taylor G, Rubin P, Drazen JMThe New England journal of medicineThe effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med. 1990 Dec 20; 323(25):1740-4.N Engl J Med1990-12-20T00:00:001990The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air.7771339Drazen JM, Lilly CM, Sperling R, Rubin P, Israel EAdvances in prostaglandin, thromboxane, and leukotriene researchRole of cysteinyl leukotrienes in spontaneous asthmatic responses. Adv Prostaglandin Thromboxane Leukot Res. 1994; 22:251-62.Adv Prostaglandin Thromboxane Leukot Res1994-01-01T00:00:001994Role of cysteinyl leukotrienes in spontaneous asthmatic responses.29403032Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KANature neuroscienceStructural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci. 2018 03; 21(3):424-431.Nat Neurosci2018-02-05T00:00:002018Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals.22976236Desikan RS, McEvoy LK, Holland D, Thompson WK, Brewer JB, Aisen PS, Andreassen OA, Hyman BT, Sperling RA, Dale AMAJNR. American journal of neuroradiologyApolipoprotein E epsilon4 does not modulate amyloid-ß-associated neurodegeneration in preclinical Alzheimer disease. AJNR Am J Neuroradiol. 2013 Mar; 34(3):505-10.AJNR Am J Neuroradiol2012-09-13T00:00:002012Apolipoprotein E epsilon4 does not modulate amyloid-ß-associated neurodegeneration in preclinical Alzheimer disease.Authorship 104324292012627Weinblatt M, Helfgott S, Coblyn J, Spragg J, Uedelhoven WM, Tumeh S, Sperling R, Lorenz R, Maier A, Weber PArthritis and rheumatismThe effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis. Arthritis Rheum. 1991 Apr; 34(4):481-5.Arthritis Rheum1991-04-01T00:00:001991The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis.22586140Vannini P, Hedden T, Huijbers W, Ward A, Johnson KA, Sperling RACerebral cortex (New York, N.Y. : 1991)The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults. Cereb Cortex. 2013 Jun; 23(6):1317-28.Cereb Cortex2012-05-14T00:00:002012The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults.22765048Amariglio RE, Frishe K, Olson LE, Wadsworth LP, Lorius N, Sperling RA, Rentz DMJournal of clinical and experimental neuropsychologyValidation of the Face Name Associative Memory Exam in cognitively normal older individuals. J Clin Exp Neuropsychol. 2012; 34(6):580-7.J Clin Exp Neuropsychol2012-03-09T00:00:002012Validation of the Face Name Associative Memory Exam in cognitively normal older individuals.9427889Martin R, Boyer P, Hammill H, Peavy H, Platzker A, Settlage R, Shah A, Sperling R, Tuomala R, Wu MThe Journal of pediatricsIncidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group. J Pediatr. 1997 Dec; 131(6):851-6.J Pediatr1997-12-01T00:00:001997Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group.